Společnost SAIC dokončila akvizici Information Security Corporation, čímž rozšířila své schopnosti v oblasti zero-trust, postkvantové kryptografie a šifrování. Finanční podmínky transakce nebyly zveřejněny.
RESTON, Va., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC), a leading mission integrator supporting defense, space, intelligence, and civilian agencies, today announced it has completed the acquisition of Information Security Corporation (ISC).
For more than three decades, ISC has delivered public key infrastructure (PKI), encryption, and credential management software to some of the most security-conscious organizations in government and industry, providing the critical cryptographic building blocks for confidentiality, integrity, and availability of sensitive data. Engineered with a forward-looking focus on automation and crypto-agility, ISC’s product suite helps customers modernize their cryptographic infrastructure and transition to post-quantum cryptography. The suite spans PKI and data protection solutions, including CertAgent, which has been on the National Security Agency’s Commercial Solutions for Classified (CSfC) Components List for more than a decade.
“This strategic tuck-in acquisition reflects our disciplined approach to investing in technology and capabilities that address the nation’s most critical challenges,” said Jim Reagan, Chief Executive Officer of SAIC. “Integrating ISC’s mission-proven cryptographic technologies with SAIC’s pedigree of delivering and operating robust zero-trust architectures, provides our intelligence and defense customers with the security and scalability to protect against rapidly evolving threats.”
“Joining SAIC marks an exciting new chapter for ISC and our employees,” said Jonathan Schulze-Hewett, Vice President of Development at ISC. “For more than three decades, our team has built innovative products to solve some of our customers’ most difficult security challenges. Joining SAIC gives us the opportunity to build on that work and bring ISC’s technology to more customers and more missions.”
ISC's technology is deeply embedded across the U.S. intelligence community and Department of War, supporting identity, authentication, and data protection in some of the government's most sensitive environments.
Financial terms were not disclosed. SAIC was supported by KPMG and ISC was advised by TideLock Partners.
About SAIC
SAIC® is a premier mission integrator focused on advancing the power of technology and innovation to serve and protect our world. Our robust portfolio of offerings across the defense, space, intelligence, and civilian markets includes secure high-end solutions in mission IT, enterprise IT, engineering services, and professional services. We integrate emerging technology, rapidly and securely, into mission critical operations that modernize and enable critical national imperatives.
We are approximately 23,000 strong; driven by mission, united by purpose, and inspired by opportunities. Headquartered in Reston, Virginia, SAIC has annual revenues of approximately $7.3 billion. For more information, visit saic.com. For ongoing news, please visit our newsroom.
Forward-Looking Statements
Certain statements in this release contain or are based on “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “guidance,” and similar words or phrases. Forward-looking statements in this release may include, among others, estimates of future revenues, operating income, earnings, earnings per share, charges, total contract value, backlog, outstanding shares and cash flows, as well as statements about future dividends, share repurchases and other capital deployment plans. Such statements are not guarantees of future performance and involve risk, uncertainties and assumptions, and actual results may differ materially from the guidance and other forward-looking statements made in this release as a result of various factors. Risks, uncertainties and assumptions that could cause or contribute to these material differences include those discussed in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Legal Proceedings” sections of our Annual Report on Form 10-K, as updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the SEC, which may be viewed or obtained through the Investor Relations section of our website at www.saic.com or on the SEC’s website at www.sec.gov. Due to such risks, uncertainties and assumptions you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. SAIC expressly disclaims any duty to update any forward-looking statement provided in this release to reflect subsequent events, actual results or changes in SAIC’s expectations. SAIC also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.
Four packaged food stocks sit on the same grocery shelves, but their dividends tell completely different stories about which companies are quietly rebuilding and which ones are still in danger of the next cut.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The center of the grocery store has been a hard place to own stocks. Conagra Brands (NYSE:CAG | CAG Price Prediction) has lost 48.84% of its value over five years, and General Mills (NYSE:GIS) and Campbell’s (NASDAQ:CPB) have also fallen hard. J.M. Smucker (NYSE:SJM) has gone the other way. All four sell off the same shelves, but each one leaves income investors with a very different dividend check and a very different level of safety.
General Mills: 127 Years of Payments and an Ultra-High Yield With a Catch General Mills yields about 7.6% on its $2.44 annualized dividend at a share price of $32.02. It qualifies as an ultra-high-yield stock, but consider where that yield came from. The quarterly payout has been $0.61 since 2025, while the shares are down 27.83% year to date and 35.86% over five years. When the price falls and the dividend stays the same, the yield rises on its own. In this case the high yield reflects doubt in the market, with the payout itself unchanged.
Its dividend history is strong. General Mills is in its 127th consecutive year of continuous dividends, and the quarterly rate went from $0.59 to $0.60 to $0.61 before leveling off. Coverage is lower. Against fiscal 2027 adjusted EPS guidance of $3.00 to $3.20, the dividend uses roughly 76% to 81% of earnings. Fiscal 2026 free cash flow was $1.63B. In the seasonally light first quarter, free cash flow came to $207.3 million, while dividends paid were $330.5M. Leverage is running “just a touch” above four times net debt to EBITDA, against a three-times target that management says will take “at least a couple years” to reach.
Bull case: The company’s pressures have names. Stretched shoppers are waiting for promotions, smaller insurgent brands are taking fruit snack share, and Wilderness dry dog food is shrinking. Management is responding with $750 million of fiscal 2027 cost savings, $3 billion in total by fiscal 2030, and new products that grew from 3% to 5% of net sales. Organic sales held flat last quarter, and adjusted EPS of $0.75 beat the $0.72 consensus.
Risk: Adjusted operating profit is guided down 8% to 13% in constant currency this fiscal year, which leaves very little room for the payout to grow.
Campbell’s: A 36% Dividend Cut That Rebuilds Coverage Campbell’s yields about 5.1% on its new $1 annualized dividend at $19.62. Trailing yield screens show a bigger number because they still include the old $0.39 checks. If you buy at today’s price, the reset rate is what you will collect. The shares are down 25.13% year to date and 41.77% over five years.
The board cut the quarterly payout to $0.25, a 36% reduction, to speed up debt reduction. Before that, the dividend rose in small steps: $0.35 from 2017, $0.37 from late 2021 and $0.39 from 2025. Coverage is now much better. The new rate uses about 56% to 61% of fiscal 2027 adjusted EPS guidance of $1.65 to $1.80. Fiscal 2026 free cash flow was $678 million, against $470 million of dividends at the old rate. The balance sheet is the pressure point: total liabilities are $11.49B against equity of $3.85B, and a $500 million bond comes due in March.
Chief executive Mick Beekhuizen called the cut “a difficult decision, but it’s an unfortunately necessary decision that we needed to take.”
Bull case: Rao’s, Goldfish, Pepperidge Farm and Swanson give Campbell’s real pricing power, and Meals & Beverages organic sales grew 3%. A new $500M cost-savings program runs through fiscal 2030, and the company plans price increases on roughly 60% of its portfolio.
Risk: Snacks are getting worse. Segment operating earnings fell 34% in the fourth quarter, and the company took $117M in impairments on its Cape Cod and Kettle Brand trademarks.
Conagra Brands: Half the Dividend, Full Focus on Debt Conagra yields about 5.2% on its $0.70 annualized payout at $13.36. Income investors should know that “held flat” describes a level that was already cut. The quarterly dividend dropped from $0.35 to $0.175, a 50% reduction, and the latest declaration kept it at that level. Trailing screens still show the old payments. The shares are down 18.46% year to date.
The lower rate is easy to cover. It uses about 47% to 50% of fiscal 2027 adjusted EPS guidance of $1.40 to $1.50. Fiscal 2026 free cash flow was $978.7 million, against $669.7 million of dividends at the old rate. First-quarter free cash flow was negative $127.9M because of legal payments and a seasonal inventory build. Leverage was 3.99 times, and management plans to pay down about $250 million of debt this year. The dividend history shows steady increases, from $0.2125 between 2018 and 2020 up to $0.35 from 2023, before the cut.
“Our target is three times,” CFO Dave Marberger said. “We are maniacally focused on getting there as soon as possible.”
Bull case: First-quarter adjusted EPS of $0.41 beat the $0.28 consensus, and Ardent Mills equity earnings rose 71.8%. Frozen volumes are falling, and higher gas prices are cutting into convenience-store snack traffic. Management is responding by trimming SKUs across a single-serve meal portfolio of more than 400 SKUs, dropping Celeste Pizza and raising marketing spend to 3% of net sales.
Risk: Costs are rising faster than planned. Cost of goods inflation is running near 7%, and transportation inflation is double the company’s original plan.
J.M. Smucker: Outlier in the Aisle With a Growing Payout Smucker yields about 3.8% on its $4.48 forward dividend at $117.21. Here the yield math runs in reverse. The stock is up 23.46% year to date, 13.15% over the past year and 16.46% over five years. A rising price has kept the yield modest even as the payout keeps growing.
This is the strongest dividend of the four. The quarterly rate rose from $1.10 to $1.12, and it has increased every year since 2017, when it was $0.75. The forward payout uses only about 41% to 43% of raised fiscal 2027 adjusted EPS guidance of $10.50 to $11.00. Full-year free cash flow guidance went up to about $1.1B, and first-quarter free cash flow alone was $337.3M. Smucker already reached its three-times leverage target in the quarter and plans to pay down roughly $500 million of debt. Management said, “We remain committed to the quarterly dividend, which we recently announced an increase.”
Bull case: Coffee has pricing power. U.S. Retail Coffee grew 13% to $807.8M, and Café Bustelo grew 23%. Uncrustables growth guidance was raised to high single digits, with new capacity coming online in McCalla, Alabama. Even after the rally, the stock trades at about 12 times forward earnings.
Risk: The headline beat had help. First-quarter adjusted EPS of $3.24 included a $0.84 per share benefit from one-time tariff refunds, and Hostess sales fell 7%.
Coverage and Debt Separate the Payouts That Hold The dividends in this group that can hold share three things: a payout well below earnings, free cash flow that grows, and leverage already near target. Smucker has all three. Campbell’s and Conagra cut their payouts to rebuild coverage. General Mills offers the highest yield of the group, but it also has the weakest earnings coverage, and its stock price has done the most to push that yield up. The same warning signs that preceded the Campbell’s and Conagra cuts tend to show up well before a board acts, and we catalogued them in a free guide to spotting dividend traps. In packaged food, the yields that held up came from companies that kept growing their cash flow.
Contact [email protected] for any questions or corrections.
BridgeBio uvedla, že BBP-418 ve studii FORTIFY v 12. měsíci normalizoval HS troponin I u 100 % léčených pacientů s LGMD2I/R9 oproti 40 % na placebu. Léčba také zlepšila nebo stabilizovala LVEF u 54 % pacientů versus 25 % na placebu.
- In exploratory analyses at Month 12, among individuals with LGMD2I/R9 (FKRP-related) with elevated HS troponin I at baseline, 100% treated with BBP-418 returned to the normal range by Month 12 versus 40% in the placebo arm (p=0.0248); HS troponin I, a blood marker of heart muscle injury, declined more with BBP-418 than placebo (LS mean difference -17.8 ng/L; 95% CI: -35.1 to -0.5; p=0.0443)
- 54% of BBP-418-treated individuals had stable or improved LVEF at Month 12 versus 25% in the placebo arm (p=0.0262)
- In data presented separately, BBP-418 treatment of LGMD2I/R9 in FORTIFY increased mean glycosylated αDG by Month 3 to the levels of asymptomatic heterozygous FKRP carriers, who do not exhibit disease; this result was sustained through Month 12
- Taken together, these findings support the potential of BBP-418 to act as a disease modifying therapy by addressing the condition at its source
- BBP-418 is under FDA Priority Review with a PDUFA target action date of November 27, 2026
PALO ALTO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a biopharmaceutical company focused on developing medicines for genetic conditions, today presented new exploratory cardiac data from the 12-month interim analysis of FORTIFY, the Phase 3 clinical trial of oral BBP-418 in individuals living with limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9) (FKRP-related). The data were presented in an oral presentation at the 31st annual Congress of the World Muscle Society in Hiroshima, Japan by Volker Straub, M.D., Ph.D. of Newcastle University, UK.
“Cardiac involvement is a major driver of morbidity and mortality in LGMD2I/R9, which is why it remains one of the greatest concerns for people living with the condition, families and treating physicians. Historically, we have been able to monitor the heart and manage complications, but we have not been able to address the underlying cause of the disease," said Dr. Straub. “What stands out in this analysis is how consistent it is: high-sensitivity troponin I fell and, in those who entered the study with elevated levels, it normalized; ejection fraction stabilized; and this happened alongside walking farther and breathing better. It’s encouraging to see that the therapeutic approach seems to work across the whole muscular system, including the heart.”
Cardiomyopathy affects approximately 30% of individuals with LGMD2I/R9 and approximately 60% of those with other FKRP genotypes, and is progressive, with an annual loss of approximately 0.4% of left ventricular ejection fraction (LVEF). In FORTIFY, 22.9% of participants (25/109) had elevated high-sensitivity (HS) troponin I at baseline and 17.1% (18/105) had an LVEF below 50%. Exploratory cardiac findings at Month 12 showed:
HS troponin I is a blood test used to detect injury to heart muscle. 100% of the participants treated with BBP-418 returned to the normal range for HS troponin l by Month 12 versus 40% in the placebo arm (p=0.0248); HS troponin I declined more with BBP-418 than placebo (LS mean difference -17.8 ng/L; 95% CI: -35.1 to -0.5; p=0.0443)At Month 12, 54% of participants treated with BBP-418 had stable or improved LVEF, a measurement of how much blood the heart's main chamber pushes out with each beat, compared with 25% of those on placebo (p=0.0262)Both HS troponin I and LVEF will continue to be monitored in the ongoing FORTIFY study
A consistent pattern across the FORTIFY interim analysis is the proportion of treated individuals reaching normal or near-normal levels on markers of the disease e.g., 38% of patients whose CK reached normal levels. In addition to the HS troponin I finding, in which 100% of evaluable BBP-418-treated participants with elevated levels at baseline returned to the normal range by Month 12, separate data presented at WMS 2026 by Anne Katrine Kjemsø Jensen, a medical student in the laboratory of John Vissing M.D., D.M.Sci., Copenhagen Neuromuscular Center of Rigshospitalet, DK, quantified αDG glycosylation in 34 asymptomatic heterozygous FKRP carriers. Results showed:
Asymptomatic carriers showed significantly reduced glycosylation versus healthy controls, thereby establishing a reference point for the level associated with normal muscle function (34% of control)In FORTIFY, BBP-418 treatment increased mean glycosylated αDG above carrier levels by Month 12, suggesting that BBP-418 can restore glycosylated αDG to asymptomatic levelsWhile many therapies in progressive neuromuscular disease aim to slow decline, BBP-418 was developed to target LGMD2I/R9 at its source, and the pattern of biomarker normalization observed to date, alongside functional improvement from baseline rather than stabilization, is consistent with the potential for BBP-418 to be a disease modifying therapy
In the Phase 3 FORTIFY trial, BBP-418 met all primary and secondary endpoints at the pre-specified 12-month interim analysis, showing treated individuals improving while placebo recipients declined across every key measure. These results were presented as a late-breaking oral presentation at the 2026 MDA Clinical and Scientific Conference, which are available here.
BridgeBio believes BBP-418 is positioned to become the first and only approved therapy for individuals living with LGMD2I/R9, addressing a significant unmet need in this disease and potentially representing the first approval of a therapy for any form of LGMD. Approximately 7,000 individuals currently live with LGMD2I/R9 and other addressable α-dystroglycanopathies in the U.S. and Europe. BBP-418 is under FDA Priority Review with a PDUFA target action date of November 27, 2026. The Company is also engaging regulatory agencies to identify an expedited path to approval for BBP-418 in Europe.
BBP-418 has previously received Orphan Drug, Fast Track, and Rare Pediatric Disease Designations from the FDA and Orphan Drug Designation from the European Medicines Agency (EMA). BBP-418 received Priority Review from the FDA, highlighting the potential for BBP-418 to address unmet need in LGMD2I/R9. Consistent with Rare Pediatric Designation from the FDA, if BBP-418 is approved, BridgeBio may qualify for a Priority Review Voucher. The Company intends to initiate clinical studies of BBP-418 in LGMD2I/R9 for individuals less than 12 years of age in the first half of 2027 and in LGMD2M/R13 and LGMD2U/R20 in the near future.
About Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)
LGMD2I/R9 is a monogenic autosomal recessive disease caused by partial loss of function mutations in the fukutin-related protein (FKRP) gene, and FKRP mutations impair glycosylation of alpha-dystroglycan (αDG), a protein associated with stabilizing muscle cells. Clinical manifestations typically present as a skeletal myopathy affecting the lower and then upper limbs, which is commonly later accompanied by pulmonary muscle and cardiac muscle involvement. Individuals who harbor a homozygous L276I genotype typically develop disease manifestations during late childhood with progression to loss of independent ambulation (25%), assisted ventilation (10%), and cardiomyopathy (30%) in adulthood. Cardiomyopathy is progressive, with an annual loss of 0.4% of left ventricular ejection fraction (LVEF). Individuals with other FKRP genotypes typically have an earlier childhood onset with a more severe clinical course, rapid loss of mobility by 20 years of age, more frequent cardiac involvement (60%), and eventual pulmonary decline by 30 years of age in nearly all cases.
About BBP-418
BBP-418 is an investigational oral glycosylation substrate therapy with potential to be the first and only therapy for LGMD2I/R9. BBP-418 is designed to saturate the partially functional FKRP enzyme with substrate thereby enhancing residual FKRP function and restoring glycosylation of αDG. Through restoration of αDG glycosylation, BBP-418 may stabilize or improve muscle function, including gross motor, ambulatory, and cardiopulmonary function.
About BridgeBio
BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke model is designed for speed, precision, and scalability. Autonomous and empowered teams focus on individual conditions, while a central hub provides the clinical, regulatory, and commercial capabilities needed to bring innovation to market. For more information, visit bridgebio.com and follow us on LinkedIn, X, Facebook, Instagram, YouTube, and TikTok.
BridgeBio Forward-Looking Statements
This press release contains forward-looking statements. Statements in this press release may include statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), which are usually identified by the use of words such as “anticipates,” “believes,” “continues,” “estimates,” “expects,” “hopes,” “intends,” “may,” “plans,” “projects,” “remains,” “seeks,” “should,” “will,” and variations of such words or similar expressions. BridgeBio intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements include statements regarding the potential clinical significance and therapeutic implications of data regarding BBP-418, including the potential for BBP-418 to act as a disease-modifying therapy for LGMD2I/R9, restore or normalize disease biomarkers, and stabilize or improve cardiac, gross motor, ambulatory and pulmonary function; the potential for BBP-418 to become the first and only approved therapy for individuals living with LGMD2I/R9 and potentially the first approved therapy for any form of LGMD; the timing and likelihood of potential regulatory approval and commercialization of BBP-418, including the PDUFA target action date of November 27, 2026; BridgeBio’s interactions with regulatory authorities regarding a potential expedited path to approval for BBP-418 in Europe; BridgeBio’s potential eligibility to receive a Priority Review Voucher if BBP-418 is approved; the continued evaluation of cardiac and other clinical measures in the ongoing FORTIFY study; and BridgeBio’s plans to initiate additional clinical studies of BBP-418, including in individuals with LGMD2I/R9 less than 12 years of age and in individuals with LGMD2M/R13 and LGMD2U/R20. Although the Company believes that its plans, intentions, expectations and strategies as reflected in or suggested by those forward-looking statements are reasonable, the Company can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a number of risks, uncertainties and assumptions, including, but not limited to, initial and ongoing data from the Company’s preclinical studies and clinical trials not being indicative of final data; the exploratory and non-alpha-controlled nature of certain analyses described in this press release and the small sample sizes on which certain of those analyses are based; that observed biomarker changes, including normalization of HS troponin I, glycosylated αDG or other disease markers, may not be replicated in additional analyses or studies or predict or translate into long-term clinical benefit, sustained improvement in cardiac or other muscle function, or prevention of disease progression; that BBP-418 may not demonstrate the anticipated efficacy, safety, therapeutic benefit or disease-modifying potential in ongoing or future clinical studies; that the design, enrollment, conduct, timing and success of ongoing and planned clinical trials may differ from current expectations; that the FDA or other regulatory authorities may not approve BBP-418 on the anticipated timeline or at all, may not agree with BridgeBio’s regulatory approval strategies, clinical trial designs, conduct or methodologies, or the sufficiency of data submitted, or may require additional data, studies or other information; that BBP-418 may not become the first and only approved therapy for LGMD2I/R9 or the first approved therapy for any form of LGMD; that BridgeBio may not identify or obtain an expedited path to approval for BBP-418 in Europe; that BridgeBio may not qualify for or receive a Priority Review Voucher; that plans to initiate additional clinical studies, including studies in individuals less than 12 years of age or in other forms of LGMD, may be delayed, modified or may not occur as expected; the potential size of the target patient populations BBP-418 is designed to treat not being as large as anticipated; the impacts of current macroeconomic and geopolitical events, including changing conditions from hostilities in Ukraine and the Middle East, increasing rates of inflation and changing interest rates, on business operations and expectations, as well as those risks set forth in the Risk Factors section of the Company’s most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K and the Company’s other filings with the U.S. Securities and Exchange Commission. Moreover, the Company operates in a very competitive and rapidly changing environment in which new risks emerge from time to time. These forward-looking statements are based upon the current expectations and beliefs of the Company’s management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by applicable law, BridgeBio assumes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
SEATTLE and WASHINGTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sabey Corporation ("Sabey") and National Real Estate Advisors, LLC ("National") today announced that Ares Secondaries funds (“Ares”) have expanded their investment in Sabey Data Center Properties, LLC ("SDCP"), an owner, developer, and operator of data centers across the United States. The additional commitment builds on Ares' minority equity investment in SDCP announced in July 2026, bringing its total investment to more than $500 million.
SDCP is a fully integrated data center platform that owns and operates hyperscale and enterprise data center campuses located in top-tier United States data center markets totaling 275 megawatts (MW), with an expansion pipeline expected to reach approximately 737 MW by 2033.
"This follow-on investment reflects continued conviction in SDCP's long-term value proposition and growth trajectory," said Kevin Verdi, Executive Vice President & Chief Investment Officer at National Real Estate Advisors. "We remain focused on disciplined growth and delivering the digital infrastructure needed to support the next generation of cloud and AI demand."
"We are pleased to deepen our relationship with Ares as we continue executing on our long-term growth strategy,” Tim Mirick, President of Sabey Data Center Properties, added. “This additional commitment reflects confidence in the strength of our platform and our ability to develop and operate the mission-critical infrastructure our customers rely on."
“We are pleased to expand our investment in SDCP and build on our relationship with the Sabey and National teams as we continue to see significant runway for growth,” said Jamie Sunday, Co-Head of Real Estate Secondaries at Ares.
The additional investment further aligns three long-term partners committed to supporting SDCP's continued growth and expanding the platform's ability to serve customers across an increasingly data-driven economy.
To learn more about Sabey Corporation, visit https://sabey.com/.
To learn more about SDCP, visit: https://sabeydatacenters.com.
About Sabey Data Center Properties (SDCP)
With a portfolio of more than four million square feet of mission-critical space, Sabey Data Centers is one of the largest privately owned multi-tenant data center owners/developers/operators in the United States. Sabey specializes in scalable, custom-built data center solutions recognized for their efficiency, low total cost of ownership, operational maturity and sustained uptime. Sabey provides sustainable data center services to many of the world's top financial, technology and healthcare companies. The company is a joint venture between Sabey Corporation and National Real Estate Advisors, LLC, acting as the investment manager on behalf of its institutional clients.
To learn more about Sabey Data Centers, please visit sabeydatacenters.com.
About Sabey Corporation
Sabey is a privately held commercial real estate development and investment company established in 1971 specializing in data center, medical and life sciences, education, government and military properties. Headquartered in Tukwila, Sabey employs more than 270 people.
About National Real Estate Advisors, LLC
National Real Estate Advisors, LLC ("National") is an investment manager developing, operating, and managing commercial real estate and infrastructure projects across the United States.
Since 2000, National has built diversified investment portfolios currently concentrated primarily in multifamily, data centers, healthcare-related, and mixed-use facilities. The firm manages separate accounts and commingled investment vehicles on behalf of investors, applying a disciplined investment process and development-led approach to value creation.
National is an independently operated subsidiary of the National Electrical Benefit Fund ("NEBF"), a pension trust with assets that are managed by National on a discretionary basis. For more information, please visit www.natadvisors.com.
About Ares Management Corporation
Ares Management Corporation (NYSE: ARES) is a leading global alternative investment manager offering clients complementary primary and secondary investment solutions across the credit, real estate, private equity and infrastructure asset classes. We seek to advance our stakeholders' long-term goals by providing flexible capital that supports businesses and creates value for our investors and within our communities. By collaborating across our investment groups, we aim to generate consistent and attractive investment returns throughout market cycles. As of June 30, 2026, Ares Management Corporation's global platform had over $671 billion of assets under management, with operations across North America, South America, Europe, Asia Pacific and the Middle East. For more information, please visit www.ares.com.
C.H. Robinson koupí RXO v hotovostně-akciové transakci za implikovanou hodnotu 5,8 mld. USD. Spojená společnost čeká do dvou let od uzavření synergie kolem 300 mil. USD.
EDEN PRAIRIE, Minn. & CHARLOTTE, N.C.--(BUSINESS WIRE)--C.H. Robinson Worldwide, Inc. (“C.H. Robinson”) (Nasdaq: CHRW) and RXO Inc. (NYSE: RXO) (“RXO”), a Fortune 1000 provider of asset-light tech-enabled transportation solutions, today announced that they have entered into a definitive agreement (the “Merger Agreement”) under which C.H. Robinson will acquire RXO in a stock-and-cash transaction for an implied value of $5.8 billion and will create a combined company with an enterprise value of over $25 billion.
This transaction is a natural next step in our transformation, allowing us to create a more scaled, resilient North American third-party logistics provider positioned to offer exceptional customer service and redefine the future of our industry.
Share The acquisition of RXO brings together two complementary networks and diversifies and strengthens C.H. Robinson’s multi-modal platform to accelerate its growth and increase its penetration across all modes and segments. Combining both companies’ robust trucking brokerage and managed transportation businesses, along with C.H. Robinson’s global forwarding and RXO’s strengths in expedited and last mile, will create a more comprehensive offering for customers across a larger and denser network. Through the implementation of its proven Lean AI operating model across RXO’s business, C.H. Robinson expects to realize approximately $300 million of net run-rate cost synergies within two years post-close. The companies expect these productivity improvements to create a more resilient platform to drive profitable growth with enhanced operating leverage and improved margins regardless of the freight market environment.
“This transaction is a natural next step in our transformation, allowing us to create a more scaled, resilient North American third-party logistics provider positioned to offer exceptional customer service and redefine the future of our industry,” said Dave Bozeman, C.H. Robinson President and Chief Executive Officer. “Like C.H. Robinson, RXO is a customer-focused company with expertise and talent that will allow us to expand our capabilities to better support customers of all sizes on their most complex challenges. By applying our proven Lean AI model to RXO’s business, we expect to significantly enhance productivity to unlock compelling cost synergies. We are confident our experienced team and disciplined execution plan will allow us to seamlessly integrate our organizations and position the combined company to capture the expected synergies, drive innovation and deepen customer relationships to enhance profitable growth and shareholder value.”
Drew Wilkerson, RXO Chairman and Chief Executive Officer, said, “Joining C.H. Robinson represents an exciting next chapter for our company, our employees and our customers. We have built a strong business by staying relentlessly focused on our customers, operating with agility and delivering solutions that help them navigate an increasingly complex supply chain. By bringing together our complementary capabilities, talented teams and shared commitment to service, we will be able to offer customers greater scale, broader capabilities and even more value. I’m incredibly proud of what our team has built and excited about the opportunities ahead as part of C.H. Robinson.”
Adam R. Karr, President and Portfolio Manager at Orbis Investments, said, “Orbis is RXO’s largest shareholder and has owned the Company since it became independent. We know the business and the team well, and we fully support this transaction. It gives RXO shareholders substantial cash today and continued ownership in a combined platform with significant upside.”
Strategic & Financial Benefits
Unlocks compelling cost synergy opportunities through C.H. Robinson’s Lean AI operating model – C.H. Robinson expects to unlock significant productivity improvements and drive operating margin expansion as it applies its proven Lean AI operating model to RXO’s business. The transaction is expected to deliver approximately $300 million of net run-rate cost synergies within two years following the transaction close, through cost-to-serve opportunities, operating efficiencies, shared-services savings and third-party spend optimization. The anticipated synergies will allow the combined company to increase operating leverage and drive significant shareholder value creation. The acquisition will also significantly expand C.H. Robinson’s proprietary datasets, enhancing the speed and precision of its AI-driven sales, matching and procurement capabilities. Increases scale in a large and fragmented market – The addition of RXO will improve C.H. Robinson’s network density and expand its capabilities, enhancing penetration across verticals and increasing volumes. The combined company’s complementary platform and diversified customer exposure will increase market visibility and enhance its ability to drive growth through market cycles. Diversifies and strengthens offerings to support customers’ end-to-end needs – The transaction will bring together C.H. Robinson’s global, multi-modal solutions with RXO’s capabilities in North American brokerage, expedited and last mile to deliver more tailored solutions, creating opportunities to deepen relationships, increase wallet share and win new enterprise customers. The companies’ complementary commercial capabilities and diverse customer base will also create compelling cross-selling opportunities. Strengthens financial profile to support deleveraging – C.H. Robinson expects the transaction to be accretive to adjusted EPS1 within nine months of the transaction close and mid-teens accretive to adjusted EPS in 2028. Additionally, the anticipated productivity improvements are expected to increase cash flow generation to support rapid de-leveraging to C.H. Robinson’s target leverage range of 1.75x to 2.25x net debt to LTM adjusted EBITDA by the end of 2028, with flexibility to continue growth investments. C.H. Robinson expects to maintain its solid investment grade credit ratings and intends to pause share repurchases until it reaches its target leverage ratio after the transaction closes. Transaction Details
Under the terms of the merger agreement, RXO stockholders will receive $17.25 per share in cash and 0.0856 shares of C.H. Robinson common stock for each RXO share they own, representing an implied total consideration of $30.25 per share.2 The transaction represents a premium of 27% to RXO’s 90-day volume-weighted average price and 29% to RXO’s closing price on Friday, October 2, 2026. Under the terms of the merger agreement, RXO stockholders may elect to receive either (i) the standard mixed consideration consisting of $17.25 in cash and 0.0856 shares of C.H. Robinson common stock, (ii) all-cash consideration of $30.25 per share or (iii) all-stock consideration of 0.1992 shares of C.H. Robinson common stock, in each case subject to proration and adjustment procedures designed to ensure that, in the aggregate, approximately 57% of the merger consideration is paid in cash and 43% is paid in shares of C.H. Robinson common stock. RXO stockholders are expected to own 11% of the combined company upon transaction close.
The merger agreement, which was unanimously approved by the Boards of both companies, is expected to close in the first half of 2027 and is subject to customary closing conditions, including regulatory approval and approval by RXO’s stockholders. In connection with the execution of the Merger Agreement, MFN Partners LP has agreed, among other things, to vote all of its shares of RXO (which represents approximately 17%) in favor of the transaction and adoption of the Merger Agreement, and, subject to certain exceptions, not to transfer its shares.
C.H. Robinson will finance the cash consideration with new debt financing and has entered into a fully underwritten commitment for a bridge facility with Morgan Stanley Senior Funding, Inc. Upon completion of the transaction, C.H. Robinson will integrate RXO primarily into its NAST division.
For additional information regarding the transaction, including resources for customers, carriers, employees and investors, please visit www.CHRobinsonAcquiresRXO.com.
Advisors
Morgan Stanley & Co. LLC is acting as financial advisor to C.H. Robinson, Gibson, Dunn & Crutcher LLP is serving as its legal counsel and Joele Frank, Wilkinson Brimmer Katcher is serving as its strategic communications advisor. Goldman Sachs & Co. LLC is serving as financial advisor to RXO and Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as its legal counsel.
Conference Call and Webcast Information:
C.H. Robinson will host a conference call at 8:00 a.m. Eastern Time today to discuss the announcement. A slide presentation and a simultaneous live audio webcast of the conference call may be accessed through C.H. Robinson’s website at investor.chrobinson.com.
About C.H. Robinson
C.H. Robinson is the global leader in Lean AI supply chains. For more than a century, companies everywhere have looked to us to reimagine how goods move. Now, as we redefine what’s next for the industry, that same drive fuels our commitment to Building Tomorrow’s Supply Chains, Today™. Trusted by 75,000 customers and 450,000 contract carriers, we manage 37 million shipments annually, representing $23 billion in freight. We deliver tailored solutions across the world via truckload, less-than-truckload, ocean, air, and more. With our unique combination of human insight and Lean AI working as one, supply chains move faster, smarter, and more sustainably. As a responsible global citizen, we proudly contribute millions to the causes that matter most to our employees. For more information, visit us at chrobinson.com (Nasdaq: CHRW).
About RXO
RXO (NYSE: RXO) is a leading provider of asset-light transportation solutions. RXO offers tech-enabled truck brokerage services together with complementary solutions including managed transportation and last mile delivery. The company combines massive capacity and cutting-edge technology to move freight efficiently through supply chains across North America. The company is headquartered in Charlotte, N.C. Visit RXO.com for more information and connect with RXO on LinkedIn, Facebook, Instagram, X and YouTube.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Exchange Act. Statements that are not historical facts, including statements about beliefs, expectations, targets or goals, the expected timing of the closing of the proposed transaction, the anticipated benefits of the proposed transaction, including synergies, and expected future financial position, total addressable market and results of operations, are forward-looking statements. These statements are based on plans, estimates, expectations and/or goals at the time the statements are made, and readers should not place undue reliance on them. Some of these forward-looking statements can be identified by the use of forward-looking words such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “projects,” “strategy,” or “anticipates,” or the negative of those words or other comparable terminology. C.H. Robinson’s and RXO’s results may differ materially from the experience and results anticipated in such statements. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions including, but not limited to, the following factors: the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; the risk that the conditions to the closing of the proposed transaction are not satisfied, including the risk that required approvals of the transaction from the stockholders of RXO or from regulators are not obtained; litigation or regulatory action relating to the transaction; the risk that the proposed transaction may not be completed on the anticipated terms, in a timely manner or at all; uncertainties as to the timing of the consummation of the proposed transaction and the ability of each party to consummate the proposed transaction; risks that the proposed transaction disrupts the current plans or operations of C.H. Robinson or RXO; the effect of the announcement of the proposed transaction on the ability of C.H. Robinson or RXO to retain and hire key personnel; competitive responses to the proposed transaction; unexpected costs, charges or expenses resulting from the transaction; the risk that C.H. Robinson is unable to obtain the anticipated debt financing in connection with the proposed transaction on the anticipated timing or terms, or at all; potential adverse effects on the market price of RXO’s and/or C.H. Robinson’s common stock, credit ratings, or operating results; fluctuations in the market value of the merger consideration, which may vary from its value as of the date of the Merger Agreement or the date of this communication, as a result of changes in the market price of C.H. Robinson common stock; potential adverse reactions or changes to relationships with employees, customers, suppliers, distributors and other business partners resulting from the announcement, pendency or completion of the proposed transaction; restrictions during the pendency of the proposed transaction on RXO’s ability to pursue certain business opportunities or strategic transactions; the potential acquisition being more expensive to complete than anticipated, including as a result of unexpected factors or events, significant transaction costs or unknown liabilities; the combined company’s ability to achieve the synergies expected from the proposed transaction, as well as delays, challenges and expenses associated with integrating the combined company’s existing businesses or realizing the anticipated benefits of the proposed transaction; competitive factors, including but not limited to pricing pressures, industry consolidation, entry of new competitors into the industries in which C.H. Robinson and RXO operate, as well as new product and marketing initiatives by C.H. Robinson’s and RXO’s competitors; risks associated with cyber-attacks, information security and data privacy; diversion of management’s time and attention from C.H. Robinson’s and RXO’s ongoing business operations due to the proposed transaction; disruptions resulting from key management changes; unknown liabilities and uncertainties regarding general economic, market sector, competitive, legal, regulatory, tax and geopolitical conditions; and legislative, regulatory, economic, competitive or technological developments. Other factors that might cause such a difference include those discussed in C.H. Robinson’s and RXO’s filings with the SEC, which include their Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and in the registration statement on Form S-4 (including the proxy statement/prospectus) to be filed in connection with the proposed transaction. For more information, see the section entitled “Risk Factors” and the forward-looking statements disclosure contained in C.H. Robinson’s and RXO’s Annual Reports on Form 10-K and in other filings. Forward-looking statements should not be relied on as predictions of future events, and these statements are not guarantees of performance or results. The forward-looking statements included in this communication are made only as of the date hereof and, except as required by applicable law, C.H. Robinson and RXO undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Additional Information about the Proposed Transaction and Where to Find It
In connection with the proposed transaction, C.H. Robinson intends to file with the SEC a registration statement on Form S-4 that will include a preliminary proxy statement of RXO that also constitutes a preliminary prospectus of C.H. Robinson. C.H. Robinson and RXO also each plan to file other relevant documents with the SEC regarding the proposed transaction. After the registration statement is declared effective, the definitive proxy statement/prospectus will be mailed to stockholders of RXO. This communication is not a substitute for the registration statement, the proxy statement/prospectus or any other document that C.H. Robinson or RXO may file with the SEC in connection with the proposed transaction. INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT ON FORM S-4, PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.
Investors and stockholders will be able to obtain free copies of these documents (if and when available), and other documents containing important information about C.H. Robinson and RXO, once such documents are filed with the SEC through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by C.H. Robinson will be available free of charge on C.H. Robinson’s website at investor.chrobinson.com/financials/sec-filings. Copies of the documents filed with the SEC by RXO will be available free of charge on RXO’s website at investors.rxo.com.
Participants in the Solicitation
C.H. Robinson, RXO and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from RXO’s stockholders in respect of the proposed transaction. Information about the directors and executive officers of C.H. Robinson, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in (i) the C.H. Robinson’s proxy statement for its 2026 Annual Meeting of Shareholders, which was filed with the SEC on March 24, 2026, including under the sections captioned “Proposal 1: Election of Directors,” “Compensation of Directors,” “Compensation Discussion and Analysis,” “Executive Compensation Tables,” “Security Ownership of Certain Beneficial Owners and Management,” and “Related Party Transactions,” (ii)the C.H. Robinson Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on February 13, 2026, including under the section captioned “Information about our Executive Officers” in Part I, Item 1, and (iii) Item 5.02 of the C.H. Robinson’s Current Report on Form 8-K filed with the SEC on June 2, 2026. Information about the directors and executive officers of RXO , including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in (i) RXO’s proxy statement for its 2026 Annual Meeting of Stockholders, which was filed with the SEC on March 30, 2026, including under the sections captioned “Proposal 1: Election of Directors,” “Director Compensation,” “Certain Relationships and Related Party Transactions,” “Security Ownership of Certain Beneficial Owners and Management,” and “Compensation Discussion and Analysis,” and (ii) RXO’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on February 9, 2026, including under the section captioned “Information about our Executive Officers” in Part I, Item 1. To the extent holdings of RXO’s securities by its directors or executive officers have changed since the applicable “as of” date described in its 2026 proxy statement, such changes have been or will be reflected on Initial Statements of Beneficial Ownership of Securities on Form 3, Statements of Changes in Beneficial Ownership on Form 4 or Annual Statements of Changes in Beneficial Ownership on Form 5 filed with the SEC, including (i) the Form 4s filed by Mr. Wilkerson on May 4, 2026 and May 19, 2026; (ii) the Form 4 filed by Mr. Morris on May 18, 2026; and (iii) the Form 4 filed by Mr. Firestone on August 25, 2026.
Other information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed transaction when such materials become available. Investors and stockholders should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from C.H. Robinson and RXO using the sources indicated above.
No Offer or Solicitation
This communication is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.
Comstock Resources zveřejní výsledky za 3. čtvrtletí 2026 po uzavření trhu 4. listopadu 2026. Následně uspořádá konferenční hovor 5. listopadu v 10:00 CT.
FRISCO, TX, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. (NYSE:CRK) plans to release its third quarter 2026 results on November 4, 2026 after the market closes and host its quarterly conference call at 10:00 a.m. CT on November 5, 2026 to discuss the third quarter results.
Parties interested in participating in the conference call telephonically will need to register at https://register-conf.media-server.com/register/BI962f0a6609044819bcc431a45cfea339. Upon registering to participate in the conference call, participants will receive the dial-in number and a personal PIN number to access the conference call. On the day of the call, please dial in at least 15 minutes in advance to ensure a timely connection to the call.
~~~
The conference call will also be broadcast live in listen-only mode and can be accessed via the website URL: https://edge.media-server.com/mmc/p/e9dram3p.
~~~
A replay of the third quarter 2026 conference call will be available for twelve months beginning at 1:00 p.m. CT on November 5, 2026. The replay of the conference can be accessed using the webcast link: https://edge.media-server.com/mmc/p/e9dram3p
About Comstock Resources:
Comstock Resources is a leading independent natural gas producer with operations focused on the development of the Haynesville Shale in North Louisiana and East Texas.
A slide show presentation on the financial results will be available on Comstock's website at www.comstockresources.com. Click on “Quarterly Results” to view the slide show.
Applied Optoelectronics dokončila svůj at-the-market program emise akcií za 600 milionů USD a prodala 5 694 845 akcií za průměrnou cenu 105,36 USD. Čistý výnos činil 587 999 985,89 USD.
, /PRNewswire/ -- Applied Optoelectronics, Inc. (NASDAQ: AAOI) ("AOI"), a leading provider of advanced optical and HFC networking products that power AI, today announced that it has completed its previously disclosed $600 million "at-the-market" equity offering program (the "ATM Program").
AOI disclosed on August 21, 2026 that it filed a prospectus supplement with the U.S. Securities and Exchange Commission to offer and sell shares of its common stock having an aggregate offering price of up to $600,000,000. The Company sold a total of 5,694,845 shares at an average sales price of $105.36 per share, representing proceeds to the Company of $587,999,985.89, net of commissions and fees.
"We are pleased to have successfully completed our third at-the-market equity offering program this year, which strengthens our balance sheet and supports our ability to address growing demand for high-speed optical connectivity in AI data centers," said Dr. Thompson Lin, AOI's Founder, President and Chief Executive Officer. "We intend to use these proceeds to continue to make investments in the business, including new equipment and machinery for production and research and development use, as we continue to scale our advanced manufacturing capacity. We thank our shareholders for their continued support of AOI and welcome our new shareholders."
The Company currently intends to use the net proceeds from the ATM Program for general corporate purposes, which may include, among other things, debt repayment, working capital, and capital expenditures, primarily in support of its manufacturing expansion efforts for data center optical devices.
Forward-Looking Information
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "could," "would," "target," "seek," "aim," "predicts," "think," "objectives," "optimistic," "new," "goal," "priorities," "strategy," "potential," "is likely," "will," "expect," "momentum," "plan" "project," "permit," "positions" or by other similar expressions that convey uncertainty of future events or outcomes. These statements include management's beliefs and expectations regarding the use of proceeds from the ATM Program and planned investments in manufacturing capacity. Such forward-looking statements reflect the views of management at the time such statements are made. These forward-looking statements involve risks and uncertainties, as well as assumptions and current expectations, which could cause the company's actual results to differ materially from those anticipated in such forward-looking statements. These risks and uncertainties include but are not limited to: reduction in the size or quantity of customer orders; change in demand for the company's products due to industry conditions; changes in manufacturing operations; volatility in manufacturing costs; delays in shipments of products; disruptions in the supply chain; change in the rate of design wins or the rate of customer acceptance of new products; the company's reliance on a small number of customers for a substantial portion of its revenues; potential pricing pressure; a decline in demand for our customers' products or their rate of deployment of their products; general conditions in the internet datacenter, cable television (CATV) broadband, telecom, or fiber-to-the-home (FTTH) markets; changes in the world economy (particularly in the United States and China); changes in the regulation and taxation of international trade, including the imposition of tariffs; changes in currency exchange rates; the negative effects of seasonality; and other risks and uncertainties described more fully in the company's documents filed with or furnished to the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2025 and our Quarterly report on Form 10-Q for the quarter ended June 30, 2026. More information about these and other risks that may impact the company's business are set forth in the "Risk Factors" section of the company's quarterly and annual reports on file with the Securities and Exchange Commission. You should not rely on forward-looking statements as predictions of future events. All forward-looking statements in this press release are based upon information available to us as of the date hereof, and qualified in their entirety by this cautionary statement. Except as required by law, we assume no obligation to update forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in the company's expectations.
About AOI
Applied Optoelectronics, Inc. (AOI) is a leading developer and manufacturer of advanced optical and HFC networking products that are the building blocks for AI datacenters, CATV and broadband fiber access networks around the world. AOI supplies this critical infrastructure to tier-one customers across cloud computing, CATV broadband, telecom, and FTTH markets. The company has R&D facilities in Atlanta, GA, and engineering and manufacturing facilities at its corporate headquarters in Sugar Land, TX, as well as in Taipei, Taiwan and Ningbo, China. For additional information, visit www.ao-inc.com.
Pagaya Technologies v září klesla o 20 %, protože investoři se obávají dopadu vysokých sazeb a volatility dluhopisového trhu na její úvěrový byznys. Ve 2. čtvrtletí výnosy vzrostly o 19 % na 387 milionů USD a čistý zisk o 172 % na 45 milionů USD.
Shares of Pagaya Technologies (PGY +3.10%) stock fell 20% in September, according to data provided by S&P Global Market Intelligence. Investors are worried about how high interest rates and bond market volatility will impact the credit evaluation company.
The AI way to lend moneyPagaya operates a credit platform driven by artificial intelligence (AI) and machine learning. It teams up with client lenders, who have Pagaya's platform integrated into their systems, to assess borrower risk quickly and more accurately than traditional models. Client partners can then approve more loans without adding risk.
Image source: Getty Images.
The platform acts as a middleman, approving these loans and then selling them as asset-backed securities (ABS) to partnering funders. The software-based model is agile and low-cost, and Pagaya takes a fee from each loan. Each incremental loan from the same provider comes without marketing and acquisition costs, and the company's growth strategy involves adding new client partners as well as driving higher engagement with existing partners.
Pagaya already works with a stellar client list of 35 partners that includes Visa (V +0.23%), U.S. Bank (USB +0.26%), and SoFi Technologies (SOFI -0.44%). It has a long pipeline of new customers that are joining the platform, and its goal is to add two to four large clients annually, focusing on large banks and auto dealers.
Pagay isn't the only name in this space, but it has an advantage in its funding model. It has relationships with 170 institutional investors and has the funding before any loans are issued. It's the top issuer of personal ABS loans in the U.S., with a triple-A rating across categories.
Can it keep up high growth?Pagaya has been reporting consistent growth and increasing profits. In the second quarter, total revenue increased 19% year over year to $387 million, and net income increased 172% to $45 million. Volume increased 33%, so there's been no shortage of new loans to approve, so far, despite the high-interest rate environment. Growth was driven by auto loans.
Premium Feature
Moneyball Superscore
68/100
Today's Change
(
3.10
%) $
0.54
Current Price
$
17.98
However, it's highly exposed to the credit industry, which has been troubled by higher borrowing costs. One area where the pressure is showing is in fee revenue less production costs (FRLPC) margin, an industry profitability metric. FRLPC increased 16% over last year in the quarter, but the margin decreased by 0.61 percentage points to 4.2%, based in part on the increased cost of capital.
Pagaya stock isn't for the risk-averse investor, but for those with a high appetite for risk, Pagaya stock looks like a bargain today. At the lower price, it trades at under 14 times trailing 12-month earnings, which is cheap for a high-growth AI stock.
Osisko Gold hlásí ze zóny Lowhee v projektu Cariboo Gold nové výsledky vrtů s 7,28 g/t Au na 16,15 m a 7,13 g/t Au na 11,60 m. Výsledky mají posílit důvěru v převod zdrojů na zásoby a další mineralizaci.
HIGHLIGHTS 3,933 m of new infill drilling in 36 holes from the Lowhee Zone 1290 m level. Highlight intercepts include:7.28 g/t Au over 16.15 m (~105 m vertical depth), including 173.66 g/t Au over 0.60 m, 6.80 g/t Au over 0.50 m, 5.39 g/t Au over 0.50 m, and 3.58 g/t Au over 0.50 m7.13 g/t Au over 11.60 m (~61 m vertical depth), including 62.06 g/t Au over 0.50 m, 31.88 g/t Au over 0.80 m, 18.85 g/t Au over 0.50 m, 7.13 g/t Au over 0.85 m, 6.47 g/t Au over 0.90 m, and 2.23 g/t Au over 0.85 m
TORONTO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Osisko Gold Group Inc. (NYSE: OGG, TSXV: OGG) ("Osisko Gold" or the "Company") is pleased to announce new results from its ongoing definition infill drilling program on 10-15 metre ("m") target spacing totaling 3,933 m in 36 holes drilled from the 1290 m level in the Lowhee Zone of the Company's flagship, permitted, 100%-owned Cariboo Gold Project (the "Project"), currently under construction in central British Columbia, Canada.
Chris Lodder, President, stated, "Ongoing underground infill drilling continues to strengthen our confidence in the Lowhee Zone of the Cariboo Gold deposit. Intercepts outside the modelled reserve stopes also suggest potential for resource conversion and upside mineralization, reinforcing the Cariboo Gold Project's potential as underground development advances into new zones."
Corporate Updates
In connection with the ongoing construction of the Cariboo Gold Project, the Company, through its wholly-owned subsidiary, Barkerville Gold Mines Ltd., has awarded the continuing underground mine development and related works contract to current contractor JDS Energy & Mining Inc. ("JDS") effective October 5, 2026.The Company also announces that it has granted an aggregate of (i) 72,700 stock options of the Company (the "Options"), and (ii) 553,700 restricted share units of the Company ("RSUs") to certain newly hired senior officers and non-executive employees (collectively, the "Incentive Awards"), pursuant to the Company's omnibus equity incentive plan ("Omnibus Plan"). The Incentive Awards are designed to align the interests of the recipients with those of shareholders and support the execution of the Company's long-term growth strategy. The Options are exercisable at a price of C$4.00 per common share of the Company (based on the October 2, 2026, closing price on the TSX Venture Exchange) and will expire on October 5, 2031. The Options will vest in three equal installments over the next three years. The RSUs will cliff vest on October 5, 2029, and are subject to time and performance conditions. DRILL ASSAY HIGHLIGHTS
This news release contains assays from thirty-six (36) diamond drillholes ("DD") completed in four fans totaling 3,933 m drilled to the northwest from the L1290-ORE-000 drill station with depths ranging from 81.20 to 150.50 m (see Table 1 and Figures 5-9). All holes were collared in HQ (63.5 millimetre diameter). Estimated true widths of intercepts are provided in Table 1. Select photon assay highlights include:
7.28 grams per tonne ("g/t") gold ("Au") over 16.15 m at ~105 m vertical depth in BMU-26-121, including: 173.66 g/t Au over 0.60 m, and6.80 g/t Au over 0.50 m, and5.39 g/t Au over 0.50 m, and3.58 g/t Au over 0.50 m 7.13 g/t Au over 11.60 m at ~61 m vertical depth in BMU-26-075 (Figure 1), including: 62.06 g/t Au over 0.50 m, and31.88 g/t Au over 0.80 m, and18.85 g/t Au over 0.50 m, and7.13 g/t Au over 0.85 m, and6.47 g/t Au over 0.90 m, and2.23 g/t Au over 0.85 m 9.40 g/t Au over 8.50 m at ~72 m vertical depth in BMU-26-076, including: 78.39 g/t Au over 0.65 m, and41.31 g/t Au over 0.55 m, and3.77 g/t Au over 0.55 m, and3.06 g/t Au over 0.50 m 29.30 g/t Au over 2.10 m at ~62 m vertical depth in BMU-26-096 (Figure 2), including: 111.38 g/t Au over 0.55 m 10.26 g/t Au over 5.75 m at ~56 m vertical depth in BMU-26-076, including: 60.62 g/t Au over 0.80 m, and7.84 g/t Au over 0.50 m, and5.28 g/t Au over 0.50 m, and4.82 g/t Au over 0.50 m 4.04 g/t Au over 14.35 m at ~78 m vertical depth in BMU-26-098, including: 29.57 g/t Au over 1.00 m, and20.35 g/t Au over 1.00 m, and7.06 g/t Au over 0.50 m 9.98 g/t Au over 5.70 m at ~91 m vertical depth in BMU-26-118, including: 72.45 g/t Au over 0.60 m, and8.75 g/t Au over 0.75 m, and6.38 g/t Au over 0.50 m, and3.16 g/t Au over 0.50 m 11.17 g/t Au over 3.05 m at ~65 m vertical depth in BMU-26-119, including: 50.82 g/t Au over 0.50 m, and14.38 g/t Au over 0.50 m 2.71 g/t Au over 9.95 m at ~63 m vertical depth in BMU-26-097, including: 19.51 g/t Au over 0.95 m, and6.95 g/t Au over 0.50 m, and4.87 g/t Au over 0.50 m 4.10 g/t Au over 6.50 m at ~40 m vertical depth in BMU-26-047, including: 17.25 g/t Au over 0.50 m, and14.98 g/t Au over 0.50 m, and9.18 g/t Au over 0.50 m, and6.33 g/t Au over 0.50 m, and2.51 g/t Au over 0.50 m Complete assay highlights, including true width estimates, are presented in Table 1. Vertical depths are measured from modelled topographic surface to the interval mid-point. Drill hole locations and orientations are listed in Table 2. Intervals not recovered were assigned zero grade. Top cuts have not been applied to high grade assays.
Cut-off assay composites from ongoing infill drilling at the 1290 Level, presented in plan in Figure 5 and in cross section in Figures 6-9, show a degree of spatial correlation with modelled reserve stopes; intercepts outside these areas suggest potential for resource conversion and upside mineralization.
FIGURE 1: 7.13 g/t Au over 11.60 m at ~61 m vertical depth in BMU-26-075
FIGURE 2: Visible gold with pyrite under hand lens in composite interval with 29.30 g/t Au over 2.1 m at ~62 m vertical depth in BMU-26-096
FIGURE 3: Cariboo Gold Project deposit map with Location of Lowhee Zone and Cow Portal underground access.
FIGURE 4: Location and overview of ongoing Lowhee Zone underground definition infill diamond drilling.
FIGURE 5: Lowhee Zone select underground drilling highlights (plan view).
FIGURE 6: L1290-ORE-F09 select underground drill assay highlights (this release) with previously released surface and underground diamond drilling results in cross section by fan. New results from adjacent fans within slice (20 m looking 029°) omitted for visual clarity.
FIGURE 7: L1290-ORE-F10 select underground drill assay highlights (this release) with previously released surface and underground diamond drilling results in cross section by fan. New results from adjacent fans within slice (20 m looking 039°) omitted for visual clarity.
FIGURE 8: L1290-ORE-F11 select underground drill assay highlights (this release) with previously released surface and underground diamond drilling results in cross section by fan. New results from adjacent fans within slice (20 m looking 046°) omitted for visual clarity.
FIGURE 9: L1290-ORE-F12 select underground drill assay highlights (this release) with previously released surface and underground diamond drilling results in cross section by fan. New results from adjacent fans within slice (20 m looking 050°) omitted for visual clarity.
Geological mapping and geochemical sampling were carried out on Barkerville Mountain from 2017-2018, with the Lowhee Zone identified as a high-priority drill target. From 2019 to 2022, a total of 167 surface drill holes were completed, totaling 54,494.5 m.
The Lowhee Zone is accessed through the Cow portal on the northwestern flank of Barkerville Mountain (Figure 3 and Figure 4). Cow portal construction was completed in Q4 2024 and development of the underground ramp into the Lowhee Zone commenced in Q1 2025. The probable mineral reserves estimate for the Lowhee Zone (with an effective date of April 10, 2025) includes 104,491 ounces of contained Au (923,162 tonnes grading 3.52 g/t Au) and represents approximately 5% of the total contained gold in the estimated probable mineral reserves for the Cariboo Gold Project.
ABOUT CARIBOO GOLD PROJECT
The Cariboo Gold Project is a permitted, 100%-owned feasibility-stage project currently under construction located in the historic Wells-Barkerville mining camp of central British Columbia, Canada. Spanning approximately 186,740 hectares, the Company's land package includes 443 mineral titles and covers an area that extends approximately 77 kilometres from northwest to southeast. In late 2024, the Project was granted the Mines Act and Environmental Management Act (British Columbia) permits, marking the successful completion of the permitting process for key approvals. On September 14, 2026, the Company announced a formal positive decision to proceed with the construction of the Project, with an expected first gold pour in Q1 2029 and commercial production in H2 2029.
Technical Reports
Scientific and technical information relating to the Cariboo Gold Project and the 2025 feasibility study on the Cariboo Gold Project is supported by the technical report, titled "NI 43-101 Technical Report, Feasibility Study for the Cariboo Gold Project, District of Wells, British Columbia, Canada" and dated June 11, 2025 (with an effective date of April 25, 2025) (the "Cariboo Technical Report").
For readers to fully understand the information in the Cariboo Technical Report, reference should be made to the full text of the Cariboo Technical Report in its entirety, including all assumptions, parameters, qualifications, limitations and methods therein. The Cariboo Technical Report is intended to be read as a whole, and sections should not be read or relied upon out of context. The Cariboo Technical Report was prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects ("NI 43-101") and is available electronically on SEDAR+ (www.sedarplus.ca) and on EDGAR (www.sec.gov) under Osisko Gold's issuer profile and on the Company's website at www.osiskogold.ca.
Qualified Persons
The scientific and technical information in this news release has been reviewed, verified and approved by Scott Smith, P. Geo., Vice President, Exploration of Osisko Gold, a "qualified person" within the meaning of NI 43-101. Verification includes core photo and three-dimensional review of logged drillhole data and assays consistent with the Company's standard procedures.
Quality Assurance (QA) – Quality Control (QC)
All drill core was whole core sampled in on-site logging facilities following daily QAQC checks for logging and sampling errors. Quality control (QC) samples are inserted at regular intervals in the sample stream, including blanks and reference materials with all sample shipments to monitor laboratory performance. Samples are bagged, labelled, sealed with numbered security tags.
Samples are taken by expeditor from the logging facilities direct to MSALABS's analytical facility in Prince George, B.C., Canada, for preparation and analysis. MSALABS is independent of the Company. The MSALABS facility is accredited to the ISO/IEC 17025 standard for gold assays, and all analytical methods include quality control materials at set frequencies with established data acceptance criteria. The entire sample is dried, crushed, and split into sealed containers. Analysis for gold is by gamma ray analysis using the Chrysos PhotonAssay (PA1408X). Samples are bombarded with gamma rays and the resulting signal is sent to the detectors.
ABOUT OSISKO GOLD GROUP INC.Osisko Gold Group Inc. is a North American gold development company focused on past-producing mining camps with district-scale potential. The Company's objective is to become an intermediate gold producer through the development of its flagship, fully permitted, 100%-owned Cariboo Gold Project, currently under construction in central British Columbia, Canada. The Project is situated within the Company's broader Cariboo regional land package, which hosts numerous prospective exploration targets and provides opportunities for future discoveries. Its Cariboo project pipeline is complemented by the Tintic Project, located in the historic East Tintic mining district in Utah, U.S.A., a brownfield property with significant exploration potential, extensive historical mining data, and access to established infrastructure. Osisko Gold is focused on developing long-life mining assets in mining-friendly jurisdictions while maintaining a disciplined approach to capital allocation, development risk management, and mineral inventory growth.For further information, visit our website at www.osiskogold.ca or contact:
Sean Roosen
Chairman and CEO
Email: [email protected]
Tel: +1 (514) 940-0685Philip Rabenok
Vice President, Investor Relations
Email: [email protected]
Tel: +1 (437) 423-3644
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking information" (within the meaning of applicable Canadian securities laws) and "forward-looking statements" (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended) (collectively, "forward-looking statements"). Such forward-looking statements are identified with words such as "may", "will", "would", "could", "anticipate", "believe", "expect", "plan", "intend", "potential", "estimate", "propose", "project", "outlook", "foresee", "objective", "strategy", variants of these words or the negative or comparable terminology, as well as terms usually used in the future and the conditional. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including the assumptions, qualifications, limitations or statements pertaining to: the utility and significance of the underground infill drilling results and the interpretation thereof; the interpretation and accuracy of intercepts outside modelled reserve stopes to suggest potential for resource conversion and upside mineralization (if at all); the potential for upside at depth and along strike of the known mineral resource footprint (if any); the interpretation and accuracy of spatial geometries, geological structure and local variability modeling and assumptions in regard to potential reserve or resource revisions (if at all); the ability and utility of exploration and infill drilling to inform resource modeling, mine planning, production stope design procedures and parameters, refinement of infill drill requirements, and the appropriate drill spacing for future infill drilling (if at all); the results (if any) of further exploration work and ability of the Company to define and expand mineral resources beyond current mineral resource estimates; mineral resource category conversion; the prospectivity of exploration in targets outside of currently defined mineral reserves and/or mineral resources; the performance of the underground mine development and related works contract with JDS and the advancement of underground development into new zones; the anticipated construction of the Cariboo Gold Project, including the expected timing of first gold pour and commercial production; the vesting, exercise and settlement of the Incentive Awards, including the satisfaction of applicable time and performance conditions; assumptions, qualifications and parameters underlying the Cariboo Technical Report (including, but not limited to, the mineral resources, mineral reserves, production profile, mine design and project economics); the results of the Cariboo Technical Report as an indicator of quality and robustness of the Cariboo Gold Project; the ability of the Company to achieve the estimates outlined in the Cariboo Technical Report in the timing contemplated (if at all); the future development and operations at the Cariboo Gold Project; management's perceptions of historical trends, current conditions and expected future developments; the utility and significance of historic data, including the significance of the district hosting past producing mines; the ability of exploration work (including drilling and sampling) to accurately predict mineralization; the ability of the Company to complete its exploration and development objectives for its projects in the timing contemplated and within expected costs (if at all); the ability to adapt to changes in gold prices, estimates of costs, estimates of planned exploration and development expenditures; the Company's strategy and objectives relating to the Cariboo Gold Project as well as its other projects; the assumptions, qualifications and limitations relating to the Cariboo Gold Project being permitted; the exploration potential and prospectivity (if any) of its properties; 'regulatory framework remaining defined and understood as well as other considerations that are believed to be appropriate in the circumstances, and any other information herein that is not a historical fact may be "forward looking information". Actual results could differ materially due to a number of factors, including, without limitation: 'risks relating to third-party approvals, including the issuance of permits by governments; risks relating to the performance of contractors, including JDS; capital market conditions and the Company's ability to access capital on terms acceptable to the Company for the contemplated exploration, development and construction at the Company's properties; risks related to the exploration, development, construction and operation of the Cariboo Gold Project, including delays and cost overruns; risks related to geological modeling and resource estimation; health, safety and security incidents; regulatory delays or changes in regulatory framework and applicable laws; labour shortages or disputes; general economic and market conditions and business conditions in the mining industry; fluctuations in commodity prices and currency exchange rates, as well as those risks and factors disclosed in the Company's most recent annual information form, financial statements and management's discussion and analysis as well as other public filings on SEDAR+ (www.sedarplus.ca) and on EDGAR (www.sec.gov).
Although the Company believes the expectations conveyed by the forward-looking statements are reasonable based on information available as of the date hereof, no assurances can be given as to future results, levels of activity and achievements. The Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by law. Forward-looking statements are not guarantees of performance and there can be no assurance that these forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
Photos accompanying this announcement are available at:
Harrow dokončila akvizici TYRVAYA od Viatris za 30 milionů USD v hotovosti s potenciálem až 100 milionů USD. TYRVAYA je první a jediný nosní sprej na suché oko schválený FDA.
First and Only FDA-Approved Nasal Spray for Dry Eye Disease Adds a Differentiated, Drop-Free Treatment Option to Harrow’s Growing Ocular Surface Franchise | Source: Harrow, Inc.
NASHVILLE, Tenn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has closed its previously announced acquisition of TYRVAYA® (varenicline solution) nasal spray 0.03 mg from Viatris Inc., a global healthcare company. At closing, Harrow acquired worldwide rights to TYRVAYA, except for Japan. Viatris retained the rights to commercialize TYRVAYA in Japan and agreed to pay Harrow royalties on any future net sales there. Consistent with the terms announced in August, Harrow paid $30 million in cash at closing and may pay up to $70 million in contingent milestone payments tied to TYRVAYA’s net sales, for potential total consideration of up to $100 million. The closing payment was funded with cash on hand.
TYRVAYA is a cholinergic agonist indicated for the treatment of the signs and symptoms of dry eye disease (DED) and is the first and only FDA-approved nasal spray for DED. Unlike topical ophthalmic therapies, TYRVAYA is administered through the nose and is thought to activate the trigeminal parasympathetic pathway to stimulate basal tear production. TYRVAYA is approved in the U.S., China, and Taiwan, with marketing applications pending in additional markets.
The addition of TYRVAYA meaningfully expands Harrow’s position in the large and growing U.S. dry eye market and complements VEVYE®, Harrow’s flagship prescription therapy for DED. With two highly differentiated branded prescription products, Harrow believes it can give eyecare professionals greater flexibility to individualize treatment based on their patients' needs and preferences.
“Today marks an important step forward for Harrow and for the physicians and patients we serve,” said Mark L. Baum, Chief Executive Officer of Harrow. “Dry eye disease is complex and multifactorial, and there is no single treatment approach that works for every patient. VEVYE and TYRVAYA approach dry eye differently and give eyecare professionals two distinct tools from one organization committed to serving this market. VEVYE remains the cornerstone of our dry eye franchise, while TYRVAYA gives us an established, complementary prescription brand with a unique route of administration and an existing base of physicians who know and use the product.”
Baum added, “We see a significant commercial opportunity ahead. TYRVAYA comes to Harrow with meaningful physician awareness, an established prescription base, and years of real-world clinical experience. By combining that foundation with Harrow’s expanding Ocular Surface commercial organization, market access capabilities, and focus on patient access and affordability, we believe we can introduce TYRVAYA to many more eyecare professionals and patients while also expanding awareness of VEVYE among existing TYRVAYA prescribers.”
TYRVAYA will be available to eyecare professionals through Harrow's commercial organization immediately after closing. As part of the acquisition, Harrow expects approximately 40 experienced personnel from Viatris, with established knowledge of TYRVAYA and the dry eye market, to join and augment Harrow’s existing Ocular Surface commercial team. Harrow expects to onboard these new colleagues during the fourth quarter of 2026. Harrow’s expanded Ocular Surface team will support both VEVYE and TYRVAYA as the integration progresses.
Harrow believes the combination of two differentiated dry eye brands and a larger, experienced field organization create several attractive commercial opportunities:
Expanded prescriber reach: The approximately 40 personnel expected to join Harrow will materially increase the size of Harrow’s Ocular Surface team, expanding its reach and frequency of engagement with ophthalmologists and optometrists who manage dry eye disease.Broader portfolio engagement: TYRVAYA brings an established prescriber base and meaningful familiarity among eyecare professionals. Bringing VEVYE and TYRVAYA together creates opportunities to deepen engagement across both brands and expand utilization across Harrow’s dry eye portfolio.Commercial efficiency: Both VEVYE and TYRVAYA utilize PhilRx as their primary specialty pharmacy and will be supported by a single Ocular Surface commercial organization, allowing Harrow to leverage shared commercial, market access, patient-support, and operational infrastructure across both brands. Harrow expects TYRVAYA to contribute more than $30 million in revenue in 2027. With commercial integration beginning in the fourth quarter of 2026, Harrow believes TYRVAYA’s established prescription base, physician awareness, and experienced commercial team, combined with Harrow’s dedicated Ocular Surface infrastructure, provide a strong foundation for growth in 2027 and beyond.
“TYRVAYA is a product I have used extensively in my dry eye practice, and its nasal route of administration makes it a truly differentiated treatment option,” said Laura Periman, MD, a board-certified ophthalmologist at Periman Eye Institute. “For patients who struggle with eye drops or contact lens wearers who want an option that does not require removing their lenses, TYRVAYA can fit very well into their treatment routine. I have seen firsthand the value of stimulating a patient’s own tear production, and I am pleased to see TYRVAYA become part of Harrow, a company deeply committed to eyecare and patient access.”
“VEVYE has become an important option in my dry eye practice because of the clinical benefits it can provide, and TYRVAYA is another therapy I know well and have prescribed for years,” said Paul Karpecki, OD, Director of Cornea and External Disease at Kentucky Eye Institute. “The two products approach dry eye very differently: VEVYE is applied directly to the ocular surface, while TYRVAYA is administered nasally and stimulates natural tear production through a distinct mechanism. Having therapies with different mechanisms and routes of administration gives me greater flexibility to individualize treatment based on each patient’s needs. I’m pleased to see both products together at Harrow, giving physicians more options for patients with this chronic disease.”
Eyecare professionals can send TYRVAYA prescriptions using their electronic medical record (EMR) software directly to Harrow’s dedicated pharmacy partner, PhilRx. Prescriptions can also be sent to any retail pharmacy. TYRVAYA is fully stocked in the wholesale distribution channel, including McKesson, Cardinal, and Cencora, and can be shipped to any retail pharmacy, generally within 24 hours of order placement.
Interested patients should ask their trusted eyecare professional whether TYRVAYA and VEYVE are right for them.
VEVYE® (cyclosporine ophthalmic solution) 0.1%
INDICATIONS AND USAGE
VEVYE® (cyclosporine ophthalmic solution) 0.1% is indicated for the treatment of the signs and symptoms of dry eye disease.
Important Safety Information
WARNINGS AND PRECAUTIONS
Potential for Eye Injury and Contamination: To avoid the potential for eye injury and/or contamination, patients should not touch the bottle tip to the eye or other surfaces.
Use with Contact Lenses: VEVYE® should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following the administration of VEVYE®.
ADVERSE REACTIONS
In clinical trials with 738 subjects receiving at least 1 dose of VEVYE®, the most common adverse reactions were instillation site reactions (8%) and temporary decreases in visual acuity (3%).
Please see full Prescribing Information for VEVYE.
INDICATIONS AND USAGE
TYRVAYA (varenicline solution) nasal spray is a cholinergic agonist indicated for the treatment of the signs and symptoms of dry eye disease.
Important Safety Information
ADVERSE REACTIONS
The most common adverse reaction reported in 82% of patients was sneezing. Events that were reported in 5–16% of patients were cough, throat irritation, and instillation-site (nose) irritation.
Please see full Prescribing Information for TYRVAYA.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and diseases of the retina. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com and connect with us on LinkedIn.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such “forward-looking statements.” Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties which may cause results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include, among others, risks related to: liquidity or results of operations; our ability to successfully implement our business plan, develop and commercialize our products, product candidates and proprietary formulations in a timely manner or at all, identify and acquire additional products, manage our pharmacy operations, service our debt, obtain financing necessary to operate our business, recruit and retain qualified personnel, manage any growth we may experience and successfully realize the benefits of this acquisition and any other acquisitions and collaborative arrangements we may pursue; competition from pharmaceutical companies, outsourcing facilities and pharmacies; general economic and business conditions, including inflation and supply chain challenges; regulatory and legal risks and uncertainties related to our pharmacy operations and the pharmacy and pharmaceutical business in general, including the ongoing communications with the U.S. Food and Drug Administration relating to compliance and quality plans at our outsourcing facility in New Jersey; physician interest in and market acceptance of our current and any future formulations and compounding pharmacies generally. These and additional risks and uncertainties are more fully described in Harrow’s filings with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the year ended December 31, 2025, and other filings with the SEC. Such documents may be read free of charge on the SEC’s web site at sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Except as required by law, Harrow undertakes no obligation to update any forward-looking statements to reflect new information, events, or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.
Investor & Media Contact:
Mike Biega
Vice President of Investor Relations and Communications [email protected]
617-913-8890
France’s Schneider Electric shares tumbled about 9% on Monday after the company announced plans to acquire US industrial software group PTC for $22.6 billion, with investors likely questioning the hefty premium and the debt burden needed to fund the deal.
Schneider said it expects to complete the all-cash acquisition in the third quarter of 2027 at $205 per PTC share.
The offer represents a 42.3% premium to PTC’s last closing price and marks the largest acquisition in Schneider’s history.
The transaction is a major expansion of Schneider’s software ambitions, but its scale has raised concerns about valuation, financing and the ability to deliver promised synergies.
The $205-per-share offer values PTC at roughly 20–21 times its expected 2027 EBITDA before synergies, a multiple that some investors consider stretched.
PTC’s valuation had fallen as low as 13.1 times next-12-month earnings this year, according to FactSet.
Schneider said the transaction is priced at 13 times earnings after taking synergies into account.
However, much of that benefit comes from projected revenue synergies, which can be more difficult to realise than cost savings.
“AI disruption fears are still weighing on software valuations, which allows acquiring PTC at a decade-low valuation but could still weigh on [Schneider] post-deal,” Jefferies analysts led by Lucas Ferhani said.
Citi analysts described the transaction as Schneider’s “largest deal yet,” but said it should not come as a surprise given the company’s earlier pursuit of acquisitions including Aveva and Bentley Systems.
“The deal may be seen as opportunistic — ‘SaaSpocalypse’ fears have led to the de-rating of many industrial software companies on AI disruption fears — and the onus will be on Schneider to show how the combined software and hardware offering fortifies its moat,” the analysts said.
They added that, given the size of the transaction, investors should seek greater disclosure around the details of the “enlarged software business within Schneider.”
Schneider will finance the acquisition through a combination of new equity and debt.
It plans to raise €5 billion to €6 billion through an Accelerated Bookbuild Offering of new shares, alongside €16 billion to €17 billion in new debt.
The financing is likely to increase Schneider’s leverage significantly and could create near-term earnings dilution for existing shareholders.
JPMorgan analysts said, “Large-scale M&A is typically unwelcome in the first instance by European investors, although Schneider Electric's deals have typically proven strategically astute, if debatable from a valuation standpoint."
JPMorgan reiterated its Overweight rating and €345 price target on Schneider, while acknowledging that the PTC deal represents roughly 12% of the French company’s market capitalisation.
The bank expects the acquisition to become accretive to sales and EBITDA over time.
Schneider expects the combined business to deliver €250 million in annual run-rate cost savings by the third year after closing.
It is also targeting about €800 million in revenue synergies.
The PTC acquisition builds on Schneider’s growing push into industrial software and artificial intelligence.
The company agreed in June to acquire Cognite Holding, a privately held provider of AI software and industrial data.
Schneider has also undergone a broader transformation in recent years.
Once primarily associated with electrical components such as fuses and circuit breakers, it now supplies critical infrastructure for data centres, including cooling systems, server racks and power distribution equipment.
Surging data-centre investment, particularly in the US, has become an increasingly important growth driver for Schneider and is helping offset weaker demand in some traditional electrical-equipment markets.
PTC provides software used to design, manufacture and service products across multiple industries.
Its portfolio has also benefited from growing interest in AI-powered industrial tools.
UBS ponechává na Cerebras Systems doporučení Buy a cílovou cenu 291,64 USD, což implikuje 75,2% růst. Firma zároveň zvýšila výhled tržeb z hlavní činnosti na rok 2026 na 880–890 milionů USD.
Cerebras stock cratered to a post-IPO low while rivals like NVIDIA and AMD surged, yet one of the world's largest banks just doubled down with a price target that implies the market is deeply, fundamentally wrong about this AI chip…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Cerebras Systems (NASDAQ:CBRS) currently trades at $166.43. The average analyst price target is $291.64, which implies 75.2% upside.
Cerebras makes wafer-scale AI chips and runs the Cerebras Inference Cloud, a service built for very fast AI inference. Its customers include OpenAI, AWS, G42, Figma (NYSE:FIG) and GSK (NYSE:GSK | GSK Price Prediction). It has also signed a multi-year OpenAI deal for 750 MW of inference compute valued at more than $20B.
UBS, one of the world’s largest banks, has set the most bullish price target at $330.00. That works out to 98.3% upside, so UBS expects the stock to roughly double. Either the market is missing a hypergrowth story or analysts are anchored to the excitement around the IPO.
Hot IPO Hits a Post-IPO Low Cerebras fell 19.5% in five sessions and hit a post-IPO low. Shares now trade below the IPO price and are down 46.5% from the first-day close of $311.07.
Second-quarter results showed the crack. GAAP revenue of $180.11M missed the $193.55M consensus, though core revenue grew 103%. Core gross margin slipped to 40.6% from 46.5% the prior quarter. Third-quarter guidance calls for 38% to 40% margin.
The selloff is specific to Cerebras. During the same week, NVIDIA (NASDAQ:NVDA) gained 3.95%.
Why UBS Still Expects the Stock to Double UBS analyst Timothy Arcuri repeated his Buy rating and $330.00 target. His thesis: the WSE-3 chip delivers up to 6x the inference performance of GPU clusters; demand for inference workloads avoiding HBM memory bottlenecks keeps growing; and sovereign AI contracts like G42 partnerships provide revenue visibility several quarters out.
The backlog supports this. Cerebras has $25.4 billion in remaining performance obligations, excluding AWS and other hyperscalers. Management raised 2026 core revenue guidance to $880 to $890 million and expects to more than triple core revenue in 2027. The average 2027 revenue estimate is $2.95 billion, with average 2027 EPS rising to $1.2737 from $0.9573 90 days ago. Over the past 30 days there were nine up revisions and no cuts.
The catalysts have dates attached. Disaggregated inference with Helios racks from Advanced Micro Devices (NASDAQ:AMD) launches in the fourth quarter and promises 5x more throughput. AWS Bedrock availability follows in early 2027, with revenue from other hyperscalers starting in mid-2027. Management says gross margin bottoms in the third quarter and then moves toward 60% plus.
The analyst ratings are skewed:
Strong Buy: 3 Buy: 7 Hold: 1 Sell: 0 Arcuri asked on the earnings call whether OpenAI and AWS could make up about two-thirds of next year’s revenue. The CEO replied that OpenAI “will stay a big part next year.” Price targets carry real uncertainty.
Cerebras Falls While Its Chip Rivals Rally Cerebras is falling on its own while its biggest rivals rally.
NVIDIA is up 25.74% year to date at $233.95. Its average target of $327.70 implies 40.1% upside, with 10 Strong Buys, 48 Buys, 2 Holds and 1 Sell.
AMD is up 196% year to date at $633.91, above its $619.51 target. It has 5 Strong Buys, 39 Buys and 11 Holds.
Cerebras has the largest analyst-implied upside in the group. That gap reflects execution risk that its larger, profitable rivals don’t carry.
Down 46.5% Since Debut as the S&P 500 Gains 12.86% This Year At $166.43, Cerebras has 75.2% upside to the $291.64 consensus target held by 11 analysts. The stock is close to its 52-week low of $160.81 and far below its high of $386.34.
Cerebras is down 46.5% since its debut. Meanwhile, the S&P 500 is up 12.86% year to date. Cerebras trades at 58.09 times sales and 217x forward earnings.
A Rare Discount Comes With OpenAI Strings Attached The bull case improves if AWS and the AMD partnership start bringing in revenue on schedule and gross margin bottoms in the third quarter as promised. The backlog already locks in years of growth, and the 2027 estimates keep rising.
The bear case improves if OpenAI moves more work to NVIDIA or if new data centers come online late. When one customer dominates the backlog, it carries more risk than the headline figure suggests. More lockup releases could also keep pressure on the stock.
The evidence leans bullish. The discount looks too steep for a company whose revenue is about to triple, the kind of early signal we cataloged in a free playbook on spotting the next NVIDIA. Still, OpenAI concentration is the risk I’d track most closely in every earnings report.
Contact [email protected] for any questions or corrections.
Polský antimonopolní úřad podezřívá Google ze zneužití dominantního postavení při vyjednávání plateb s vydavateli obsahu. Úřad tvrdí, že firma neposkytla dostatek dat pro férová jednání.
Poland's antitrust watchdog said on Monday it suspected Alphabet's (GOOGL.O) Google of abusing its dominant market position while negotiating content payments with domestic media publishers.
The Office of Competition and Consumer Protection, known by its Polish abbreviation UOKiK, said the charges relate to how Google negotiates remuneration for displaying articles and snippets in its search results, Google News and Discover services.
The companies named in the statement are Alphabet Inc, Google LLC, Google Ireland Limited and Google Poland, none of which immediately responded to a Reuters request for comment.
UOKiK alleges Google failed to provide publishers with the necessary data to properly assess offers, leading to an information imbalance that prevented fair negotiations on payment for content.
"Big tech companies cannot place themselves above the law," UOKiK President Tomasz Chrostny said in the statement, adding the lack of data led to negotiations becoming illusory and tending towards Google imposing terms.
The dispute stems from a 2024 Polish copyright law amendment that implemented an EU directive under which online services may use press publishers' content in return for remuneration.
The maximum fine for abusing a dominant market position may amount to 10% of a company's turnover, the regulator said.
It added the investigation was separate from the European Commission probe opened in December 2025 into whether Google used publishers' content in its AI services without adequate compensation or giving them the ability to object.
The Polish probe, which focuses on Google Search, Google News and Discover services, is being carried out independently following an agreement with the Commission, UOKiK said.
In December 2024, Polish e-commerce group Allegro's price comparison platform Ceneo sued Alphabet for 2.33 billion zlotys ($568 million) in damages for alleged anti-competitive behaviour.
Azimuth Capital Investment Management zvýšila ve 2. čtvrtletí podíl ve společnosti Amazon.com o 23,5 % na 130 567 akcií. Hodnota pozice činila 31,1 milionu USD.
Azimuth Capital Investment Management LLC lifted its position in Amazon.com, Inc. (NASDAQ:AMZN – Free Report) by 23.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 130,567 shares of the e-commerce giant’s stock after acquiring an additional 24,833 shares during the quarter. Amazon.com makes up approximately 1.1% of Azimuth Capital Investment Management LLC’s portfolio, making the stock its 15th largest position. Azimuth Capital Investment Management LLC’s holdings in Amazon.com were worth $31,119,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in AMZN. Bank of America Corp DE bought a new stake in Amazon.com in the 2nd quarter worth about $22,218,775,000. Bank of New York Mellon Corp bought a new position in shares of Amazon.com during the 2nd quarter worth approximately $16,341,405,000. Invesco Ltd. lifted its position in shares of Amazon.com by 3.3% during the 4th quarter. Invesco Ltd. now owns 59,604,857 shares of the e-commerce giant’s stock worth $13,757,993,000 after buying an additional 1,879,630 shares in the last quarter. Legal & General Group Plc bought a new position in shares of Amazon.com during the 2nd quarter worth approximately $12,831,376,000. Finally, Amundi boosted its stake in shares of Amazon.com by 14.1% in the 1st quarter. Amundi now owns 61,400,503 shares of the e-commerce giant’s stock worth $12,787,883,000 after buying an additional 7,590,952 shares during the last quarter. Hedge funds and other institutional investors own 72.20% of the company’s stock.
Analyst Ratings Changes Several equities analysts have recently issued reports on the company. Bank of America upped their target price on Amazon.com from $310.00 to $320.00 and gave the company a “buy” rating in a report on Friday, July 31st. HSBC reissued a “buy” rating and issued a $310.00 price objective on shares of Amazon.com in a research report on Friday, July 31st. Zacks Research downgraded Amazon.com from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 14th. Needham & Company LLC reaffirmed a “buy” rating and set a $300.00 target price on shares of Amazon.com in a research report on Friday, July 31st. Finally, Oppenheimer reiterated an “outperform” rating on shares of Amazon.com in a research note on Friday, July 31st. Fifty-six investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $321.63.
Get Our Latest Stock Report on AMZN Key Headlines Impacting Amazon.com Here are the key news stories impacting Amazon.com this week:
Positive Sentiment: AWS data-center push received support: Amazon Web Services pledged more than $1 billion over five years for communities hosting its U.S. data centers, including job training, education and infrastructure initiatives. The investment is intended to ease resistance to new facilities and help Amazon secure capacity for AI workloads. Amazon to invest $1 billion over five years in US data center communities Positive Sentiment: AI and AWS growth remain the main bullish catalyst: Reports highlighted AWS’s rapid expansion, a more than $1 billion Synopsys agreement supporting custom-chip development, and Anthropic’s expected long-term AWS commitments of roughly $110 billion. Amazon also launched an AI agent that audits customers’ cloud environments, potentially increasing AWS usage while improving customer cost, security and performance management. Amazon Is Both Landlord And Shareholder In Anthropic’s Giant Cloud Bet Positive Sentiment: Analyst confidence provided additional support: Goldman Sachs added Amazon to its conviction list, while New Street raised its price target to $385 and maintained a Buy rating. Analysts cited AWS growth, generative AI exposure and potential retail-margin improvement as reasons for longer-term upside. New Street Adjusts Price Target on Amazon.com to $385 Neutral Sentiment: Amazon is reportedly exploring an $8 billion chip sale-and-leaseback: Moving Nvidia AI chips to an investment vehicle could make the balance sheet more asset-light and help fund capital spending, but it also underscores the scale of Amazon’s AI infrastructure costs and financing requirements. Amazon seeks to offload $8 billion of Nvidia chips Negative Sentiment: Investors face profitability and regulatory risks: Analysts questioned how much AWS earnings are distorted by unrealized Anthropic investment gains, while surging AI capital expenditures could pressure free cash flow. Potential tougher EU cloud rules, data-center opposition, warehouse labor actions and Prime-related settlement payments add further uncertainty. What Are Amazon Investors Paying for AWS Without Investment Gains? Insider Activity In other news, CEO Matthew S. Garman sold 14,541 shares of Amazon.com stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $259.06, for a total value of $3,766,991.46. Following the completion of the transaction, the chief executive officer owned 17,794 shares in the company, valued at $4,609,713.64. This trade represents a 44.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Andrew Jassy sold 20,000 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $259.01, for a total transaction of $5,180,200.00. Following the completion of the sale, the chief executive officer directly owned 2,235,766 shares in the company, valued at approximately $579,085,751.66. This trade represents a 0.89% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 70,589 shares of company stock valued at $18,329,015. 8.90% of the stock is currently owned by corporate insiders.
Amazon.com Price Performance Shares of NASDAQ AMZN opened at $251.52 on Monday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.03 and a quick ratio of 0.87. The stock has a market capitalization of $2.71 trillion, a PE ratio of 20.23, a P/E/G ratio of 1.95 and a beta of 1.45. Amazon.com, Inc. has a one year low of $196.00 and a one year high of $287.20. The business’s fifty day moving average price is $257.06 and its 200-day moving average price is $248.51.
Amazon.com (NASDAQ:AMZN – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The e-commerce giant reported $5.75 earnings per share for the quarter, topping the consensus estimate of $1.82 by $3.93. Amazon.com had a return on equity of 18.00% and a net margin of 17.44%.The company had revenue of $200.61 billion during the quarter, compared to analyst estimates of $197.03 billion. During the same quarter last year, the firm posted $1.68 EPS. The firm’s revenue for the quarter was up 19.6% on a year-over-year basis. On average, equities research analysts anticipate that Amazon.com, Inc. will post 8.01 EPS for the current year.
Amazon.com Profile (Free Report)
Amazon.com, Inc is a global technology and commerce company that operates online marketplaces, physical stores, and a broad portfolio of digital and cloud-based services. The company offers consumer products across categories such as electronics, household goods, apparel, groceries, and entertainment, while also providing third-party sellers with tools for listing, selling, and fulfilling orders.
Amazon’s major businesses include Amazon Web Services (AWS), which provides cloud computing, storage, database, analytics, and artificial intelligence services; Prime, a membership program that includes shipping, streaming, and other benefits; and digital entertainment services such as Prime Video, Amazon Music, Kindle, and Audible.
Further Reading Five stocks we like better than Amazon.com Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for Amazon.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amazon.com and related companies with MarketBeat.com's FREE daily email newsletter.
Angeles Wealth Management LLC lifted its stake in Amazon.com, Inc. (NASDAQ:AMZN – Free Report) by 18.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 118,524 shares of the e-commerce giant’s stock after purchasing an additional 18,648 shares during the period. Amazon.com accounts for about 1.1% of Angeles Wealth Management LLC’s investment portfolio, making the stock its 15th biggest holding. Angeles Wealth Management LLC’s holdings in Amazon.com were worth $28,249,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently modified their holdings of the company. Silvant Capital Management LLC purchased a new stake in Amazon.com in the 2nd quarter worth $60,065,000. Public Employees Retirement System of Ohio purchased a new position in shares of Amazon.com during the second quarter valued at about $909,868,000. Northstar Financial Companies Inc. bought a new stake in shares of Amazon.com in the second quarter worth about $3,376,000. Gryphon Financial Partners LLC increased its holdings in shares of Amazon.com by 7.5% in the first quarter. Gryphon Financial Partners LLC now owns 73,085 shares of the e-commerce giant’s stock worth $15,221,000 after purchasing an additional 5,125 shares during the last quarter. Finally, First Citizens Bank & Trust Co. increased its holdings in shares of Amazon.com by 1.7% in the first quarter. First Citizens Bank & Trust Co. now owns 303,862 shares of the e-commerce giant’s stock worth $63,285,000 after purchasing an additional 5,104 shares during the last quarter. Institutional investors own 72.20% of the company’s stock.
Key Headlines Impacting Amazon.com Here are the key news stories impacting Amazon.com this week:
Positive Sentiment: AWS data-center push received support: Amazon Web Services pledged more than $1 billion over five years for communities hosting its U.S. data centers, including job training, education and infrastructure initiatives. The investment is intended to ease resistance to new facilities and help Amazon secure capacity for AI workloads. Amazon to invest $1 billion over five years in US data center communities Positive Sentiment: AI and AWS growth remain the main bullish catalyst: Reports highlighted AWS’s rapid expansion, a more than $1 billion Synopsys agreement supporting custom-chip development, and Anthropic’s expected long-term AWS commitments of roughly $110 billion. Amazon also launched an AI agent that audits customers’ cloud environments, potentially increasing AWS usage while improving customer cost, security and performance management. Amazon Is Both Landlord And Shareholder In Anthropic’s Giant Cloud Bet Positive Sentiment: Analyst confidence provided additional support: Goldman Sachs added Amazon to its conviction list, while New Street raised its price target to $385 and maintained a Buy rating. Analysts cited AWS growth, generative AI exposure and potential retail-margin improvement as reasons for longer-term upside. New Street Adjusts Price Target on Amazon.com to $385 Neutral Sentiment: Amazon is reportedly exploring an $8 billion chip sale-and-leaseback: Moving Nvidia AI chips to an investment vehicle could make the balance sheet more asset-light and help fund capital spending, but it also underscores the scale of Amazon’s AI infrastructure costs and financing requirements. Amazon seeks to offload $8 billion of Nvidia chips Negative Sentiment: Investors face profitability and regulatory risks: Analysts questioned how much AWS earnings are distorted by unrealized Anthropic investment gains, while surging AI capital expenditures could pressure free cash flow. Potential tougher EU cloud rules, data-center opposition, warehouse labor actions and Prime-related settlement payments add further uncertainty. What Are Amazon Investors Paying for AWS Without Investment Gains? Analyst Ratings Changes A number of equities analysts recently commented on the company. Needham & Company LLC reissued a “buy” rating and set a $300.00 price target on shares of Amazon.com in a research note on Friday, July 31st. Pivotal Research reaffirmed a “buy” rating and issued a $333.00 price objective (up from $320.00) on shares of Amazon.com in a research note on Friday, July 31st. JPMorgan Chase & Co. upped their price objective on Amazon.com from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Mizuho set a $330.00 target price on Amazon.com and gave the company an “outperform” rating in a research report on Friday, July 31st. Finally, Royal Bank Of Canada raised their target price on shares of Amazon.com from $320.00 to $330.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Fifty-six equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $321.63. Check Out Our Latest Report on AMZN
Amazon.com Price Performance Shares of Amazon.com stock opened at $251.52 on Monday. The stock has a market cap of $2.71 trillion, a price-to-earnings ratio of 20.23, a price-to-earnings-growth ratio of 1.95 and a beta of 1.45. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.87 and a current ratio of 1.03. The stock has a 50 day moving average price of $257.06 and a 200-day moving average price of $248.51. Amazon.com, Inc. has a one year low of $196.00 and a one year high of $287.20.
Amazon.com (NASDAQ:AMZN – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The e-commerce giant reported $5.75 earnings per share for the quarter, beating the consensus estimate of $1.82 by $3.93. Amazon.com had a return on equity of 18.00% and a net margin of 17.44%.The company had revenue of $200.61 billion for the quarter, compared to analyst estimates of $197.03 billion. During the same quarter in the prior year, the firm posted $1.68 EPS. Amazon.com’s quarterly revenue was up 19.6% compared to the same quarter last year. Equities analysts expect that Amazon.com, Inc. will post 8.01 EPS for the current year.
Insider Buying and Selling In other news, SVP David Zapolsky sold 9,258 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $259.77, for a total transaction of $2,404,950.66. Following the transaction, the senior vice president owned 41,190 shares of the company’s stock, valued at approximately $10,699,926.30. This represents a 18.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Shelley Reynolds sold 2,343 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $259.01, for a total value of $606,860.43. Following the completion of the sale, the vice president owned 119,780 shares in the company, valued at approximately $31,024,217.80. The trade was a 1.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 70,589 shares of company stock worth $18,329,015 over the last three months. 8.90% of the stock is currently owned by company insiders.
Amazon.com Company Profile (Free Report)
Amazon.com, Inc is a global technology and commerce company that operates online marketplaces, physical stores, and a broad portfolio of digital and cloud-based services. The company offers consumer products across categories such as electronics, household goods, apparel, groceries, and entertainment, while also providing third-party sellers with tools for listing, selling, and fulfilling orders.
Amazon’s major businesses include Amazon Web Services (AWS), which provides cloud computing, storage, database, analytics, and artificial intelligence services; Prime, a membership program that includes shipping, streaming, and other benefits; and digital entertainment services such as Prime Video, Amazon Music, Kindle, and Audible.
See Also Five stocks we like better than Amazon.com Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for Amazon.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amazon.com and related companies with MarketBeat.com's FREE daily email newsletter.
Advisory Solutions Group LLC bought a new position in shares of Amazon.com, Inc. (NASDAQ:AMZN – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 6,726 shares of the e-commerce giant’s stock, valued at approximately $1,603,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Trust Asset Management LLC grew its stake in Amazon.com by 3.3% in the 2nd quarter. Trust Asset Management LLC now owns 107,563 shares of the e-commerce giant’s stock valued at $26,000 after buying an additional 3,414 shares during the last quarter. TOP Private Wealth LLC. bought a new position in Amazon.com in the 2nd quarter worth $29,000. Bard Associates Inc. acquired a new position in Amazon.com during the 2nd quarter worth $32,000. Longfellow Investment Management Co. LLC acquired a new position in Amazon.com during the 2nd quarter worth $33,000. Finally, Lifetime Wealth Management P.C. bought a new stake in Amazon.com during the fourth quarter valued at about $45,000. Institutional investors and hedge funds own 72.20% of the company’s stock.
Key Stories Impacting Amazon.com Here are the key news stories impacting Amazon.com this week:
Positive Sentiment: AWS data-center push received support: Amazon Web Services pledged more than $1 billion over five years for communities hosting its U.S. data centers, including job training, education and infrastructure initiatives. The investment is intended to ease resistance to new facilities and help Amazon secure capacity for AI workloads. Amazon to invest $1 billion over five years in US data center communities Positive Sentiment: AI and AWS growth remain the main bullish catalyst: Reports highlighted AWS’s rapid expansion, a more than $1 billion Synopsys agreement supporting custom-chip development, and Anthropic’s expected long-term AWS commitments of roughly $110 billion. Amazon also launched an AI agent that audits customers’ cloud environments, potentially increasing AWS usage while improving customer cost, security and performance management. Amazon Is Both Landlord And Shareholder In Anthropic’s Giant Cloud Bet Positive Sentiment: Analyst confidence provided additional support: Goldman Sachs added Amazon to its conviction list, while New Street raised its price target to $385 and maintained a Buy rating. Analysts cited AWS growth, generative AI exposure and potential retail-margin improvement as reasons for longer-term upside. New Street Adjusts Price Target on Amazon.com to $385 Neutral Sentiment: Amazon is reportedly exploring an $8 billion chip sale-and-leaseback: Moving Nvidia AI chips to an investment vehicle could make the balance sheet more asset-light and help fund capital spending, but it also underscores the scale of Amazon’s AI infrastructure costs and financing requirements. Amazon seeks to offload $8 billion of Nvidia chips Negative Sentiment: Investors face profitability and regulatory risks: Analysts questioned how much AWS earnings are distorted by unrealized Anthropic investment gains, while surging AI capital expenditures could pressure free cash flow. Potential tougher EU cloud rules, data-center opposition, warehouse labor actions and Prime-related settlement payments add further uncertainty. What Are Amazon Investors Paying for AWS Without Investment Gains? Wall Street Analyst Weigh In Several equities research analysts have recently issued reports on AMZN shares. Rosenblatt Securities raised their price target on Amazon.com from $335.00 to $360.00 and gave the company a “buy” rating in a research report on Wednesday, September 30th. JPMorgan Chase & Co. boosted their price objective on Amazon.com from $330.00 to $365.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Bank of America increased their target price on Amazon.com from $310.00 to $320.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Monness Crespi & Hardt raised their target price on Amazon.com from $315.00 to $330.00 and gave the company a “buy” rating in a report on Friday, July 31st. Finally, Truist Financial lifted their price target on Amazon.com from $320.00 to $350.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Fifty-six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Amazon.com presently has a consensus rating of “Moderate Buy” and an average target price of $321.63. Check Out Our Latest Report on Amazon.com
Insider Buying and Selling at Amazon.com In related news, SVP David Zapolsky sold 9,258 shares of the firm’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $259.77, for a total value of $2,404,950.66. Following the completion of the transaction, the senior vice president directly owned 41,190 shares of the company’s stock, valued at $10,699,926.30. This trade represents a 18.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Shelley Reynolds sold 2,343 shares of Amazon.com stock in a transaction on Friday, August 21st. The stock was sold at an average price of $259.01, for a total transaction of $606,860.43. Following the sale, the vice president owned 119,780 shares in the company, valued at $31,024,217.80. This represents a 1.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 70,589 shares of company stock valued at $18,329,015 in the last quarter. 8.90% of the stock is currently owned by corporate insiders.
Amazon.com Stock Performance Shares of AMZN opened at $251.52 on Monday. Amazon.com, Inc. has a 12-month low of $196.00 and a 12-month high of $287.20. The company has a quick ratio of 0.87, a current ratio of 1.03 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $2.71 trillion, a price-to-earnings ratio of 20.23, a P/E/G ratio of 1.95 and a beta of 1.45. The stock’s 50-day moving average price is $257.06 and its 200 day moving average price is $248.51.
Amazon.com (NASDAQ:AMZN – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The e-commerce giant reported $5.75 EPS for the quarter, beating the consensus estimate of $1.82 by $3.93. Amazon.com had a return on equity of 18.00% and a net margin of 17.44%.The firm had revenue of $200.61 billion during the quarter, compared to analysts’ expectations of $197.03 billion. During the same quarter in the prior year, the firm posted $1.68 EPS. The company’s revenue for the quarter was up 19.6% on a year-over-year basis. As a group, research analysts predict that Amazon.com, Inc. will post 8.01 earnings per share for the current year.
Amazon.com Company Profile (Free Report)
Amazon.com, Inc is a global technology and commerce company that operates online marketplaces, physical stores, and a broad portfolio of digital and cloud-based services. The company offers consumer products across categories such as electronics, household goods, apparel, groceries, and entertainment, while also providing third-party sellers with tools for listing, selling, and fulfilling orders.
Amazon’s major businesses include Amazon Web Services (AWS), which provides cloud computing, storage, database, analytics, and artificial intelligence services; Prime, a membership program that includes shipping, streaming, and other benefits; and digital entertainment services such as Prime Video, Amazon Music, Kindle, and Audible.
Recommended Stories Five stocks we like better than Amazon.com Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for Amazon.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amazon.com and related companies with MarketBeat.com's FREE daily email newsletter.
Ketron Financial lowered its stake in Microsoft Corporation (NASDAQ:MSFT – Free Report) by 11.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 32,056 shares of the software giant’s stock after selling 3,994 shares during the quarter. Microsoft comprises about 3.7% of Ketron Financial’s portfolio, making the stock its 6th biggest holding. Ketron Financial’s holdings in Microsoft were worth $11,958,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently bought and sold shares of MSFT. Friedenthal Financial raised its position in Microsoft by 6.2% in the first quarter. Friedenthal Financial now owns 431 shares of the software giant’s stock valued at $160,000 after purchasing an additional 25 shares during the period. Sequent Planning LLC lifted its stake in Microsoft by 0.7% during the 1st quarter. Sequent Planning LLC now owns 3,733 shares of the software giant’s stock worth $1,382,000 after acquiring an additional 25 shares in the last quarter. Riverpoint Wealth Management Holdings LLC lifted its stake in Microsoft by 0.5% during the 1st quarter. Riverpoint Wealth Management Holdings LLC now owns 5,543 shares of the software giant’s stock worth $2,052,000 after acquiring an additional 26 shares in the last quarter. American Investment Services Inc. boosted its holdings in Microsoft by 3.1% during the 1st quarter. American Investment Services Inc. now owns 876 shares of the software giant’s stock valued at $324,000 after acquiring an additional 26 shares during the period. Finally, REAP Financial Group LLC grew its position in Microsoft by 1.1% in the 2nd quarter. REAP Financial Group LLC now owns 2,453 shares of the software giant’s stock valued at $915,000 after acquiring an additional 26 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company’s stock.
Microsoft Stock Performance Shares of Microsoft stock opened at $517.53 on Monday. The firm has a market capitalization of $3.84 trillion, a P/E ratio of 28.82, a P/E/G ratio of 1.66 and a beta of 1.10. Microsoft Corporation has a 52 week low of $349.20 and a 52 week high of $553.72. The company has a quick ratio of 1.22, a current ratio of 1.23 and a debt-to-equity ratio of 0.07. The firm’s 50 day moving average is $490.08 and its two-hundred day moving average is $430.19.
Microsoft (NASDAQ:MSFT – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The software giant reported $4.74 EPS for the quarter, topping the consensus estimate of $4.24 by $0.50. The firm had revenue of $90.01 billion for the quarter, compared to analyst estimates of $87.62 billion. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. Microsoft’s revenue for the quarter was up 17.7% compared to the same quarter last year. During the same period last year, the business earned $3.65 EPS. Research analysts forecast that Microsoft Corporation will post 19.62 EPS for the current fiscal year. Microsoft Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Thursday, December 10th. Investors of record on Thursday, November 19th will be given a $0.98 dividend. This is a boost from Microsoft’s previous quarterly dividend of $0.91. The ex-dividend date of this dividend is Thursday, November 19th. This represents a $3.92 dividend on an annualized basis and a dividend yield of 0.8%. Microsoft’s payout ratio is currently 20.27%.
Analyst Ratings Changes Several equities research analysts recently weighed in on MSFT shares. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Microsoft in a research note on Monday, July 20th. Mizuho reduced their price objective on Microsoft from $515.00 to $490.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 15th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Microsoft in a report on Thursday, September 10th. Barclays decreased their price objective on Microsoft from $545.00 to $512.00 and set an “overweight” rating for the company in a research note on Thursday, July 30th. Finally, KeyCorp reissued an “overweight” rating on shares of Microsoft in a research report on Thursday, September 3rd. Forty-three research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $571.18.
Check Out Our Latest Stock Analysis on Microsoft
Insider Transactions at Microsoft In other news, EVP Amy Hood sold 41,674 shares of Microsoft stock in a transaction on Monday, September 14th. The shares were sold at an average price of $498.27, for a total value of $20,764,903.98. Following the transaction, the executive vice president directly owned 533,624 shares of the company’s stock, valued at $265,888,830.48. The trade was a 7.24% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Satya Nadella sold 86,525 shares of the company’s stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $501.46, for a total transaction of $43,388,826.50. Following the completion of the sale, the chief executive officer owned 486,763 shares of the company’s stock, valued at approximately $244,092,173.98. This trade represents a 15.09% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 143,009 shares of company stock worth $71,420,699 in the last three months. Corporate insiders own 0.03% of the company’s stock.
Key Stories Impacting Microsoft Here are the key news stories impacting Microsoft this week:
Positive Sentiment: Azure and AI demand remain the primary catalyst. Investor data and analyst commentary point to accelerating Azure demand, while Microsoft’s recent earnings showed its fastest cloud growth in four years. The improving demand is helping ease concerns that the company’s substantial AI infrastructure spending will not generate adequate returns. Ca$htag: MSFT Azure Cloud Drives Soaring Demand Positive Sentiment: Wells Fargo added Microsoft to its Q4 Tactical Ideas list and raised its price target to $725, citing Azure’s growth potential and the prospect of improved AI monetization through Copilot. The action adds to a series of bullish analyst revisions; one report noted that 52 analysts covering Microsoft currently have no sell ratings. With Azure as a Catalyst, Microsoft Is Positioned for Sustained Growth Positive Sentiment: Microsoft’s OpenAI relationship provides potential additional value. Investors are increasingly focused on Microsoft’s stake and commercial partnership with OpenAI, particularly ahead of a possible OpenAI initial public offering that could provide a market reference for the investment. OpenAI’s Future IPO Keeps Me Buying Microsoft Positive Sentiment: Microsoft introduced new real-time AI speech models for customer-service agents, multilingual assistants and voice interfaces. The products broaden Microsoft’s enterprise AI offering and could support additional cloud consumption and software revenue. Microsoft Targets Contact Center Market With Real-Time AI Voice Models Neutral Sentiment: Investors are awaiting Microsoft’s October 7 Surface and Windows event. New hardware or Windows updates could support the ecosystem, although the event has not yet produced a material earnings catalyst. Microsoft Stock Notches Up Ahead of the Surface Show Negative Sentiment: Risks include heavy AI capital spending, valuation concerns and broader market concentration. Critics argue that rising data-center capacity could pressure compute pricing and returns, while strategists warn that a market correction could disproportionately affect megacap technology stocks. Microsoft’s dividend remains affordable, but AI infrastructure spending and lease commitments could limit future dividend growth. Morgan Stanley Strategist Sees Market Drawdown Potential Microsoft Profile (Free Report)
Microsoft Corporation is a global technology company that develops software, cloud services, devices, gaming products and business solutions. Founded in 1975 by Bill Gates and Paul Allen, the company is best known for the Windows operating system and Microsoft Office productivity software. Microsoft is headquartered in Redmond, Washington, and serves consumers, businesses, governments and educational institutions worldwide.
Microsoft’s productivity and business offerings include Microsoft 365 applications such as Word, Excel, PowerPoint and Outlook, along with collaboration tools including Teams.
Read More Five stocks we like better than Microsoft Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning? Want to see what other hedge funds are holding MSFT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Microsoft Corporation (NASDAQ:MSFT – Free Report).
Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
Cumberland Partners Ltd lifted its holdings in shares of Microsoft Corporation (NASDAQ:MSFT – Free Report) by 18.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 176,987 shares of the software giant’s stock after purchasing an additional 27,230 shares during the quarter. Microsoft comprises about 4.3% of Cumberland Partners Ltd’s holdings, making the stock its 3rd biggest holding. Cumberland Partners Ltd’s holdings in Microsoft were worth $66,020,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Friedenthal Financial boosted its position in Microsoft by 6.2% in the 1st quarter. Friedenthal Financial now owns 431 shares of the software giant’s stock valued at $160,000 after buying an additional 25 shares during the period. Sequent Planning LLC grew its stake in shares of Microsoft by 0.7% in the first quarter. Sequent Planning LLC now owns 3,733 shares of the software giant’s stock worth $1,382,000 after acquiring an additional 25 shares in the last quarter. Riverpoint Wealth Management Holdings LLC increased its position in shares of Microsoft by 0.5% during the first quarter. Riverpoint Wealth Management Holdings LLC now owns 5,543 shares of the software giant’s stock worth $2,052,000 after acquiring an additional 26 shares during the period. American Investment Services Inc. increased its position in shares of Microsoft by 3.1% during the first quarter. American Investment Services Inc. now owns 876 shares of the software giant’s stock worth $324,000 after acquiring an additional 26 shares during the period. Finally, REAP Financial Group LLC raised its stake in shares of Microsoft by 1.1% in the second quarter. REAP Financial Group LLC now owns 2,453 shares of the software giant’s stock valued at $915,000 after acquiring an additional 26 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company’s stock.
Analysts Set New Price Targets A number of research analysts recently issued reports on MSFT shares. Wells Fargo & Company lifted their target price on Microsoft from $700.00 to $725.00 and gave the company an “overweight” rating in a report on Thursday. Morgan Stanley restated an “overweight” rating on shares of Microsoft in a report on Thursday, July 30th. Mizuho reduced their price target on Microsoft from $515.00 to $490.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 15th. Oppenheimer lifted their price objective on Microsoft from $515.00 to $570.00 and gave the company an “outperform” rating in a research note on Tuesday, September 22nd. Finally, TD Cowen reissued a “buy” rating and set a $540.00 price objective on shares of Microsoft in a research report on Thursday, July 30th. Forty-three analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $571.18.
Read Our Latest Stock Report on MSFT Insider Transactions at Microsoft In related news, CEO Satya Nadella sold 86,525 shares of the company’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $501.46, for a total value of $43,388,826.50. Following the completion of the sale, the chief executive officer directly owned 486,763 shares of the company’s stock, valued at $244,092,173.98. This represents a 15.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Judson Althoff sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $487.89, for a total value of $4,878,900.00. Following the transaction, the chief executive officer owned 100,447 shares in the company, valued at $49,007,086.83. This represents a 9.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 143,009 shares of company stock worth $71,420,699. 0.03% of the stock is owned by company insiders.
Key Headlines Impacting Microsoft Here are the key news stories impacting Microsoft this week:
Positive Sentiment: Azure and AI demand remain the primary catalyst. Investor data and analyst commentary point to accelerating Azure demand, while Microsoft’s recent earnings showed its fastest cloud growth in four years. The improving demand is helping ease concerns that the company’s substantial AI infrastructure spending will not generate adequate returns. Ca$htag: MSFT Azure Cloud Drives Soaring Demand Positive Sentiment: Wells Fargo added Microsoft to its Q4 Tactical Ideas list and raised its price target to $725, citing Azure’s growth potential and the prospect of improved AI monetization through Copilot. The action adds to a series of bullish analyst revisions; one report noted that 52 analysts covering Microsoft currently have no sell ratings. With Azure as a Catalyst, Microsoft Is Positioned for Sustained Growth Positive Sentiment: Microsoft’s OpenAI relationship provides potential additional value. Investors are increasingly focused on Microsoft’s stake and commercial partnership with OpenAI, particularly ahead of a possible OpenAI initial public offering that could provide a market reference for the investment. OpenAI’s Future IPO Keeps Me Buying Microsoft Positive Sentiment: Microsoft introduced new real-time AI speech models for customer-service agents, multilingual assistants and voice interfaces. The products broaden Microsoft’s enterprise AI offering and could support additional cloud consumption and software revenue. Microsoft Targets Contact Center Market With Real-Time AI Voice Models Neutral Sentiment: Investors are awaiting Microsoft’s October 7 Surface and Windows event. New hardware or Windows updates could support the ecosystem, although the event has not yet produced a material earnings catalyst. Microsoft Stock Notches Up Ahead of the Surface Show Negative Sentiment: Risks include heavy AI capital spending, valuation concerns and broader market concentration. Critics argue that rising data-center capacity could pressure compute pricing and returns, while strategists warn that a market correction could disproportionately affect megacap technology stocks. Microsoft’s dividend remains affordable, but AI infrastructure spending and lease commitments could limit future dividend growth. Morgan Stanley Strategist Sees Market Drawdown Potential Microsoft Price Performance Shares of NASDAQ:MSFT opened at $517.53 on Monday. The firm has a 50 day simple moving average of $490.08 and a 200-day simple moving average of $430.19. Microsoft Corporation has a twelve month low of $349.20 and a twelve month high of $553.72. The company has a current ratio of 1.23, a quick ratio of 1.22 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $3.84 trillion, a PE ratio of 28.82, a P/E/G ratio of 1.66 and a beta of 1.10.
Microsoft (NASDAQ:MSFT – Get Free Report) last posted its earnings results on Wednesday, July 29th. The software giant reported $4.74 EPS for the quarter, beating analysts’ consensus estimates of $4.24 by $0.50. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. The firm had revenue of $90.01 billion for the quarter, compared to the consensus estimate of $87.62 billion. During the same period last year, the firm posted $3.65 EPS. The company’s revenue was up 17.7% on a year-over-year basis. On average, equities analysts predict that Microsoft Corporation will post 19.62 EPS for the current fiscal year.
Microsoft Increases Dividend The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 10th. Shareholders of record on Thursday, November 19th will be issued a dividend of $0.98 per share. The ex-dividend date of this dividend is Thursday, November 19th. This is a positive change from Microsoft’s previous quarterly dividend of $0.91. This represents a $3.92 annualized dividend and a dividend yield of 0.8%. Microsoft’s dividend payout ratio is 20.27%.
Microsoft Profile (Free Report)
Microsoft Corporation is a global technology company that develops software, cloud services, devices, gaming products and business solutions. Founded in 1975 by Bill Gates and Paul Allen, the company is best known for the Windows operating system and Microsoft Office productivity software. Microsoft is headquartered in Redmond, Washington, and serves consumers, businesses, governments and educational institutions worldwide.
Microsoft’s productivity and business offerings include Microsoft 365 applications such as Word, Excel, PowerPoint and Outlook, along with collaboration tools including Teams.
Read More Five stocks we like better than Microsoft Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning? Want to see what other hedge funds are holding MSFT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Microsoft Corporation (NASDAQ:MSFT – Free Report).
Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
Microsoft mění strategii AI na účtování podle využití, protože Copilot a další nástroje zatím nejsou v podnicích dost rozšířené. Nadella chce, aby byla AI nasazená napříč firmami, ne jen v několika produktech.
On a sunny day in Seattle in late September, about 50 executives representing large Microsoft customers had a rare opportunity. They could ask anything of CEO Satya Nadella.
One attendee wanted to know what Microsoft could do to help companies adapt to the artificial intelligence age. Nadella responded by emphasizing the importance of "diffusion inside the enterprise," meaning AI tools need to be widely deployed.
"Like all things, change is always bottom up, top down, and middle up," said Nadella, sporting a tight black crewneck and dark gray slacks, as he strode across the stage at the downtown Paccar Pavilion.
For the 59-year-old Nadella, who's spent over half his life at Microsoft, the gathering landed at a pivotal moment, as the software giant tries to magnify its role in the AI boom. Of late, Nadella has been inserting himself more into the AI discourse, posting on X last month about the need for "deliberate pacing" in model development, and days later addressing safety fears at the All-In Summit in Los Angeles.
Despite its almost $4 trillion market cap, Microsoft has yet to break out as an AI leader. Nvidia dominates in AI chips, Anthropic and OpenAI boast the foremost models, Meta just released the first mass-market personal agent, and Google's Gemini-powered services are popular with businesses and consumers.
Microsoft was aggressively early to AI through an investment in OpenAI, but that alliance has frayed. While the software giant has a big business in renting out chips for AI developers through its Azure cloud, its Copilot technology isn't pervasive in the workplace, and its proprietary AI models remain niche.
The company is hosting a Windows and Surface event in San Francisco on Wednesday, describing it in an invitation as "a conversation on how local AI will shape the next chapter of the PC."
Wall Street is lukewarm on the story. Even factoring in a sharp third-quarter rally, the stock is trailing its megacap peers and the broader Nasdaq this year, up just 7% as of Friday's close. Microsoft hasn't beaten the S&P 500 in a calendar year since 2023.
Nasdaq vs. S&P 500 since the end of 2023
Tiffany Wade, co-portfolio manager at Microsoft shareholder Columbia Threadneedle, said there are a lot of unknowns about Copilot, which is the centerpiece of Nadella's AI strategy.
"I think there needs to be a little bit more maturity of the product before we figure out actually what the best solution or what pricing is," Wade said in an interview.
For longtime Microsoft investors, Nadella has a solid track record when it comes to navigating industry shifts. He was named CEO in 2014, succeeding Steve Ballmer, who had presided over a roughly 33% drop in the stock price during his 14-year tenure, as Microsoft slipped into the beleaguered category of legacy software.
Nadella proceeded to turn Microsoft into a cloud powerhouse. He tossed aside perpetual Office software licenses and pushed the company into subscription-based software-as-a-service offerings alongside Azure infrastructure. And he permitted customers to integrate products from bitter rivals like Oracle and Salesforce, rather than insisting on a pure Microsoft stack.
Trained as an electrical engineer and computer scientist, Nadella became a savvy dealmaker, expanding Microsoft through acquisitions of "Minecraft"-maker Mojang, business social network LinkedIn and code-sharing service GitHub.
In recent months, Nadella has acknowledged to investors that he's got to change the business model yet again, this time to reflect the AI-fueled move toward consumption-based pricing. That means becoming a vendor of large volumes of tokens, which measure computing usage and represent the currency of the AI economy.
Success would mean "further expanding our TAM," Nadella said on Microsoft's July earnings call, adopting the acronym for total addressable market.
watch now
Much of the growth story Nadella preaches involves the production of software. Develop more code and do it faster, boosted by the latest and greatest AI tools.
"We went from the code assist to the agentic coding to software factory all within one year," Nadella said at the customer gathering late last month.
Now he wants to see Microsoft clients open their own software factories, spending more along the way to help churn out code. He's also hoping to empower non-technical knowledge workers. Some of Nadella's lieutenants at the event unveiled a Copilot "super app" that can perform increasingly complex tasks, generate simple applications and function as a virtual teammate.
Nadella had a preview of what was coming.
Microsoft first invested in OpenAI in 2019, when the company was still a fledgling lab. In 2021, a year before ChatGPT launched, Microsoft and OpenAI collaborated to release GitHub Copilot, a tool that could write parts of applications and websites based on vast swaths of public source code.
They'd created an early sensation. But as the generative AI market took off, developers moved to products from AI-native startups like Cursor, now owned by SpaceX, and Anthropic, which rolled out Claude Code.
'Learned lessons'Microsoft's sluggishness in keeping up with the rapid changes cost GitHub market share.
Earlier this year, Microsoft adjusted the pricing for the coding tool to align more with computing demand. Some customers initially balked, but by July the company said it had racked up 50 million users, up from 26 million last October, meaning that one in five on GitHub were on board.
Nadella said on the July earnings call that GitHub Copilot sales growth accelerated 60% from the previous quarter, with "significant consumption revenue after the new model went into effect."
"GitHub Copilot went out and learned lessons," said Kyle Daigle, the unit's operating chief, in an interview.
Daigle said GitHub employees shared their lessons with other teams at Microsoft that are eyeing consumption-based pricing schemes.
Hayete Gallot, Microsoft's executive vice president for security products, said the company will charge clients according to how intensely they use the technology.
"I always say to my team, when customers consume, it means we add value. And for me, the truth starts with customers," Gallot said. "If they don't consume, it means we're not giving value."
Currently, Microsoft's enterprise portfolio is reliant on subscriptions. For its core Microsoft 365 productivity suite, which includes Word, Excel and Teams, customers sign up for years at a time, and Copilot costs an extra $30 per person each month. Microsoft has 30 million Copilot seats. The commercial Office 365 base exceeds 450 million.
One area of uncertainty in Microsoft's AI roadmap revolves around Mustafa Suleyman.
Suleyman previously co-founded AI lab DeepMind, which Google bought in 2014. Nadella hired him in 2024 to lead AI initiatives as Microsoft's relationship with OpenAI was cooling.
Last year, Microsoft lost its status as OpenAI's exclusive cloud provider, and this year its license on OpenAI intellectual property became non-exclusive. That left the software company with a massive investment in the AI lab but less preferential treatment. Microsoft said in April that it continues to serve as OpenAI's "primary cloud partner."
Suleyman's group has rolled out models for coding, image generation and reasoning. This week he boasted on X that a new speech-to-text model was "the most accurate real time transcription model in the world... #1 !!!" But for raw digital intellect, the team has yet to rival Anthropic or OpenAI, according to independent leaderboards.
Microsoft executives say there are benefits to having model and application development under the same roof. The group building Teams and other Office productivity apps has seen higher performance from Suleyman's transcription models at a lower price, and engineers get clear feedback as they build out products, said Executive Vice President Charles Lamanna.
"The collaboration is much tighter with Mustafa," he said.
Suleyman maintains a high profile at Microsoft, but his responsibilities have shifted. In March, Microsoft announced that it was bringing together the engineering groups for its commercial and consumer Copilot assistants, as adoption had been sluggish. Jacob Andreou was promoted to executive vice president for Copilot experience, and Suleyman was charged with focusing on model development.
Nadella, meanwhile, has been downplaying the importance of world-beating models in isolation.
"In my view, our priority has to be building a frontier ecosystem, not just a frontier model, so value flows broadly across every company, every industry, and every country," he wrote in a post on his SN Scratchpad website in June.
At the September Copilot event, Nadella stood before a slide declaring that Copilot could connect to "every model," with the Anthropic, OpenAI, SpaceX and Microsoft AI logos.
Fixing the economicsIncreasingly, Microsoft is finding the model leaders encroaching on its turf, as they release products for cybersecurity, customer service and other functions.
In January, as Anthropic's Claude Code was building momentum, Microsoft executives were impressed with its ability to tap a bevy of tools to get things done, said Jared Spataro, Microsoft's marketing chief for AI at work. Microsoft was losing deals to Anthropic, promoting a close study of a rising competitor, said a person familiar with the matter, who asked not to be named due to confidentiality.
A Microsoft spokesperson declined to comment.
Spataro said the company sensed a need to change the mechanics.
"It became very clear to us at that moment. Like, oh wow, the economics are not going to be such that we're going to be able to offer now the best outcome within a fixed price per user per month," Spataro said. "We realized that we needed to start to think about the business model."
The company got cracking on a more comprehensive approach to consumption-based pricing that it calls usage-based billing, or UBB. The first UBB product was Copilot Cowork, which accepts large productivity assignments and shows its progress, Spataro said.
Nadella said on the July earnings call that "earlier this month, we added usage-based billing to Cowork with thousands of customers already paying for and actively using it."
Derrick Wood, an analyst at Cowen, said it was a strong signal.
"It may have the effect of what we saw when Claude Code, for example, shifted to consumption pricing, and you saw token bills go significantly higher," said Wood, who recommends buying Microsoft shares. "There's definitely the possibility for that to happen with Cowork."
Nadella is a user. On a podcast recorded after the September event, he said he can ask Cowork to prepare a supply chain optimization spreadsheet showing multiple scenarios.
"It'll create a fantastic artifact," he said.
David Berry, a vice president at advisory group Directions on Microsoft, said budget-conscious IT executives aren't all ready to take the Cowork plunge.
"There's a very real concern that you just kind of turn it on and people are going to start draining the bank," Berry said. "There's no way to determine if people are actually getting any benefit from it."
With the ChatGPT era nearing its four-year anniversary, Microsoft is still looking for a smash hit, whether at the model or application layer. While Nadella earned investor trust in reviving Microsoft once, he can't afford to let the company become an also-ran in AI.
Berry said he still sees Nadella as the right person to command the ship.
"He seems to be able to handle the situations or identify the situations and come up with a plan to change and evolve the business," he said. "The challenge is we're facing a lot more of the unknowns in a sense with AI, so it's a lot of different market dynamics going on, but he seems to have a plan, and he's working the plan."
In Seattle, Nadella ended his response to the transformation question by saying that those at the top of organizations play a key role.
"Leaders who are hands-on are able to change," he said. "Otherwise, they're all from press event to press event, right?"
He added, "It's kind of like you've got to be in it."
AMD má pro OpenAI a Meta opce až na 320 milionů akcií za 0,01 USD, což by při plném uplatnění zvýšilo počet akcií zhruba na 1,95 miliardy. Vše ale závisí na dodávkách GPU a splnění podmínek.
When Advanced Micro Devices (AMD +2.95%) agreed in October 2025 to supply OpenAI with up to 6 gigawatts of its artificial intelligence (AI) chips, it also gave OpenAI a warrant for up to 160 million AMD shares at $0.01 each. In February, Meta Platforms (META +0.30%) signed on for up to another 6 gigawatts and got a similar deal.
The last batch of shares under each warrant carries a $600 stock price threshold. This looked far off when the OpenAI deal was announced, with AMD stock near $165. But the stock first closed above $600 on Sept. 21, and it traded around $616 as of this writing.
At that price, 320 million shares would be worth about $197 billion.
Image source: Advanced Micro Devices Inc.
AMD stock is already past $600The two warrants work nearly the same way. Each covers up to 160 million shares at an exercise price of a penny. The first tranche vests with the customer's first gigawatt of AMD Instinct graphics processing units (GPUs), and all 160 million shares vest only when its purchases hit 6 gigawatts. A gigawatt measures the electricity a data center draws, so it sizes a deployment by power instead of by chip count.
Each tranche also has a stock price threshold, and those climb to $600 for the final tranche. OpenAI's warrant adds separate stock-performance thresholds on top of that. OpenAI and Meta have technical and commercial conditions to meet, too, before vested shares can be exercised. OpenAI's warrant runs through Oct. 5, 2030, and Meta's through Feb. 23, 2031.
As of June 27, no warrant shares had vested, according to AMD's latest quarterly filing. That's not a surprise, because shipments for both customers' first gigawatt were set to start in the second half of this year. But with the stock over $600, I think the GPU deliveries now matter more for vesting than the share price does.
AMD had around 1.63 billion shares outstanding as of July 29, according to its second-quarter 10-Q. Adding 320 million would bring the total to around 1.95 billion.
In other words, OpenAI and Meta might wind up owning around 16% of the enlarged company. Every current share's claim on AMD's profit would drop by about the same 16%, with the same earnings spread among more shares.
And buybacks can't help much. AMD bought back just $221 million of its stock in the first half of 2026. Even the $9.2 billion left on its authorization as of June 27 would retire only around 15 million shares at about $616 per share.
Meanwhile, AMD's pending all-stock purchase of AI research lab World Labs, valued at about $8.2 billion, might add roughly 13 million extra shares at this price.
12 gigawatts of GPUsThe warrant shares only appear if the GPUs ship, though.
"[I]n terms of the revenue per gigawatt, I think we've said double-digit billions. We're still in that range," CEO Lisa Su said on AMD's second-quarter earnings call in August.
Even at the bottom of that range, 12 gigawatts comes to at least $120 billion in revenue before every warrant share vests. That's more than seven times the $16.6 billion AMD's data center segment brought in during all of 2025.
And the segment is gaining speed. Data center revenue climbed from $5.4 billion in Q4 2025 to $5.8 billion in Q1 2026 and $6.7 billion in Q2 -- more than doubling year over year in that latest quarter. Sequential growth accelerated from around 7% to 16%.
Sure, AMD is giving up lots of stock for these sales. Split evenly, 320 million shares across 12 gigawatts is around 27 million shares a gigawatt, or about $16 billion in stock at $616 a share. AMD hasn't revealed the size of each tranche, so the real number per gigawatt might differ.
Management argues the trade pays off. When the OpenAI deal was announced, CFO Jean Hu said it was "expected to be highly accretive to AMD's non-GAAP earnings-per-share." In other words, the extra profit should more than make up for the extra shares.
Premium Feature
Moneyball Superscore
94/100
Today's Change
(
2.95
%) $
18.18
Current Price
$
633.91
The dilution isn't my top worryI think management's case is plausible. After all, the warrant shares can only exist if AMD delivers the sales behind them.
My bigger concern is the price. AMD stock costs around 40 times the earnings analysts expect for 2027. If all 320 million warrant shares existed now, the same profit would put the stock closer to 47 times earnings.
The stock is also already past the $600 mark set for the last tranche. But at around $616 per share, I think investors are paying now for gigawatts AMD still needs to deliver over the next several years.
Oriental Harbor Investment Master Fund ve 2. čtvrtletí snížil podíl v NVIDIA o 15,7 % a prodal 201 882 akcií. Po transakci držel 1 083 827 akcií v hodnotě 216,863,000 USD.
Oriental Harbor Investment Master Fund reduced its stake in NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 15.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,083,827 shares of the computer hardware maker’s stock after selling 201,882 shares during the period. NVIDIA makes up approximately 13.1% of Oriental Harbor Investment Master Fund’s portfolio, making the stock its 3rd biggest position. Oriental Harbor Investment Master Fund’s holdings in NVIDIA were worth $216,863,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also made changes to their positions in the stock. Bank of America Corp DE boosted its position in shares of NVIDIA by 2.1% during the first quarter. Bank of America Corp DE now owns 191,200,989 shares of the computer hardware maker’s stock worth $33,345,453,000 after buying an additional 4,019,505 shares during the period. Invesco Ltd. raised its holdings in shares of NVIDIA by 0.3% in the 4th quarter. Invesco Ltd. now owns 143,239,504 shares of the computer hardware maker’s stock valued at $26,714,167,000 after buying an additional 446,178 shares during the period. Amundi lifted its stake in NVIDIA by 10.4% during the 1st quarter. Amundi now owns 133,768,018 shares of the computer hardware maker’s stock worth $23,329,141,000 after acquiring an additional 12,575,177 shares in the last quarter. J. Stern & Co. LLP grew its position in NVIDIA by 13,709.1% in the 4th quarter. J. Stern & Co. LLP now owns 125,760,307 shares of the computer hardware maker’s stock valued at $23,454,297,000 after acquiring an additional 124,849,603 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in NVIDIA by 0.6% during the first quarter. Dimensional Fund Advisors LP now owns 94,521,253 shares of the computer hardware maker’s stock worth $16,479,126,000 after purchasing an additional 555,221 shares during the period. 65.27% of the stock is currently owned by institutional investors and hedge funds.
NVIDIA Price Performance Shares of NVDA opened at $233.95 on Monday. The firm has a market capitalization of $5.64 trillion, a price-to-earnings ratio of 29.58, a PEG ratio of 1.81 and a beta of 2.22. The firm’s fifty day simple moving average is $218.74 and its 200-day simple moving average is $207.65. NVIDIA Corporation has a twelve month low of $164.27 and a twelve month high of $237.88. The company has a current ratio of 4.59, a quick ratio of 3.85 and a debt-to-equity ratio of 0.14.
NVIDIA (NASDAQ:NVDA – Get Free Report) last issued its earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 EPS for the quarter, topping analysts’ consensus estimates of $2.09 by $0.13. The firm had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The company’s revenue was up 105.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.05 earnings per share. Equities analysts forecast that NVIDIA Corporation will post 9.25 EPS for the current fiscal year. NVIDIA announced that its board has authorized a share repurchase program on Monday, September 28th that authorizes the company to buyback $150.00 billion in outstanding shares. This buyback authorization authorizes the computer hardware maker to buy up to 2.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its shares are undervalued.
NVIDIA Dividend Announcement The firm also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Thursday, September 10th. NVIDIA’s payout ratio is 12.64%.
Insider Transactions at NVIDIA In other news, Director Mark A. Stevens sold 622,239 shares of the firm’s stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $231.62, for a total transaction of $144,122,997.18. Following the sale, the director owned 2,336,531 shares of the company’s stock, valued at approximately $541,187,310.22. This trade represents a 21.03% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Timothy S. Teter sold 30,460 shares of the business’s stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $222.80, for a total value of $6,786,488.00. Following the sale, the executive vice president owned 2,687,660 shares of the company’s stock, valued at approximately $598,810,648. The trade was a 1.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 1,766,118 shares of company stock valued at $399,450,353. 3.94% of the stock is currently owned by corporate insiders.
Key Headlines Impacting NVIDIA Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution Analysts Set New Price Targets NVDA has been the topic of several research reports. Wells Fargo & Company set a $210.00 price target on shares of NVIDIA in a research report on Friday. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of NVIDIA in a research note on Monday, August 31st. Itau BBA Securities decreased their price target on shares of NVIDIA from $256.00 to $218.00 in a research report on Wednesday, June 24th. UBS Group set a $300.00 price target on shares of NVIDIA and gave the stock a “buy” rating in a research note on Thursday, August 27th. Finally, Piper Sandler initiated coverage on NVIDIA in a research report on Wednesday, September 9th. They set an “overweight” rating and a $300.00 price objective on the stock. Four analysts have rated the stock with a Strong Buy rating, fifty have issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $320.71.
View Our Latest Research Report on NVDA
NVIDIA Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Recommended Stories Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Fischer Financial Services Inc. grew its stake in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 3.0% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 109,580 shares of the computer hardware maker’s stock after acquiring an additional 3,197 shares during the quarter. NVIDIA comprises about 5.5% of Fischer Financial Services Inc.’s portfolio, making the stock its 6th biggest holding. Fischer Financial Services Inc.’s holdings in NVIDIA were worth $21,926,000 as of its most recent filing with the SEC.
Other hedge funds have also recently bought and sold shares of the company. Lifetime Wealth Management P.C. bought a new position in NVIDIA in the fourth quarter valued at approximately $26,000. Longview Financial Advisors Inc. bought a new position in shares of NVIDIA in the 1st quarter valued at $27,000. Langley Wealth Management LLC bought a new position in shares of NVIDIA in the 2nd quarter valued at $34,000. Phillip James Consulting Co. acquired a new position in shares of NVIDIA during the 1st quarter worth $40,000. Finally, Frankly Finances LLC acquired a new position in NVIDIA during the second quarter worth about $60,000. 65.27% of the stock is owned by institutional investors.
NVIDIA Stock Performance NASDAQ NVDA opened at $233.95 on Monday. The firm has a market capitalization of $5.64 trillion, a PE ratio of 29.58, a price-to-earnings-growth ratio of 1.81 and a beta of 2.22. The business’s 50-day moving average price is $218.74 and its two-hundred day moving average price is $207.65. The company has a current ratio of 4.59, a quick ratio of 3.85 and a debt-to-equity ratio of 0.14. NVIDIA Corporation has a 12 month low of $164.27 and a 12 month high of $237.88.
NVIDIA (NASDAQ:NVDA – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.13. NVIDIA had a return on equity of 96.04% and a net margin of 63.66%.The company had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. During the same period last year, the company earned $1.05 earnings per share. The firm’s revenue was up 105.9% compared to the same quarter last year. On average, analysts expect that NVIDIA Corporation will post 9.25 EPS for the current year. NVIDIA Announces Dividend The company also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Thursday, September 10th were given a $0.25 dividend. The ex-dividend date was Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. NVIDIA’s payout ratio is 12.64%.
NVIDIA declared that its Board of Directors has initiated a stock buyback program on Monday, September 28th that authorizes the company to buyback $150.00 billion in outstanding shares. This buyback authorization authorizes the computer hardware maker to purchase up to 2.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.
Analysts Set New Price Targets NVDA has been the subject of a number of research reports. Sanford C. Bernstein reissued a “buy” rating on shares of NVIDIA in a report on Monday, September 21st. Mizuho set a $315.00 price target on shares of NVIDIA and gave the stock an “outperform” rating in a report on Thursday, August 27th. Piper Sandler began coverage on NVIDIA in a research note on Wednesday, September 9th. They issued an “overweight” rating and a $300.00 price target for the company. BMO Capital Markets set a $340.00 price objective on NVIDIA and gave the company an “outperform” rating in a report on Thursday, August 20th. Finally, China Renaissance boosted their price objective on NVIDIA from $319.00 to $330.00 and gave the stock a “buy” rating in a research report on Monday, August 31st. Four analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $320.71.
View Our Latest Stock Report on NVDA
Key Stories Impacting NVIDIA Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution Insider Activity In other news, CFO Colette Kress sold 34,918 shares of NVIDIA stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of $219.05, for a total value of $7,648,787.90. Following the completion of the transaction, the chief financial officer directly owned 765,103 shares of the company’s stock, valued at approximately $167,595,812.15. This trade represents a 4.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark A. Stevens sold 622,239 shares of the firm’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $231.62, for a total value of $144,122,997.18. Following the sale, the director directly owned 2,336,531 shares of the company’s stock, valued at $541,187,310.22. This represents a 21.03% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 1,766,118 shares of company stock valued at $399,450,353. 3.94% of the stock is currently owned by insiders.
NVIDIA Company Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Featured Stories Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning? Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Advisors Capital Management LLC raised its holdings in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 4.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,271,599 shares of the computer hardware maker’s stock after purchasing an additional 54,830 shares during the period. NVIDIA comprises about 2.7% of Advisors Capital Management LLC’s portfolio, making the stock its 4th largest holding. Advisors Capital Management LLC’s holdings in NVIDIA were worth $254,434,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of NVDA. Lifetime Wealth Management P.C. bought a new position in shares of NVIDIA in the fourth quarter valued at approximately $26,000. Longview Financial Advisors Inc. acquired a new position in shares of NVIDIA during the first quarter valued at approximately $27,000. Phillip James Consulting Co. bought a new stake in NVIDIA during the first quarter worth approximately $40,000. Frankly Finances LLC bought a new stake in NVIDIA during the second quarter worth approximately $60,000. Finally, Lam Group Inc. acquired a new stake in NVIDIA in the first quarter worth approximately $77,000. 65.27% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth Several equities analysts have recently issued reports on the company. KeyCorp reiterated an “overweight” rating and set a $330.00 price target on shares of NVIDIA in a research report on Monday, August 24th. HSBC upped their price objective on NVIDIA from $360.00 to $365.00 in a report on Thursday, August 27th. China Renaissance raised their target price on NVIDIA from $319.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, August 31st. JPMorgan Chase & Co. lifted their target price on NVIDIA from $280.00 to $320.00 and gave the stock an “overweight” rating in a report on Thursday, August 27th. Finally, UBS Group set a $300.00 price target on shares of NVIDIA and gave the company a “buy” rating in a report on Thursday, August 27th. Four analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $320.71.
View Our Latest Stock Analysis on NVDA More NVIDIA News Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution NVIDIA Stock Performance Shares of NASDAQ NVDA opened at $233.95 on Monday. The company has a quick ratio of 3.85, a current ratio of 4.59 and a debt-to-equity ratio of 0.14. NVIDIA Corporation has a 12 month low of $164.27 and a 12 month high of $237.88. The company has a market cap of $5.64 trillion, a price-to-earnings ratio of 29.58, a P/E/G ratio of 1.81 and a beta of 2.22. The business has a fifty day simple moving average of $218.74 and a 200-day simple moving average of $207.65.
NVIDIA (NASDAQ:NVDA – Get Free Report) last released its earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.13. The business had revenue of $96.22 billion for the quarter, compared to the consensus estimate of $92.27 billion. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The firm’s quarterly revenue was up 105.9% compared to the same quarter last year. During the same period last year, the firm posted $1.05 earnings per share. Sell-side analysts predict that NVIDIA Corporation will post 9.25 EPS for the current year.
NVIDIA Announces Dividend The business also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Thursday, September 10th were paid a $0.25 dividend. The ex-dividend date of this dividend was Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. NVIDIA’s dividend payout ratio is 12.64%.
NVIDIA declared that its board has approved a share repurchase program on Monday, September 28th that permits the company to repurchase $150.00 billion in outstanding shares. This repurchase authorization permits the computer hardware maker to buy up to 2.8% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its stock is undervalued.
Insider Buying and Selling In other NVIDIA news, EVP Timothy S. Teter sold 30,460 shares of the business’s stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $222.80, for a total value of $6,786,488.00. Following the transaction, the executive vice president owned 2,687,660 shares in the company, valued at $598,810,648. The trade was a 1.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Colette Kress sold 34,918 shares of the firm’s stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of $219.05, for a total value of $7,648,787.90. Following the sale, the chief financial officer directly owned 765,103 shares of the company’s stock, valued at $167,595,812.15. This trade represents a 4.36% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,766,118 shares of company stock worth $399,450,353. Corporate insiders own 3.94% of the company’s stock.
NVIDIA Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Featured Stories Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Asahi Life Asset Management ve 2. čtvrtletí snížila podíl v NVIDIA o 5,6 % a prodala 2 716 akcií. Po prodeji držela 45 848 akcií v hodnotě 9,174 milionu USD.
Asahi Life Asset Management CO. LTD. lessened its holdings in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 5.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,848 shares of the computer hardware maker’s stock after selling 2,716 shares during the quarter. NVIDIA comprises approximately 5.2% of Asahi Life Asset Management CO. LTD.’s portfolio, making the stock its 3rd biggest holding. Asahi Life Asset Management CO. LTD.’s holdings in NVIDIA were worth $9,174,000 at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of the business. Financial Alternatives Inc boosted its holdings in NVIDIA by 24.9% during the 2nd quarter. Financial Alternatives Inc now owns 3,192 shares of the computer hardware maker’s stock valued at $639,000 after acquiring an additional 636 shares during the period. MSH Capital Advisors LLC grew its position in NVIDIA by 55.6% during the 2nd quarter. MSH Capital Advisors LLC now owns 31,284 shares of the computer hardware maker’s stock worth $6,260,000 after acquiring an additional 11,177 shares during the last quarter. Strategic Equity Management increased its stake in NVIDIA by 24.9% in the 2nd quarter. Strategic Equity Management now owns 1,772 shares of the computer hardware maker’s stock worth $355,000 after purchasing an additional 353 shares during the period. Toews Corp ADV purchased a new position in NVIDIA in the 2nd quarter worth approximately $479,000. Finally, Edmond DE Rothschild Holding S.A. lifted its position in NVIDIA by 17.9% in the second quarter. Edmond DE Rothschild Holding S.A. now owns 1,537,950 shares of the computer hardware maker’s stock valued at $307,728,000 after purchasing an additional 233,722 shares during the last quarter. Hedge funds and other institutional investors own 65.27% of the company’s stock.
Insider Buying and Selling at NVIDIA In related news, CFO Colette Kress sold 34,918 shares of NVIDIA stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $219.05, for a total transaction of $7,648,787.90. Following the sale, the chief financial officer directly owned 765,103 shares in the company, valued at $167,595,812.15. The trade was a 4.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark A. Stevens sold 622,239 shares of the company’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $231.62, for a total value of $144,122,997.18. Following the completion of the sale, the director directly owned 2,336,531 shares in the company, valued at approximately $541,187,310.22. The trade was a 21.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 1,766,118 shares of company stock valued at $399,450,353. 3.94% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes A number of research firms have recently weighed in on NVDA. UBS Group set a $300.00 price objective on NVIDIA and gave the company a “buy” rating in a research note on Thursday, August 27th. Wall Street Zen lowered shares of NVIDIA from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 26th. BMO Capital Markets set a $340.00 price target on shares of NVIDIA and gave the company an “outperform” rating in a report on Thursday, August 20th. Melius Research set a $420.00 price target on shares of NVIDIA in a research report on Thursday, August 27th. Finally, Morgan Stanley set a $230.00 price target on shares of NVIDIA in a report on Friday. Four investment analysts have rated the stock with a Strong Buy rating, fifty have given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $320.71. Get Our Latest Stock Report on NVIDIA
NVIDIA Price Performance Shares of NASDAQ NVDA opened at $233.95 on Monday. The firm has a fifty day simple moving average of $218.74 and a two-hundred day simple moving average of $207.65. NVIDIA Corporation has a 12 month low of $164.27 and a 12 month high of $237.88. The company has a current ratio of 4.59, a quick ratio of 3.85 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $5.64 trillion, a PE ratio of 29.58, a price-to-earnings-growth ratio of 1.81 and a beta of 2.22.
NVIDIA (NASDAQ:NVDA – Get Free Report) last announced its earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share for the quarter, beating analysts’ consensus estimates of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The firm had revenue of $96.22 billion for the quarter, compared to analyst estimates of $92.27 billion. During the same quarter in the previous year, the firm posted $1.05 EPS. The company’s revenue for the quarter was up 105.9% compared to the same quarter last year. Equities analysts expect that NVIDIA Corporation will post 9.25 earnings per share for the current year.
NVIDIA announced that its Board of Directors has approved a share buyback plan on Monday, September 28th that allows the company to buyback $150.00 billion in outstanding shares. This buyback authorization allows the computer hardware maker to reacquire up to 2.8% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s management believes its stock is undervalued.
NVIDIA Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend was Thursday, September 10th. NVIDIA’s payout ratio is presently 12.64%.
NVIDIA News Roundup Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution NVIDIA Company Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
See Also Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Algebris UK Ltd. ve 2. čtvrtletí nově nakoupila 11 098 akcií NVIDIA za zhruba 2,214 milionu USD. Institucionální investoři nyní drží 65,27 % akcií společnosti.
Algebris UK Ltd. purchased a new position in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 11,098 shares of the computer hardware maker’s stock, valued at approximately $2,214,000.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Lifetime Wealth Management P.C. bought a new stake in shares of NVIDIA during the 4th quarter valued at about $26,000. Longview Financial Advisors Inc. bought a new stake in NVIDIA in the first quarter worth approximately $27,000. Langley Wealth Management LLC acquired a new position in NVIDIA in the second quarter valued at approximately $34,000. Phillip James Consulting Co. acquired a new position in NVIDIA in the first quarter valued at approximately $40,000. Finally, Frankly Finances LLC bought a new position in shares of NVIDIA during the 2nd quarter worth approximately $60,000. Institutional investors and hedge funds own 65.27% of the company’s stock.
Key NVIDIA News Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution NVIDIA Price Performance NVDA stock opened at $233.95 on Monday. NVIDIA Corporation has a twelve month low of $164.27 and a twelve month high of $237.88. The company has a quick ratio of 3.85, a current ratio of 4.59 and a debt-to-equity ratio of 0.14. The stock’s 50 day moving average is $218.74 and its 200-day moving average is $207.65. The firm has a market capitalization of $5.64 trillion, a PE ratio of 29.58, a P/E/G ratio of 1.81 and a beta of 2.22. NVIDIA (NASDAQ:NVDA – Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.09 by $0.13. NVIDIA had a return on equity of 96.04% and a net margin of 63.66%.The business had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. During the same quarter in the prior year, the company posted $1.05 earnings per share. NVIDIA’s revenue was up 105.9% compared to the same quarter last year. Sell-side analysts expect that NVIDIA Corporation will post 9.25 EPS for the current fiscal year.
NVIDIA announced that its Board of Directors has initiated a stock buyback program on Monday, September 28th that authorizes the company to buyback $150.00 billion in shares. This buyback authorization authorizes the computer hardware maker to buy up to 2.8% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.
NVIDIA Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Thursday, September 10th. NVIDIA’s payout ratio is currently 12.64%.
Insider Transactions at NVIDIA In related news, CFO Colette Kress sold 34,918 shares of the firm’s stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $219.05, for a total transaction of $7,648,787.90. Following the transaction, the chief financial officer directly owned 765,103 shares of the company’s stock, valued at $167,595,812.15. This trade represents a 4.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Timothy S. Teter sold 30,460 shares of NVIDIA stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $222.80, for a total transaction of $6,786,488.00. Following the completion of the sale, the executive vice president directly owned 2,687,660 shares in the company, valued at approximately $598,810,648. This represents a 1.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,766,118 shares of company stock worth $399,450,353 in the last quarter. 3.94% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth Several analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of NVIDIA in a research report on Monday, August 31st. Piper Sandler started coverage on shares of NVIDIA in a research note on Wednesday, September 9th. They set an “overweight” rating and a $300.00 target price on the stock. Sanford C. Bernstein restated a “buy” rating on shares of NVIDIA in a report on Monday, September 21st. JPMorgan Chase & Co. lifted their price target on shares of NVIDIA from $280.00 to $320.00 and gave the company an “overweight” rating in a research note on Thursday, August 27th. Finally, KeyCorp reiterated an “overweight” rating and set a $330.00 price objective on shares of NVIDIA in a report on Monday, August 24th. Four equities research analysts have rated the stock with a Strong Buy rating, fifty have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $320.71.
Get Our Latest Analysis on NVDA
NVIDIA Company Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Featured Stories Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Trillium Asset Management ve 2. čtvrtletí snížila podíl v NVIDIA o 18,3 % a prodala 266 278 akcií. Po prodeji držela 1 192 453 akcií v hodnotě 238,6 milionu USD.
Trillium Asset Management LLC cut its stake in NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 18.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,192,453 shares of the computer hardware maker’s stock after selling 266,278 shares during the period. NVIDIA makes up approximately 7.3% of Trillium Asset Management LLC’s holdings, making the stock its largest holding. Trillium Asset Management LLC’s holdings in NVIDIA were worth $238,598,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in the company. Lifetime Wealth Management P.C. purchased a new position in NVIDIA during the 4th quarter valued at about $26,000. Longview Financial Advisors Inc. acquired a new position in shares of NVIDIA in the first quarter valued at approximately $27,000. Langley Wealth Management LLC acquired a new position in shares of NVIDIA in the second quarter valued at approximately $34,000. Phillip James Consulting Co. purchased a new position in shares of NVIDIA during the first quarter valued at approximately $40,000. Finally, Frankly Finances LLC purchased a new position in shares of NVIDIA during the second quarter valued at approximately $60,000. Hedge funds and other institutional investors own 65.27% of the company’s stock.
More NVIDIA News Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution Analyst Upgrades and Downgrades A number of equities research analysts have recently commented on the company. Raymond James Financial set a $515.00 price objective on NVIDIA and gave the company a “strong-buy” rating in a research report on Thursday, August 27th. Wells Fargo & Company set a $210.00 target price on shares of NVIDIA in a research note on Friday. Citigroup reiterated a “buy” rating and set a $315.00 target price (up from $300.00) on shares of NVIDIA in a report on Thursday, August 27th. Wedbush boosted their target price on shares of NVIDIA from $330.00 to $345.00 and gave the stock an “outperform” rating in a research report on Thursday, August 27th. Finally, China Renaissance upped their target price on shares of NVIDIA from $319.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, August 31st. Four equities research analysts have rated the stock with a Strong Buy rating, fifty have given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $320.71. Get Our Latest Stock Analysis on NVDA
NVIDIA Price Performance Shares of NVDA opened at $233.95 on Monday. The firm has a market cap of $5.64 trillion, a price-to-earnings ratio of 29.58, a PEG ratio of 1.81 and a beta of 2.22. NVIDIA Corporation has a 52 week low of $164.27 and a 52 week high of $237.88. The stock has a 50 day moving average of $218.74 and a 200-day moving average of $207.65. The company has a current ratio of 4.59, a quick ratio of 3.85 and a debt-to-equity ratio of 0.14.
NVIDIA (NASDAQ:NVDA – Get Free Report) last posted its quarterly earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 EPS for the quarter, beating the consensus estimate of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The business had revenue of $96.22 billion during the quarter, compared to analyst estimates of $92.27 billion. During the same period in the previous year, the business posted $1.05 EPS. The company’s quarterly revenue was up 105.9% on a year-over-year basis. As a group, analysts forecast that NVIDIA Corporation will post 9.25 EPS for the current year.
NVIDIA Dividend Announcement The business also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date was Thursday, September 10th. NVIDIA’s payout ratio is 12.64%.
NVIDIA declared that its board has authorized a stock repurchase program on Monday, September 28th that permits the company to repurchase $150.00 billion in outstanding shares. This repurchase authorization permits the computer hardware maker to purchase up to 2.8% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its stock is undervalued.
Insiders Place Their Bets In other NVIDIA news, CFO Colette Kress sold 34,918 shares of the company’s stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $219.05, for a total value of $7,648,787.90. Following the completion of the sale, the chief financial officer directly owned 765,103 shares in the company, valued at $167,595,812.15. This represents a 4.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Timothy Teter sold 30,460 shares of the company’s stock in a transaction on Monday, September 21st. The shares were sold at an average price of $222.80, for a total value of $6,786,488.00. Following the completion of the sale, the executive vice president owned 2,687,660 shares of the company’s stock, valued at approximately $598,810,648. This trade represents a 1.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,766,118 shares of company stock worth $399,450,353 over the last ninety days. Company insiders own 3.94% of the company’s stock.
NVIDIA Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Read More Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Oxford Financial Group LTD. LLC ve 2. čtvrtletí snížila podíl v NVIDIA o 23,6 % a prodala 27 153 akcií. Po prodeji držela 87 951 akcií v hodnotě 17,598 milionu USD.
Oxford Financial Group LTD. LLC reduced its holdings in NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 23.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 87,951 shares of the computer hardware maker’s stock after selling 27,153 shares during the period. NVIDIA comprises about 0.9% of Oxford Financial Group LTD. LLC’s holdings, making the stock its 15th largest holding. Oxford Financial Group LTD. LLC’s holdings in NVIDIA were worth $17,598,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in NVDA. Kilter Group LLC lifted its position in NVIDIA by 5.9% in the 2nd quarter. Kilter Group LLC now owns 8,795 shares of the computer hardware maker’s stock worth $1,760,000 after buying an additional 491 shares in the last quarter. D L Carlson Investment Group Inc. grew its holdings in shares of NVIDIA by 0.6% during the 2nd quarter. D L Carlson Investment Group Inc. now owns 114,511 shares of the computer hardware maker’s stock valued at $22,912,000 after acquiring an additional 706 shares in the last quarter. Fischer Financial Services Inc. grew its holdings in shares of NVIDIA by 3.0% during the 2nd quarter. Fischer Financial Services Inc. now owns 109,580 shares of the computer hardware maker’s stock valued at $21,926,000 after acquiring an additional 3,197 shares in the last quarter. Ninepoint Partners LP acquired a new position in shares of NVIDIA in the second quarter worth $5,039,000. Finally, SGL Investment Advisors Inc. increased its position in NVIDIA by 1.4% in the 2nd quarter. SGL Investment Advisors Inc. now owns 40,345 shares of the computer hardware maker’s stock worth $8,777,000 after purchasing an additional 549 shares during the last quarter. Institutional investors and hedge funds own 65.27% of the company’s stock.
NVIDIA News Roundup Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution Wall Street Analyst Weigh In Several brokerages have recently commented on NVDA. President Capital increased their price target on shares of NVIDIA from $295.00 to $330.00 in a research note on Thursday, August 27th. BMO Capital Markets set a $340.00 price target on NVIDIA and gave the stock an “outperform” rating in a research report on Thursday, August 20th. Raymond James Financial set a $515.00 target price on shares of NVIDIA and gave the company a “strong-buy” rating in a research note on Thursday, August 27th. Zacks Research raised shares of NVIDIA from a “hold” rating to a “strong-buy” rating in a report on Monday, September 21st. Finally, Weiss Ratings restated a “buy (b)” rating on shares of NVIDIA in a research report on Wednesday, July 8th. Four equities research analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $320.71. Read Our Latest Analysis on NVIDIA
Insider Activity at NVIDIA In other NVIDIA news, CFO Colette Kress sold 34,918 shares of the stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $219.05, for a total transaction of $7,648,787.90. Following the sale, the chief financial officer owned 765,103 shares of the company’s stock, valued at $167,595,812.15. This represents a 4.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Timothy S. Teter sold 30,460 shares of the firm’s stock in a transaction dated Monday, September 21st. The shares were sold at an average price of $222.80, for a total transaction of $6,786,488.00. Following the completion of the sale, the executive vice president owned 2,687,660 shares of the company’s stock, valued at $598,810,648. The trade was a 1.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,766,118 shares of company stock valued at $399,450,353 over the last ninety days. 3.94% of the stock is owned by insiders.
NVIDIA Stock Performance Shares of NASDAQ:NVDA opened at $233.95 on Monday. The business’s fifty day moving average price is $218.74 and its two-hundred day moving average price is $207.65. The company has a debt-to-equity ratio of 0.14, a current ratio of 4.59 and a quick ratio of 3.85. NVIDIA Corporation has a fifty-two week low of $164.27 and a fifty-two week high of $237.88. The stock has a market capitalization of $5.64 trillion, a price-to-earnings ratio of 29.58, a price-to-earnings-growth ratio of 1.81 and a beta of 2.22.
NVIDIA (NASDAQ:NVDA – Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The firm had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. During the same period last year, the firm posted $1.05 EPS. The firm’s quarterly revenue was up 105.9% on a year-over-year basis. As a group, analysts predict that NVIDIA Corporation will post 9.25 EPS for the current fiscal year.
NVIDIA Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Thursday, September 10th were paid a $0.25 dividend. The ex-dividend date was Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. NVIDIA’s dividend payout ratio (DPR) is 12.64%.
NVIDIA declared that its Board of Directors has initiated a stock repurchase plan on Monday, September 28th that permits the company to buyback $150.00 billion in outstanding shares. This buyback authorization permits the computer hardware maker to reacquire up to 2.8% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.
NVIDIA Company Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Read More Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
PCM Encore LLC trimmed its stake in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 3.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 129,660 shares of the computer hardware maker’s stock after selling 4,491 shares during the quarter. NVIDIA comprises 4.6% of PCM Encore LLC’s investment portfolio, making the stock its 2nd biggest holding. PCM Encore LLC’s holdings in NVIDIA were worth $25,944,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Bank of America Corp DE boosted its holdings in NVIDIA by 2.1% in the 1st quarter. Bank of America Corp DE now owns 191,200,989 shares of the computer hardware maker’s stock valued at $33,345,453,000 after purchasing an additional 4,019,505 shares in the last quarter. Invesco Ltd. lifted its stake in shares of NVIDIA by 0.3% in the fourth quarter. Invesco Ltd. now owns 143,239,504 shares of the computer hardware maker’s stock valued at $26,714,167,000 after purchasing an additional 446,178 shares during the period. J. Stern & Co. LLP boosted its stake in shares of NVIDIA by 13,709.1% during the 4th quarter. J. Stern & Co. LLP now owns 125,760,307 shares of the computer hardware maker’s stock worth $23,454,297,000 after acquiring an additional 124,849,603 shares in the last quarter. Amundi raised its holdings in NVIDIA by 10.4% during the first quarter. Amundi now owns 133,768,018 shares of the computer hardware maker’s stock worth $23,329,141,000 after purchasing an additional 12,575,177 shares during the last quarter. Finally, Deutsche Bank AG boosted its position in shares of NVIDIA by 2.3% in the 2nd quarter. Deutsche Bank AG now owns 91,954,159 shares of the computer hardware maker’s stock worth $18,399,108,000 after buying an additional 2,045,101 shares in the last quarter. Hedge funds and other institutional investors own 65.27% of the company’s stock.
Analyst Upgrades and Downgrades A number of research firms recently issued reports on NVDA. Jefferies Financial Group reaffirmed a “buy” rating on shares of NVIDIA in a research note on Wednesday, August 26th. Royal Bank Of Canada raised their price target on NVIDIA from $300.00 to $330.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. Weiss Ratings restated a “buy (b)” rating on shares of NVIDIA in a report on Wednesday, July 8th. Piper Sandler assumed coverage on shares of NVIDIA in a research note on Wednesday, September 9th. They set an “overweight” rating and a $300.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of NVIDIA in a report on Monday, August 31st. Four research analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $320.71.
Check Out Our Latest Stock Analysis on NVDA Key Headlines Impacting NVIDIA Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution NVIDIA Stock Performance Shares of NVDA stock opened at $233.95 on Monday. The company’s fifty day simple moving average is $218.74 and its 200-day simple moving average is $207.65. The company has a current ratio of 4.59, a quick ratio of 3.85 and a debt-to-equity ratio of 0.14. NVIDIA Corporation has a 52 week low of $164.27 and a 52 week high of $237.88. The company has a market cap of $5.64 trillion, a PE ratio of 29.58, a P/E/G ratio of 1.81 and a beta of 2.22.
NVIDIA (NASDAQ:NVDA – Get Free Report) last issued its earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.13. The company had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. NVIDIA had a return on equity of 96.04% and a net margin of 63.66%.The company’s revenue was up 105.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.05 earnings per share. As a group, equities research analysts anticipate that NVIDIA Corporation will post 9.25 EPS for the current year.
NVIDIA Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were issued a $0.25 dividend. The ex-dividend date was Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a yield of 0.4%. NVIDIA’s payout ratio is currently 12.64%.
NVIDIA declared that its board has approved a share repurchase program on Monday, September 28th that permits the company to buyback $150.00 billion in outstanding shares. This buyback authorization permits the computer hardware maker to buy up to 2.8% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.
Insider Buying and Selling In other NVIDIA news, Director Mark A. Stevens sold 622,239 shares of NVIDIA stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $231.62, for a total transaction of $144,122,997.18. Following the sale, the director directly owned 2,336,531 shares in the company, valued at $541,187,310.22. The trade was a 21.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Colette Kress sold 34,918 shares of the stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $219.05, for a total value of $7,648,787.90. Following the transaction, the chief financial officer owned 765,103 shares of the company’s stock, valued at approximately $167,595,812.15. This trade represents a 4.36% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 1,766,118 shares of company stock worth $399,450,353. 3.94% of the stock is currently owned by corporate insiders.
NVIDIA Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Read More Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Silvant Capital Management ve 2. čtvrtletí zvýšil podíl v NVIDIA o 1,9 % na 2 174 219 akcií. NVIDIA je nyní jeho největší pozicí s hodnotou 435,04 mil. USD.
Silvant Capital Management LLC increased its stake in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 1.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,174,219 shares of the computer hardware maker’s stock after buying an additional 40,560 shares during the quarter. NVIDIA accounts for 12.7% of Silvant Capital Management LLC’s investment portfolio, making the stock its largest holding. Silvant Capital Management LLC’s holdings in NVIDIA were worth $435,040,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also added to or reduced their stakes in the company. Impax Asset Management Group plc increased its stake in shares of NVIDIA by 2.2% during the 2nd quarter. Impax Asset Management Group plc now owns 3,722,756 shares of the computer hardware maker’s stock worth $744,886,000 after purchasing an additional 81,671 shares during the last quarter. KilterHowling LLC raised its stake in shares of NVIDIA by 2.6% in the second quarter. KilterHowling LLC now owns 8,185 shares of the computer hardware maker’s stock valued at $1,638,000 after buying an additional 211 shares during the period. Kilter Group LLC raised its stake in shares of NVIDIA by 5.9% in the second quarter. Kilter Group LLC now owns 8,795 shares of the computer hardware maker’s stock valued at $1,760,000 after buying an additional 491 shares during the period. D L Carlson Investment Group Inc. lifted its position in shares of NVIDIA by 0.6% during the 2nd quarter. D L Carlson Investment Group Inc. now owns 114,511 shares of the computer hardware maker’s stock valued at $22,912,000 after buying an additional 706 shares during the last quarter. Finally, Fischer Financial Services Inc. grew its stake in shares of NVIDIA by 3.0% during the 2nd quarter. Fischer Financial Services Inc. now owns 109,580 shares of the computer hardware maker’s stock worth $21,926,000 after acquiring an additional 3,197 shares during the period. 65.27% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades Several research firms recently commented on NVDA. Truist Financial raised their price objective on shares of NVIDIA from $307.00 to $346.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. Daiwa Securities Group decreased their price objective on shares of NVIDIA from $255.00 to $245.00 and set an “outperform” rating on the stock in a research report on Thursday, September 17th. Cantor Fitzgerald restated an “overweight” rating and set a $350.00 price target on shares of NVIDIA in a research report on Thursday. Morgan Stanley set a $230.00 price objective on NVIDIA in a research report on Friday. Finally, JPMorgan Chase & Co. boosted their target price on NVIDIA from $280.00 to $320.00 and gave the stock an “overweight” rating in a research report on Thursday, August 27th. Four equities research analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $320.71.
Read Our Latest Analysis on NVIDIA Trending Headlines about NVIDIA Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution Insider Buying and Selling In related news, Director Mark Stevens sold 622,239 shares of the company’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $231.62, for a total value of $144,122,997.18. Following the sale, the director directly owned 2,336,531 shares of the company’s stock, valued at $541,187,310.22. This represents a 21.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Timothy Teter sold 30,460 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $222.80, for a total transaction of $6,786,488.00. Following the completion of the transaction, the executive vice president owned 2,687,660 shares of the company’s stock, valued at approximately $598,810,648. The trade was a 1.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,766,118 shares of company stock valued at $399,450,353 over the last ninety days. Company insiders own 3.94% of the company’s stock.
NVIDIA Stock Performance NASDAQ:NVDA opened at $233.95 on Monday. NVIDIA Corporation has a twelve month low of $164.27 and a twelve month high of $237.88. The company has a quick ratio of 3.85, a current ratio of 4.59 and a debt-to-equity ratio of 0.14. The firm’s fifty day simple moving average is $218.74 and its 200 day simple moving average is $207.65. The stock has a market cap of $5.64 trillion, a P/E ratio of 29.58, a price-to-earnings-growth ratio of 1.81 and a beta of 2.22.
NVIDIA (NASDAQ:NVDA – Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The company had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. During the same period in the prior year, the firm earned $1.05 earnings per share. NVIDIA’s revenue was up 105.9% on a year-over-year basis. As a group, research analysts predict that NVIDIA Corporation will post 9.25 EPS for the current year.
NVIDIA Announces Dividend The company also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Thursday, September 10th were given a dividend of $0.25 per share. The ex-dividend date was Thursday, September 10th. This represents a $1.00 annualized dividend and a dividend yield of 0.4%. NVIDIA’s payout ratio is currently 12.64%.
NVIDIA declared that its board has initiated a stock repurchase plan on Monday, September 28th that allows the company to repurchase $150.00 billion in outstanding shares. This repurchase authorization allows the computer hardware maker to repurchase up to 2.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s management believes its stock is undervalued.
NVIDIA Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Further Reading Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning? Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Canadian Goldfields dokončila odběr 329 půdních vzorků na projektu Miminiska a brzy zahájí plošný letecký magnetický průzkum, aby našla nové cíle pro další vrtání.
VANCOUVER, British Columbia, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Canadian Goldfields Discovery Corp. (TSX-V: CGM, OTCQB: CGMXF) (“Canadian Goldfields” or the “Company”) is pleased to announce the completion of soil geochemistry and upcoming commencement of a property-wide airborne magnetic survey at its 6,366-hectare Miminiska Gold Project in northwestern Ontario. The programs are intended to identify new exploration targets, support future drilling and further define regional controls on gold mineralization.
Construction of a winterized exploration camp is underway at Miminiska to support continued field activities and future drilling. Approximately 40% of current site staff are members of the Eabametoong First Nation (“EFN”).
Ian Dasti, Vice-President of Exploration, P.Geo., commented: “We have a 14-kilometre prospective trend at Miminiska with historical drilling concentrated at the Miminiska and Frond Zones, leaving more than 12 kilometres of strike largely untested. Our current programs are designed to systematically evaluate this broader opportunity. By integrating soil geochemistry with property-wide airborne magnetics and our existing geological data, we aim to improve our understanding of the controls on gold mineralization and advance growth-focused target generation for future drilling.”
Highlights
Growth-Focused Target Generation: Soil geochemistry and upcoming property-wide airborne magnetics will be integrated with geological data to develop new exploration targets for future drilling.Systematic Geochemical Coverage: 329 soil samples collected between Frond and Wottam Lake on a 50 m × 100 m grid, with assays pending.Property-Wide Airborne Geophysics: HeliGT airborne magnetic survey expected to commence before the end of October to further define geological and structural controls on gold mineralization.Winter Exploration Infrastructure: Winterized exploration camp under construction to support continued field activities and future drilling.Strong Local Participation: 40% of current Miminiska site staff are members of Eabametoong First Nation. Soil Geochemistry
The Company completed 329 soil samples, including quality-control samples, along 39 Ha of the prospective trend between Frond and Wottam Lake on a 50-metre by 100-metre grid. The program is designed to:
Initiate systematic geochemical coverage across prospective ground between Frond and Wottam Lake;Identify gold and trace-element geochemical patterns for follow-up exploration; andSupport target generation through integration with geological mapping, historical data and airborne geophysics. Samples have been submitted to Activation Laboratories Ltd. (“Actlabs”) for gold and trace-element analysis, with results anticipated before the end of October 2026.
Airborne Geophysics
The Company is preparing to commence a HeliGT airborne magnetic survey across the entire Miminiska Property using SHA Geophysics. The survey is designed to:
Provide high-resolution magnetic coverage across the 6,366-hectare Project;Further define geological and structural controls on gold mineralization; andSupport target generation through integration with soil geochemistry, geological mapping and historical data. The survey is expected to commence before the end of October 2026.
Winter Exploration Camp
Construction of the Company’s winterized exploration camp at Miminiska is underway to support continued field activities and future drilling.
Approximately 40% of current Miminiska site staff are members of Eabametoong First Nation (“EFN”). Canadian Goldfields continues to work collaboratively with EFN as exploration activities at Miminiska advance.
Selected Historical Drill Results
Approximately 28,000 metres of historical drilling has been completed at Miminiska, concentrated principally at the Miminiska and Frond Zones. Selected historical drill results are presented below. These results are historical in nature, have not been independently verified by the Qualified Person and are reported as core lengths that do not necessarily represent true widths.
AreaHole IDAzimuth (°)Dip (°)From (m)To (m)Interval (m)Au (g/t)Miminiska0603-08358.4-7051.9472.7820.845.75Miminiska88C-10315-5065.3869.343.9612.69Miminiska0603-18358.1-50120.57131.7511.184.49 including 120.57124.303.737.29Miminiska0604-32358-66235.78241.105.3213.95Frond87-13144-50125.79127.101.3114.74Frond87-10144-4567.7969.041.257.53Frond87-14144-6561.6662.000.3437.02Frond87-15144-7092.2093.150.9511.32 NI 43-101 Technical Report on the Miminiska Property, Northern Ontario, Canada, prepared by APEX Geoscience Ltd. for Canadian Goldfields, authored by Qualified Persons Edward Parker, B.Sc., P.Geo., and Eliza D. Verigeanu, M.Sc., P.Geo. Frond Zone results adapted from Neal & Miller Report, 1987. Effective date of December 1, 2025.
About Canadian Goldfields Discovery Corp.
Canadian Goldfields Discovery Corp. is a Canadian mineral exploration company focused on advancing district-scale gold opportunities in Ontario, Canada. The Company’s portfolio includes the flagship Miminiska Gold Project in northwestern Ontario and the Swayze Central Gold Property located within the prospective Swayze Greenstone Belt near Timmins.
Miminiska hosts a gold-rich banded iron formation (“BIF”) system with multiple high-grade intercepts drilled across the Miminiska and Frond Zones and more than 14 km of underexplored strike extent. Supported by approximately 28,000 m of historical drilling, the project demonstrates significant scale potential with mineralization remaining open along strike and at depth. The Swayze Central Gold Property complements the Company’s portfolio with historical high-grade gold occurrences and additional district-scale exploration upside in one of Canada’s most established mining regions.
Canadian Goldfields is led by a lean and execution-focused leadership team committed to disciplined exploration, systematic discovery and long-term value creation through the advancement of high-quality gold assets in tier-one mining jurisdictions.
On behalf of the Company,
John G. Booth, Chief Executive Officer and Director
Additional Information
Harp Gosal | Director of Capital Markets & Communications
Canadian Goldfields Discovery Corp.
Phone: (604) 218-1142
Email: [email protected]
Qualified Persons and Technical Disclosure
The scientific and technical information contained in this news release has been reviewed and approved by Ian Raymond Dasti, P.Geo, Vice-President of Exploration of Canadian Goldfields Discovery Corp., and a Qualified Person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI-43101”).
Mr. Dasti has reviewed the technical information disclosed in this news release and has approved its dissemination. The information presented herein relates to planned exploration activities at the Company’s Miminiska Gold Project, including the design and objectives of the geochemical soil sampling program.
Historical exploration information referenced in this news release has been compiled from publicly available sources and historical reports. A Qualified Person has not completed sufficient work to independently verify all historical information, and the Company is not treating such information as current mineral resources or mineral reserves as defined by NI 43-101. Historical results, mineral occurrences, and exploration data should not be relied upon as indicative of future exploration results.
The Company considers historical exploration information to be relevant for the purpose of guiding future exploration programs; however, readers are cautioned that such information may not be representative of actual mineralization or exploration potential on the Property.
Forward-Looking Statements
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by many material factors, many of which are beyond their respective control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the Company’s planned exploration program for the Miminiska Gold Property is subject to change. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company does not undertake to publicly update or revise forward-looking information.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
The Pentagon placed a massive bet on a single American company to break China's stranglehold on rare earth magnets, and General Motors is first in line to find out if that wager pays off.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
On July 10, 2025, the Department of Defense agreed to buy $400 million of convertible preferred stock in MP Materials (NYSE:MP), along with a ten-year warrant. The government’s projected ownership stake of 15% made it the company’s largest shareholder. The deal also included a $150 million loan to expand Mountain Pass and a 10-year commitment to buy all of the company’s output at $110/kg for neodymium-praseodymium (NdPr), the key rare earth input in permanent magnets.
General Motors (NYSE:GM | GM Price Prediction) is first in line for MP’s magnets, according to The Business Journals. The Pentagon deal and GM supply agreement fund different facilities on separate schedules.
Pentagon Capital Targets Mountain Pass and a Future Plant Pentagon money funds upgrades at Mountain Pass in California and a separate magnet plant called 10X. Commissioning at 10X is expected around 2028. The Department of War remains MP’s partner on the project.
GM’s Magnets Come From an Already Running Texas Plant GM’s magnets come from a different facility, and MP paid for it. The two companies signed their supply agreement in December 2021 and released the details in April 2022. MP backed the deal with a $700 million investment commitment of its own to supply magnets for GM’s Ultium-platform electric vehicles. MP began commercially producing rare earth metal for GM in 2024. Its Independence facility in Fort Worth has made neodymium-iron-boron magnets since December 2025, according to MP’s fourth-quarter 2025 earnings release filed with the SEC.
Reports on delivery timing conflict. In mid-September, The Business Journals reported that MP delivered its first magnets to GM from Fort Worth. Days later, GM Authority described GM as “About To” take delivery. On MP’s August earnings call, the CFO said regular production deliveries should begin sometime in the fourth quarter of 2026, starting at small volumes. No exact shipment date has been made public. The best reading of the record is that the milestone is underway or very close.
Mine to Magnet Under One Roof Co-founder and CEO James Litinsky said “no single entity” elsewhere handles the entire supply chain under one roof. MP is America’s only fully integrated rare earth producer, from mining and processing through metallization and magnet manufacturing. Its customers include Apple (NASDAQ:AAPL) and U.S. aerospace and defense contractors.
China has dominated rare earths since Deng Xiaoping’s 1992 comment that the Middle East has oil and China has rare earths. MP stopped selling concentrate to China in July 2025.
Stock Already Traded the Pentagon Story MP’s share price at each of its recent filings shows how the market responded. At its May 8, 2025 filing, before the agreement, shares stood at $23.90. At its August 7, 2025 filing, weeks after the deal, they were at $77.05. They were at $72.20 at the May 7, 2026 filing and $48.47 at the August 6, 2026 filing.
The shares closed at $46.98 on Friday, October 2, 2026, up 1.93% for the session. That close left them down 33.81% over one year and 14.13% over one month, for a market value of $8.37 billion. Over ten years, they are up 369.70%.
The stock ran up sharply on Pentagon news, then gave back much of the gain. MP rallied on unrelated headlines, including a 6% surge in late September as traders considered the critical minerals growth story, according to 24/7 Wall St.
China’s grip on the rare earth supply chain is the whole reason the Pentagon wrote the check, and we mapped out why the fix takes years, not weeks, in a free guide here: The Next Nvidia Playbook.
Amin Credits MP’s Pace for the Shorter Timeline GM’s chief supply officer Shilpan Amin said the full development cycle should have taken 8 years. The companies got there in 5 years because of MP’s pace. Litinsky said finding customers who believe in you is the “hardest thing” early on. GM signed as an anchor customer in 2021, before Washington invested capital, and that commitment cut the schedules.
The GM milestone shows Independence works. Government capital depends on 10X, still under construction and expected to begin commissioning around 2028.
Contact [email protected] for any questions or corrections.
A prominent fund manager went on live television to call Chevron and ExxonMobil cheap laggards, but the actual performance data from the past year tells a very different story about who is really falling behind.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
On CNBC on Friday, Oct. 2, Michael Cuggino, president of Permanent Portfolio Family of Funds, said energy stocks “have not kept up with the broader market even as we speak.” He used that point to recommend Chevron (NYSE:CVX | CVX Price Prediction) and ExxonMobil (NYSE:XOM) as cheap total-return plays. The performance numbers point the other way.
Oil Majors Have Outrun the Index by a Wide Margin As of Friday’s close on Oct. 2, Exxon is up more than 34% over the past year at $164.39. Chevron is up nearly 33% at $207.20. Over the same period, the S&P 500 gained less than 13%. Chevron also set a 52-week high of $214.06 on Sept. 11. Over the last month, the benchmark index edged up 0.75%, while Chevron lost 2.16% and Exxon gained 0.15%.
Cuggino’s Valuation Case Holds Up, With One Adjustment Cuggino’s argument is about price. He said both stocks trade at about 13 times next year’s earnings, with dividend yields of 3.5% and 2.5%. He compared that with an S&P 500 offering a 4.5% earnings yield. Checked against consensus 2027 EPS of $14.1367 for Chevron and $11.0760 for Exxon, both stocks trade closer to 15x. Their current yields are 3.42% and 2.53%. That is a little more expensive than the on-air figure, but still a discount to the market.
Others share his view. On Sept. 8, Jim Cramer called Chevron the portfolio version of a kicker: an excellent 3.44% yield that usually doesn’t move with the rest of the market.
Rising Earnings Estimates Explain the Rally Chevron’s second quarter brought adjusted EPS of $6.06, revenue up 51.4% to $67.20B, and free cash flow of $18.1 billion. Brent averaged $104 per barrel in the quarter. CEO Mike Wirth said: “Costs always matter. They always will.”
Analysts have been raising their numbers. The 2027 consensus for Chevron was $12.6254 90 days ago. Over the past 30 days, 10 analysts revised up and 3 revised down. Exxon CEO Darren Woods described a quarter with “more than $14 billion of earnings, more than $17 billion of free cash flow, and a more than $7 billion reduction in net debt.”
Microsoft Is Buying Chevron’s Power for AI Chevron signed a 20-year take-or-pay power purchase agreement with Microsoft (NASDAQ:MSFT). The deal covers 2.67 gigawatts of capacity for a West Texas data center complex, and Chevron expects “mid-teens returns.” Wirth said the company is ready “to help power American AI dominance.” The companies building AI depend on energy majors to grow, and this deal gives Chevron a long-dated source of committed revenue.
A Slide in Crude Would Undercut the Pitch WTI peaked at $102.13 in May and fallen to $83.9 by August. In its May outlook, the EIA forecast Brent averaging $79.39 in 2027. If prices follow that path, estimates shrink and today’s 15x multiple looks less cheap. Wall Street is also split: Chevron has 20 Buy ratings or Strong Buy ratings, while Exxon has 15 Hold ratings.
The stocks have already outpaced the market on returns. The case for owning them now rests on valuation, income and earnings revisions. Watch the third-quarter reports, where consensus calls for $4.7322 per share at Chevron and $3.6501 at Exxon.
Contact [email protected] for any questions or corrections.
Oracle spálila miliardy volného peněžního toku, ale má backlog 664 miliard USD, který má se zhruba z poloviny proměnit v tržby během příštích 36 měsíců. Wall Street vidí 67% potenciál růstu.
Oracle just burned through billions in free cash flow while a $664 billion backlog sits waiting to convert, and Wall Street analysts are betting the gap between those two numbers holds the key to a 67% return.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Oracle (NYSE:ORCL | ORCL Price Prediction) trades at $142.50. Cash burn today funds AI capacity customers have already signed up to use.
Oracle built its name on database software and enterprise applications. Cloud now drives the story, reaching 60% of total revenue last quarter. The stock is down 50.16% over the past year from a 52-week high of $319.46. Investors pulled back after free cash flow came in at negative $23.7 billion in fiscal 2026 and negative $5.4 billion last quarter.
A $664 Billion Backlog Is Converting Into Revenue Q1 fiscal 2027 revenue rose 29.6% to $19.345 billion, with cloud infrastructure revenue up 121% to $7.39 billion. Remaining performance obligations hit $664 billion, with management expecting “around half of our RPO to convert into sales over the next 36 months.” GPU utilization was 97.9%, and renewed capacity commanded a 20% premium.
Oracle booked over $30 billion in new AI contracts requiring no extra cash, mostly structured as prepayments or bring-your-own-hardware deals. Operating cash flow rose 184% to $23.1 billion. Guidance calls for at least $90 billion in fiscal 2027 revenue and $8.10 in non-GAAP EPS. The stock trades at 18x forward earnings with a PEG ratio of 0.807.
A Ballooning Capex Bill Strains the Balance Sheet Capex reached $28.5 billion in a single quarter, and management expects $90 to $95 billion for the full year. When asked when free cash flow turns positive, management said, “We haven’t given a particular timeframe on that yet.” Interest expense rose 55% to $1.4 billion, and total liabilities stand at $236.06 billion. A completed $20 billion at-the-market equity program diluted existing shareholders.
Software license revenue fell 15%. The backlog is concentrated in a few large AI customers, and new sites in New Mexico and Wisconsin still face regulatory approval and power hurdles (the same power and cooling constraint we broke down across seven AI infrastructure suppliers: here). Shares fell 13% after the Q2 fiscal 2026 revenue miss.
Investor Day Could Settle the Margin Debate Management expects gross margins to flatten as expansion finishes and will detail margins at its upcoming Investor Day. Shares trade under the 200-day moving average of $162.89 and near the 50-day average of $143.59. A firm free cash flow timeline or smooth Vera Rubin delivery would strengthen the bull case. A capex increase without matching prepayments would strengthen the bearish thesis.
Wall Street Sees 67% Upside in a Stock Cut in Half The average analyst target is $237.97, meaning 67% upside. Of 43 analysts covering the stock:
Strong Buy: 7 Buy: 28 Hold: 7 Sell: 1 Oracle trades at 22 times trailing earnings. Over the past year the stock lost 50.16% while the S&P 500 gained 15.01%. Year to date, Oracle is down 26.28% and the index is up 12.86%.
Negative Free Cash Flow Is Funding a Contracted Growth Engine At $142.50, Oracle’s investment case rests on cash flow quality and backlog conversion.
Negative free cash flow exaggerates the problem. After prepayments, Q1 cash capex was $18 billion, below operating cash flow. Management caps full-year net cash capex at 70 billion. Hilary Maxson said scaled projects deliver “a free cash flow conversion ratio of something like 100% to post-tax EBITDA.”
RPO conversion drives upside. Q2 guidance calls for 65-71% cloud growth. Co-founder Larry Ellison also canceled his plan to sell Oracle stock.
The thesis breaks if renewal pricing falls, utilization drops, or the prepayment share shrinks and forces more debt. Those three signals are the key metrics to monitor each quarter.
At 18x forward earnings, Oracle carries a $664 billion signed backlog, with prepayments already offsetting part of its cash burn.
Contact [email protected] for any questions or corrections.
LyondellBasell (NYSE: LYB) oznámí výsledky hospodaření za 3. čtvrtletí 2026 před otevřením trhu 30. října. Následně uspořádá webcast a konferenční hovor.
HOUSTON and LONDON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), a leader in the global chemical industry, will announce its third-quarter 2026 financial results before the U.S. market opens Friday, Oct. 30, followed by a webcast and teleconference to discuss the results at 11 a.m. EDT.
Teleconference and webcast details
Friday, Oct. 30, 2026
11 a.m. EDT
Hosted by David Dennison, head of investor relations
Access the webcast 10 to 15 minutes prior to the start of the call at www.lyb.com/earnings.
Presentation slides
Presentation slides will be available at the time of the teleconference and afterward at www.lyb.com/earnings.
Replay information
A replay of the call will be available from 1 p.m. EDT Oct. 30 until Nov. 30, 2026. The replay dial-in numbers are:
Toll-Free: 877-660-6853
Toll: 201-612-7415
Access ID: 13746219
About LyondellBasell
We are LyondellBasell (NYSE: LYB) – a leader in the global chemical industry creating solutions for everyday sustainable living. Through advanced technology and focused investments, we are enabling a circular and low carbon economy. Across all we do, we aim to unlock value for our customers, investors and society. As one of the world's largest producers of polymers and a leader in polyolefin technologies, we develop, manufacture and market high-quality and innovative products for applications ranging from sustainable transportation and food safety to clean water and quality healthcare. For more information, please visit www.lyondellbasell.com or follow @LyondellBasell on LinkedIn.
Palantir ve 2. čtvrtletí meziročně zvýšil tržby o 93 % a americké komerční tržby vyskočily o 149 % na 764 milionů USD. Michael Burry mezitím dál navyšuje short na akcii.
One of the most exciting yet controversial stocks in the market today is no doubt Palantir Technologies (PLTR -0.68%). The stock is up nearly 675% over the past five years, as of this writing, but it has also drawn criticism from respected short-seller Michael Burry. Burry made a name for himself by calling the housing collapse and is one of the key figures in the movie The Big Short, which documented that collapse.
The running joke around Palantir has long been that no one actually knows what the company does, despite the stock's strong performance. The company was formed shortly after the Sept. 11, 2001, terrorist attacks and was backed by PayPal co-founder Peter Thiel, who believed PayPal's fraud-detection framework could be adapted for use by security analysts.
Image source: Getty Images.
Palantir's first commercially successful product, stemming from these efforts, was its Gotham platform. The solution could gather and analyze data from disparate sources and help spot anomalies to detect potential threats. The government used the platform to follow money trails to uncover terrorist activities, and its Foundry solution was later adopted to track COVID-19 cases. Today, its platforms are used for a variety of use cases by the government, including out on the battlefield, helping with military intelligence.
While Foundry is used by the government, it has also helped push the company into the commercial market. Foundry aggregates information from various parts of an organization and unifies it into an ontology that links the data to physical objects and real-world processes. The solution took off after the company built its Artificial Intelligence Platform (AIP) on top of it, serving as an AI orchestration layer. The combination of clean data that can be linked to physical assets and everyday concepts has significantly reduced AI hallucinations in third-party AI models and delivered actionable insights. In essence, this has turned Palantir's AIP into something akin to an AI operating system.
Palantir consistently reports accelerating growth The rise of AI and the launch of Palantir's AIP set in motion huge growth for the company, especially in the U.S. commercial sector. The company's revenue growth has now accelerated for 12 consecutive quarters, culminating in a huge 93% year-over-year surge in Q2 2026.
Metric (YOY)
Q2 2023
Q3 2023
Q4 2024
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue growth
13%
17%
20%
21%
27%
30%
36%
39%
48%
63%
70%
85%
93%
Source: Company earnings reports. YOY = Year over year.
U.S. commercial revenue has been leading the way, skyrocketing 149% last quarter to $764 million in the quarter, while U.S. commercial remaining deal value soared 124% to $6.24 billion. The company is both adding new customers at a strong clip and seeing rapid growth with existing customers. Last quarter, its U.S. commercial customer count rose by 35% year over year and 6% sequentially. Perhaps the most impressive metric from Palantir's Q2 report, though, was its net revenue retention, which measures revenue growth from existing customers that have been with the company for more than 12 months. This metric came in at an eye-popping 157%.
Despite Palantir's impressive growth, Burry has thrown shade on the stock and has been increasing his short position. The most obvious knock on the stock is its valuation, which currently sits at a forward price-to-sales (P/S) ratio of 37 times 2027 analyst estimates. That's a hefty valuation, although the hypergrowth Palantir is currently experiencing can bring that multiple down pretty quickly if it can be sustained.
Premium Feature
Moneyball Superscore
87/100
Today's Change
(
-0.68
%) $
-1.29
Current Price
$
188.75
Burry has also argued that Palantir's metrics resemble those of a consulting firm like Accenture rather than a software-as-a-service (SaaS) company, given its mounting receivables. However, the company's 85% gross margin doesn't look like anything close to Accenture's 32% gross margin last quarter, and its receivables are tied directly to how the government pays its customers.
Burry also thinks AI models could threaten Palantir's competitive moat. First, admitting the company has a moat seems to contradict his first argument that it is more akin to a consulting firm, as expressing concern over a threat to a moat implicitly acknowledges that a moat exists in the first place. Meanwhile, the importance of AI-model-agnostic software layers is becoming more evident by the day. AIP does not compete with AI models, and instead is a hugely important orchestration layer that sits on top of them.
Overall, while I agree Palantir stock isn't cheap, I still think it could become one of the largest and most important AI companies in the world over the next decade. This makes the bullish case stronger.
Geoffrey Seiler has positions in PayPal. The Motley Fool has positions in and recommends Accenture Plc, Palantir Technologies, and PayPal. The Motley Fool recommends the following options: long January 2028 $260 calls on Accenture Plc, short December 2026 $62.50 calls on PayPal, and short January 2028 $280 calls on Accenture Plc. The Motley Fool has a disclosure policy.
Micron oznámil tržby ve výši 54,23 miliardy USD, upravený zisk 33,42 USD na akcii a hrubou marži 87 %. Firma zároveň čeká v 1. fiskálním čtvrtletí tržby kolem 61,5 miliardy USD.
Micron Technology NASDAQ:MU keeps delivering exceptional numbers, but investors are proving harder to impress.
The shares hovered around flat in Monday pre-market trading after struggling to build momentum following last week’s record results.
Micron reported $54.23 billion of fiscal fourth-quarter revenue, adjusted earnings of $33.42 a share and an 87% adjusted gross margin.
It also guided current-quarter revenue to roughly $61.5 billion, well above Wall Street expectations.
Micron’s guidance remains exceptional. The company expects fiscal first-quarter revenue of $61.5 billion, plus or minus $1.5 billion, adjusted gross margin of about 86.25% and adjusted earnings of $38.15 a share.
But the size of the surprise is shrinking. MarketWatch noted that Micron’s latest revenue beat was 5% above consensus, compared with upside surprises of about 20% to 40% in previous quarters.
Deutsche Bank analyst Melissa Weathers said there was “some incremental squishiness on the margin front this quarter." She kept a Buy rating and $1,550 target, but highlighted elevated incentive-related costs weighing on margins and operating expenses.
Micron’s adjusted gross margin reached 87% in the fiscal fourth quarter, while management guided to 86.25% for November.
That is hardly weak profitability. But when a stock has already rerated around scarcity, even a small margin dip can trigger questions about whether earnings are nearing a peak.
Demand remains unusually strong, as more than 75% of Micron’s fiscal 2027 output is committed across customers, while strategic customer commitments have reached $32 billion.
The question is whether future AI systems will continue using memory at the intensity investors now assume.
BNP Paribas analyst Karl Ackerman has highlighted two possible risks. Nvidia could reduce memory specifications on future Rubin Ultra systems, while broader adoption of Compute Express Link could allow servers to pool memory more efficiently.
Ackerman remains bullish, with an Outperform rating and a $1,700 target.
It is that Micron’s valuation increasingly assumes exceptionally high memory content for years.
Even modest gains in efficiency could force investors to rethink long-term growth before actual demand turns weak.
The bullish counterargument is valuation. Cantor Fitzgerald analyst C.J. Muse maintained an Overweight rating and $2,000 target after earnings.
He said Micron is “simply too cheap to ignore,” pointing to a valuation of about 5.6 times his calendar 2027 earnings estimate of $188 a share.
Cantor models more than $333 billion of free cash flow over the next eight quarters, with aggressive buybacks potentially beginning after CHIPS Act restrictions expire in December.
D.A. Davidson analyst Gil Luria said management’s expectation that memory conditions could be even tighter in 2028 helps address fears that current fundamentals represent another cyclical peak.
Micron now has 26 strategic customer agreements, while management says supply-demand conditions may tighten further through fiscal 2027 and 2028.
That leaves the stock caught between two interpretations.
Either Micron is nearing peak profitability, or Wall Street is still valuing a structurally changed memory company as though another collapse is inevitable.
Charles Schwab zveřejní výsledky za 3. čtvrtletí před otevřením trhu 15. října; analytici čekají EPS 1,67 USD a tržby 7,21 miliardy USD. Akcie v pátek klesly o 1,7 % na 96,70 USD.
The Charles Schwab Corporation (NYSE:SCHW) will release earnings for its third quarter before the opening bell on Thursday, Oct. 15.
Analysts expect the Westlake, Texas-based company to report quarterly earnings of $1.67 per share, up from $1.31 per share in the year-ago period. The consensus estimate for SCHWs quarterly revenue is $7.21 billion. It reported $6.13 billion last year, according to Benzinga Pro.
On Oct. 1, Charles Schwab announced it will begin dual listing its common stock on the Texas Stock Exchange (TXSE).
Shares of Charles Schwab fell 1.7% to close at $96.70 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
Piper Sandler analyst Patrick Moley maintained the stock with a Neutral rating and cut the price target from $118 to $100 on Oct. 2, 2026. This analyst has an accuracy rate of 79%. Compass Point analyst Ed Engel initiated coverage on the stock with a Buy rating and a price target of $135 on Aug. 3, 2026. This analyst has an accuracy rate of 61%. Morgan Stanley analyst Michael Cyprys maintained the stock with an Overweight rating and raised the price target from $133 to $136 on July 27, 2026. This analyst has an accuracy rate of 67%. Argus Research analyst Stephen Biggar maintained the stock with a Buy rating and raised the price target from $108 to $114 on July 23, 2026. This analyst has an accuracy rate of 72%. UBS analyst Michael Brown maintained the stock with a Buy rating and raised the price target from $122 to $128 on July 22, 2026. This analyst has an accuracy rate of 56%. Considering buying SCHW stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Analytici u Dell Technologies drží průměrné doporučení „Moderate Buy“ a 1letou cílovou cenu 569,12 USD. Firma zároveň oznámila silné hospodářské výsledky za čtvrtletí, když výnosy meziročně vzrostly o 57,7 %.
Shares of Dell Technologies Inc. (NYSE:DELL – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the thirty-six analysts that are currently covering the stock, MarketBeat.com reports. Eight analysts have rated the stock with a hold recommendation, twenty-seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $569.12.
Several equities research analysts have recently weighed in on the company. Citigroup raised their price objective on Dell Technologies from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, September 2nd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Dell Technologies in a report on Wednesday, August 12th. Morgan Stanley increased their price target on Dell Technologies from $499.00 to $511.00 and gave the company an “equal weight” rating in a research report on Monday, September 21st. Barclays lifted their price target on Dell Technologies from $550.00 to $603.00 and gave the stock an “overweight” rating in a research note on Wednesday, September 2nd. Finally, The Goldman Sachs Group boosted their price objective on Dell Technologies from $510.00 to $570.00 and gave the stock a “buy” rating in a report on Wednesday, September 2nd.
Get Our Latest Research Report on DELL
Insiders Place Their Bets In related news, Director Lynn Vojvodich Radakovich sold 2,022 shares of the firm’s stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $565.28, for a total value of $1,142,996.16. Following the completion of the transaction, the director owned 25,267 shares of the company’s stock, valued at approximately $14,282,929.76. This trade represents a 7.41% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Spv-2 L.P. Sl sold 46,253 shares of Dell Technologies stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $585.91, for a total transaction of $27,100,095.23. Following the transaction, the director owned 114,714 shares in the company, valued at approximately $67,212,079.74. The trade was a 28.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,906,193 shares of company stock worth $994,871,197 in the last quarter. Corporate insiders own 41.50% of the company’s stock. Institutional Inflows and Outflows Several large investors have recently bought and sold shares of the business. Noble Wealth Management PBC boosted its position in Dell Technologies by 113.6% during the 3rd quarter. Noble Wealth Management PBC now owns 47 shares of the technology company’s stock worth $25,000 after acquiring an additional 25 shares during the period. Cornerstone Financial Management LLC increased its holdings in shares of Dell Technologies by 56.1% in the 2nd quarter. Cornerstone Financial Management LLC now owns 64 shares of the technology company’s stock valued at $28,000 after purchasing an additional 23 shares during the period. Premier Financial Group purchased a new stake in shares of Dell Technologies in the second quarter worth approximately $34,000. Byrne Asset Management LLC purchased a new stake in shares of Dell Technologies in the second quarter worth approximately $38,000. Finally, Atwood & Palmer Inc. boosted its holdings in shares of Dell Technologies by 860.0% during the second quarter. Atwood & Palmer Inc. now owns 96 shares of the technology company’s stock worth $41,000 after purchasing an additional 86 shares during the period. 76.37% of the stock is owned by institutional investors and hedge funds.
More Dell Technologies News Here are the key news stories impacting Dell Technologies this week:
Positive Sentiment: Japan AI data-center partnership: Dell is joining Japan’s JERA and U.K.-based RHAELM in a more than $15 billion AI infrastructure project. The initiative is intended to address power constraints and accelerate data-center development, potentially creating additional demand for Dell’s servers and related infrastructure. JERA teams up with Dell and RHAELM on AI infrastructure development in Japan Positive Sentiment: AI server momentum remains strong: Recent earnings showed $60.9 billion in AI-server orders, $16.4 billion in AI-server revenue and a $95 billion ending backlog. Investors view these figures as evidence that enterprise AI spending is translating into substantial demand for Dell’s infrastructure products. Dell climbs on AI server backlog Positive Sentiment: Raised outlook supports confidence: Management lifted fiscal 2027 revenue guidance to approximately $192 billion, reinforcing expectations for continued growth from AI servers and data-center infrastructure. Wall Street price-target increases and Dell’s recent addition to the S&P 100 are also supporting visibility and institutional demand. Dell gains as AI server momentum and recent index inclusion support sentiment Positive Sentiment: Strong earnings performance: Dell’s latest quarterly results exceeded consensus expectations, with revenue up 57.7% year over year and earnings per share well above estimates. The results strengthened the market’s view that AI-related demand is accelerating the company’s growth. Neutral Sentiment: Dell also introduced new Pro Rugged laptops for field and industrial users. The product expansion broadens the portfolio but is likely less significant to the stock than the company’s AI-server business. Dell Pro Rugged line introduces new laptops Negative Sentiment: Quiver data shows extensive insider selling, including transactions by senior executives and affiliated investment entities, with no reported insider purchases over the past six months. Such sales may be planned or liquidity-related, but they can weigh on sentiment, particularly after the stock’s substantial run-up. Dell Technologies Trading Down 0.1% NYSE:DELL opened at $562.03 on Monday. The company has a 50-day moving average of $490.74 and a 200-day moving average of $368.22. The firm has a market cap of $357.35 billion, a price-to-earnings ratio of 32.62, a price-to-earnings-growth ratio of 0.58 and a beta of 1.37. Dell Technologies has a twelve month low of $110.22 and a twelve month high of $595.51.
Dell Technologies (NYSE:DELL – Get Free Report) last released its earnings results on Tuesday, September 1st. The technology company reported $7.04 EPS for the quarter, beating the consensus estimate of $4.91 by $2.13. The business had revenue of $46.97 billion during the quarter, compared to analyst estimates of $44.89 billion. Dell Technologies had a net margin of 7.53% and a negative return on equity of 578.85%. The business’s quarterly revenue was up 57.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.70 earnings per share. Dell Technologies has set its FY 2027 guidance at 25.500-25.500 EPS and its Q3 2027 guidance at 6.500-6.500 EPS. On average, research analysts forecast that Dell Technologies will post 25.13 earnings per share for the current year.
Dell Technologies Dividend Announcement The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Tuesday, October 20th will be issued a dividend of $0.63 per share. The ex-dividend date is Tuesday, October 20th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 0.4%. Dell Technologies’s payout ratio is currently 14.63%.
Dell Technologies Company Profile (Get Free Report)
Dell Technologies Inc (NYSE: DELL) is a global technology company that develops, sells and supports information technology hardware, software and services. Its offerings include personal computers, workstations, monitors, accessories and other client devices, as well as enterprise infrastructure products such as servers, storage systems, networking equipment and data protection solutions.
The company also provides technology consulting, support, managed services and infrastructure solutions designed to help organizations operate data centers, private and hybrid clouds, artificial intelligence workloads and digital workplaces.
Featured Stories Five stocks we like better than Dell Technologies Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for Dell Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dell Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
CALGARY, Alberta, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) today announced that it has entered into a definitive arrangement agreement to acquire Athabasca Oil Corporation (TSX: ATH) (“Athabasca”) in a cash and stock transaction with an implied enterprise value of $5.7 billion.
Transaction Highlights
Clear strategic fit with Cenovus’s core oil sands business – Adds approximately 45 thousand barrels of oil equivalent per day (MBOE/d)1, including thermal production proximal to Cenovus’s Christina Lake, May River and Thornbury assets, expanding the company’s position in a core resource fairway.High-quality, long-life resource – Over 75 years of proved plus probable reserves life1, including high-quality oil sands assets at Leismer and Corner, providing significant growth potential and a pathway to accelerate thermal production to 115 thousand barrels per day (Mbbls/d) by 2032.Leverages Cenovus’s SAGD operating expertise – Application of Cenovus's proven SAGD operating model to Athabasca’s assets is expected to enhance reservoir performance, reduce steam-to-oil ratios, and accelerate resource recovery. Together with a differentiated project execution track record, including the profitable completion of over 30 successful oil sands phase expansions to date, Cenovus is uniquely positioned to optimize the value of the acquired SAGD assets.$85 million of annual corporate and commercial synergies – Cenovus expects to realize approximately $85 million per year of corporate and commercial synergies, with the majority captured in the first full year following closing of the transaction.Consolidates scalable Duvernay platform – Consolidates ownership of Duvernay Energy Corporation, a high-quality, oil-weighted position in the Kaybob Duvernay, with the option to accelerate development and grow production to a sustainable 20 MBOE/d. “This transaction strengthens our position in one of the world’s premier oil-producing regions and is a natural extension of our oil sands strategy,” said Jon McKenzie, Cenovus President & Chief Executive Officer. “Athabasca’s high-quality, long-life assets fit well with our portfolio and provide a clear opportunity to apply our scale and operating expertise to improve performance, grow production and create long-term shareholder value.”
1 Production and reserves life based on estimated 2026 production exit rate. See Advisory.
Transaction details
Under the terms of the arrangement agreement, Cenovus will acquire all of the issued and outstanding common shares of Athabasca at a price of $12.00 per share, payable in cash and Cenovus common shares. Each Athabasca shareholder (other than dissenting Athabasca shareholders) will have the option to elect to receive, for each Athabasca common share held: (i) $12.00 in cash; (ii) 0.264 of a Cenovus common share; or (iii) such other proportion of cash and Cenovus shares as specified by the Athabasca shareholder. Shareholders who do not make a valid election will be deemed to have elected to receive cash for each of their Athabasca common shares.
All elections will be subject to pro-ration based on a maximum of $4.3 billion in cash, equivalent to 75% of the total consideration, and a maximum of 44.4 million Cenovus common shares, equivalent to 35% of the total consideration. As a result, the aggregate consideration will comprise between 65% and 75% cash and between 25% and 35% Cenovus shares, based on elections made and deemed to be made by Athabasca shareholders. Depending on a particular shareholder’s election and pro-rationing, an Athabasca shareholder may ultimately receive entirely cash, entirely Cenovus shares or a combination of both.
Transaction funding
The cash portion of the consideration will be funded with cash on hand and certain short-term borrowings. Cenovus’s financial framework and net debt target of $4 billion are to remain unchanged.
Cenovus’s net debt at the end of the third quarter was approximately $3.0 billion. Including the cash component of this transaction, year-end 2026 pro forma net debt is expected to be between $5.0 billion to $5.5 billion2 at strip pricing representing less than 0.5 times adjusted funds flow3.
2 Assumes the maximum aggregate cash consideration of 75% or $4.3 billion and includes estimated transaction costs incurred upon closing. Forecasted at forward strip pricing as of September 30, 2026. Pro forma net debt may differ based on Athabasca shareholder elections and pro-ration.
3 Non-GAAP financial measure. See Advisory.
Timing and approvals
The transaction has been unanimously approved by the Board of Directors of both companies. Athabasca’s directors and executive officers have entered into voting and support agreements with Cenovus, pursuant to which they have agreed, subject to their terms, to vote all Athabasca common shares beneficially owned or controlled by them, representing approximately 2.2% of Athabasca’s issued and outstanding common shares, in favour of the transaction.
Cenovus expects the acquisition to close in December 2026, subject to the satisfaction of customary closing conditions, including regulatory approvals and approval of the transaction by Athabasca shareholders. The transaction is not subject to any financing contingency.
Advisors
CIBC Capital Markets is acting as the exclusive financial advisor to Cenovus. McCarthy Tétrault LLP is acting as legal advisor to Cenovus.
Conference call today
Cenovus will host a conference call today, October 5, 2026, starting at 7 a.m. MT (9 a.m. ET).
For analysts wanting to join the call, please register in advance.
To participate in the live conference call, you must complete the online registration form in advance of the conference call start time. Register ahead of time to receive a unique PIN to access the conference call via telephone. Once registered, participants can dial into the conference call from their telephone via the unique PIN or click on the "Call Me" option to receive an automated call directly.
An audio webcast will also be available and archived for approximately 30 days.
A slide presentation with further details on the transaction can also be accessed in the investor section of our website at cenovus.com.
Advisory
Basis of Presentation
Cenovus reports financial results in Canadian dollars and presents production volumes on a net to Cenovus before royalties basis, unless otherwise stated. Cenovus prepares its financial statements in accordance with International Financial Reporting Standards (IFRS) Accounting Standards.
Forward-looking Information
This news release contains certain forward-looking statements and forward-looking information (collectively referred to as “forward-looking information”) within the meaning of applicable securities legislation about Cenovus’s current expectations, estimates and projections about the future of Cenovus, including following the acquisition of Athabasca, based on certain assumptions made in light of Cenovus’s experiences and perceptions of historical trends. Although Cenovus believes that the expectations represented by such forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Forward-looking information in this news release is identified by words such as “accelerate”, “acquire”, “anticipate”, “consolidate”, “create”, “depend”, “enhance”, “expect”, “leverage”, “maintain”, “may”, “opportunity”, “optimize”, “option”, “position”, “potential”, “realize”, “reduce”, “remain”, “synergy”, “target” and “will” or similar expressions and includes suggestions of future outcomes, including, but not limited to, statements about: acquiring all of the issued and outstanding common shares of Athabasca pursuant to a plan of arrangement (the “Acquisition”); elections of Athabasca shareholders and the associated pro-rations of cash and share consideration; integrating Cenovus’s and Athabasca’s businesses and operations and realizing the anticipated strategic, operational, commercial, corporate and financial benefits and synergies of the Acquisition and value and timing thereof; anticipated operation and development plans, including but not limited to, integrated development, expansion, existing asset optimization and potential asset integrations; the ownership consolidation of Duvernay Energy Corporation and the benefits therefrom; Cenovus's ability to provide a scalable platform and the associated optionality to accelerate development; the benefits of the Acquisition and the timing for realizing such benefits, including with respect to SAGD operation scaling, asset fit, thermal production growth, development, steam-to-oil ratio reduction, accelerated resource recovery, reserve and resource life, value optimization of Athabasca’s and Duvernay Energy Corporation's assets, integration of assets, synergies and the sources of such synergies, accretion to adjusted funds flow per share, long-term shareholder value, accretion to asset quality and financial impact; the funding of consideration; Cenovus's financial framework and net debt target of $4 billion remaining unchanged following the closing of the Acquisition; net debt and pro forma net debt following the closing of the Acquisition; anticipated pro forma net debt relative to adjusted funds flow at strip pricing; and timing of closing of the Acquisition.
Developing forward-looking information involves reliance on a number of assumptions and consideration of certain risks and uncertainties, some of which are specific to Cenovus and Athabasca and others that apply to the industry generally. The factors or assumptions on which the forward-looking information in this news release is based include, but are not limited to: information currently available to Cenovus about itself and Athabasca and the businesses in which they operate; the completion of the Acquisition on anticipated terms and timing; the satisfaction of customary closing conditions and obtaining regulatory and Athabasca shareholder approvals; general economic, market and business conditions; anticipated tax treatment; that actions by third parties do not delay or otherwise adversely affect completion of the Acquisition; that any litigation relating to the Acquisition does not prevent, materially delay or otherwise adversely affect its completion; integrating Cenovus’s and Athabasca’s businesses and operations and realizing the anticipated strategic, operational, commercial, corporate and financial benefits and synergies of the Acquisition and value and timing thereof; anticipated operation and development plans, including but not limited to, integrated development, expansion, existing asset optimization and potential asset integrations; the ownership consolidation of Duvernay Energy Corporation and the benefits therefrom; Cenovus's ability to provide a scalable platform and the associated optionality to accelerate development; the benefits of the Acquisition and the timing for realizing such benefits, including with respect to SAGD operation scaling, asset fit, thermal production growth, development, steam-to-oil ratio reduction, accelerated resource recovery, reserve and resource life, value optimization of Athabasca’s and Duvernay Energy Corporation's assets, integration of assets, synergies and the sources of such synergies, accretion to adjusted funds flow per share, long-term shareholder value, accretion to asset quality and financial impact; the accuracy of the reserve and resource estimates and the operating and development assumptions underlying the anticipated outcomes; that adverse reactions or changes to business relationships, including with employees, suppliers, customers, competitors or credit rating agencies, arising from the announcement or completion of the Acquisition, do not materially impair completion, integration or realization of the anticipated benefits; combined company production estimates; the quality of the integrated resource/assets meeting expectations; that there will be no material change to Athabasca’s operations prior to completion of the Acquisition; assumptions regarding Athabasca shareholder elections and the associated rounding and pro-ration of cash and share consideration, including the applicable aggregate limits; the availability of cash on hand and short-term borrowings to fund the cash consideration and Cenovus’s ability to issue the shares required to satisfy the share consideration; Cenovus’s financial framework and net debt target remaining unchanged; the assumptions regarding shareholder elections, commodity prices, operating results, capital spending and funding underlying anticipated net debt, pro forma net debt and pro forma net debt relative to adjusted funds flow at strip pricing; no material changes to laws and regulations adversely affecting Cenovus’s or Athabasca’s operations or the Acquisition; commodity prices; and the assumptions inherent in Cenovus’s updated 2026 corporate guidance available on cenovus.com.
The risk factors and uncertainties that could cause actual results to differ materially from the forward-looking information in this news release include, but are not limited to: changes to general economic, market and business conditions; not completing the Acquisition on anticipated terms and timing, or at all, including failure to satisfy customary closing conditions or obtain required regulatory and Athabasca shareholder approvals; failing to complete the Acquisition on the terms contemplated by the arrangement agreement between Cenovus and Athabasca; differences in Athabasca shareholder elections and the resulting cash and share consideration from those assumed; the combined company’s inability to issue securities; potential litigation relating to the Acquisition that could be instituted against Cenovus or Athabasca; the delay or inability to integrate Cenovus’s and Athabasca’s businesses and operations and realizing the anticipated strategic, operational, commercial, corporate and financial benefits and synergies of the Acquisition and value and timing thereof; potential adverse reactions or changes to business relationships, including with employees, suppliers, customers, competitors or credit rating agencies, resulting from the announcement or completion of the Acquisition; the inability or failure to achieve the anticipated operation and development plans, including but not limited to, integrated development, expansion, existing asset optimization and potential asset integrations; delay or inability to achieve the anticipated benefits from the ownership consolidation of Duvernay Energy Corporation; Cenovus's ability to provide a scalable platform and the associated optionality to accelerate development; delay or inability to achieve the anticipated benefits of the Acquisition and the timing for realizing such benefits, including with respect to SAGD operation scaling, asset fit, thermal production growth, development, steam-to-oil ratio reduction, accelerated resource recovery, reserve and resource life, value optimization of Athabasca’s and Duvernay Energy Corporation's assets, integration of assets, synergies and the sources of such synergies, accretion to adjusted funds flow per share, long-term shareholder value, accretion to asset quality and financial impact; inaccuracies in reserve and resource estimates or in the underlying operating and development assumptions; the quality of the integrated resource/assets failing to meet expectations; changes to Cenovus’s financial framework or net debt target; differences in shareholder elections, commodity prices, operating results, capital spending or funding; net debt, pro forma net debt or pro forma net debt relative to adjusted funds flow differing from anticipated levels; material changes to laws and regulations adversely affecting Cenovus’s or Athabasca’s operations or the Acquisition; the consequences of not completing the Acquisition, including the volatility of the share prices of Cenovus and Athabasca, negative reactions from the investment community and the required payment of certain costs related to the Acquisition; potential undisclosed liabilities in respect of Athabasca unidentified during the due diligence process; inaccuracies in the pro forma financial information of the combined company after the Acquisition; the interpretation of the Acquisition by tax authorities; the focus of management’s time and attention on the Acquisition and other disruptions arising from the Acquisition; volatility of, and other assumptions regarding, commodity prices; product supply and demand; market competition, including from alternative energy sources; inability to maintain relationships with partners or successfully manage and operate integrated businesses; and other risks identified under “Risk Management and Risk Factors” and “Advisory” in Cenovus’s Management’s Discussion and Analysis (MD&A) for the periods ended December 31, 2025 and June 30, 2026 and the risk factors, assumptions and uncertainties described in other documents Cenovus files from time to time with securities regulatory authorities in Canada (available on SEDAR+ at sedarplus.ca, on EDGAR at sec.gov and Cenovus’s website at cenovus.com).
The guidance in respect of Cenovus's expectations of future periods in this news release may be considered to be a financial outlook for the purposes of applicable Canadian securities laws. Such information is based on assumptions about future events, including economic conditions and proposed courses of action, based on management's assessment of the relevant information currently available, and which may become available in the future. These projections constitute forward-looking statements and are based on several material factors and assumptions set out above. Actual results may differ significantly from such projections. See above for a discussion of certain risks that could cause actual results to vary. The financial outlook contained in this news release has been approved by management as of the date of this news release. Readers are cautioned that any such financial outlook contained herein should not be used for purposes other than those for which it is disclosed herein. Cenovus and its management believe that the financial outlook contained in this news release has been prepared based on assumptions that are reasonable in the circumstances, reflecting management's best estimates and judgments, and represents, to the best of management's knowledge and opinion, expected and targeted financial results. However, because this information is highly subjective, it should not be relied on as necessarily indicative of future results.
In respect of the net debt disclosure herein, readers are directed to Cenovus’s MD&A for the periods ended December 31, 2025 and June 30, 2026 (available on SEDAR+ at sedarplus.ca, on EDGAR at sec.gov and Cenovus’s website at cenovus.com), which includes a detailed composition of how Cenovus calculates the metric.
Except as required by applicable securities laws, Cenovus disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are cautioned that the foregoing lists are not exhaustive and are made as at the date hereof. Events or circumstances could cause actual results to differ materially from those estimated or projected and expressed in, or implied by, the forward-looking information. For additional information regarding Cenovus’s material risk factors, the assumptions made, and risks and uncertainties which could cause actual results to differ from the anticipated results, refer to “Risk Management and Risk Factors” and “Advisory” in Cenovus’s MD&A for the periods ended December 31, 2025 and June 30, 2026 and to the risk factors, assumptions and uncertainties described in other documents Cenovus files from time to time with securities regulatory authorities in Canada (available on SEDAR+ at sedarplus.ca, on EDGAR at sec.gov and Cenovus’s website at cenovus.com).
Specified Financial Measures
Certain financial measures in this news release do not have a standardized meaning as prescribed by IFRS Accounting Standards including Adjusted Funds Flow. These measures may not be comparable to similar measures presented by other issuers and are described and presented in order to provide shareholders and potential investors with additional measures for analyzing our ability to generate funds to finance our operations and information regarding our liquidity. This additional information should not be considered in isolation, or as a substitute for, measures prepared in accordance with IFRS Accounting Standards. Readers are directed to “Advisory – Specified Financial Measures” in Cenovus’s MD&A for the periods ended June 30, 2026 for further information.
Oil and Gas Advisory
Barrels of Oil Equivalent – natural gas volumes are converted to BOE on the basis of six Mcf to one bbl. BOE may be misleading, particularly if used in isolation. A conversion ratio of one bbl to six Mcf is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent value equivalency at the wellhead. Given that the value ratio based on the current price of crude oil compared with natural gas is significantly different from the energy equivalency conversion ratio of 6:1, utilizing a conversion on a 6:1 basis is not an accurate reflection of value.
This news release makes assumptions relating to future production volumes based on reserve evaluation calculations prepared by third-party independent evaluators. Statements relating to "reserves" are deemed to be forward-looking statements as they involve the implied assessment based on certain estimates and assumptions that the reserves described can be profitably produced in the future. There are numerous uncertainties inherent in estimating quantities of proved and proved plus probable reserves and in projecting future rates of production. The total amount or timing of actual future production may vary significantly from reserves and production estimates.
This press release contains certain oil and gas metrics, such as “reserves life”, which do not have standardized meanings or standard methods of calculation and therefore such measures may not be comparable to similar measures used by other companies and should not be used to make comparisons. Such metrics have been included herein to provide readers with additional information regarding Cenovus’s acquisition of Athabasca; however, such measures are not reliable indicators of future performance and future performance may not compare to performance in previous periods and therefore such metrics should not be unduly relied upon.
Athabasca reserves life is calculated using total gross reserves on a 2P basis and dividing them by Athabasca management’s current anticipated 2026 exit production, in each case as included in Athabasca’s public disclosure. Although Cenovus has no knowledge that would indicate that any information contained in the documents filed by Athabasca are untrue or incomplete, Cenovus does not assume any responsibility for the accuracy or completeness of the information contained in such documents, or for any failure by Athabasca to disclose events that may have occurred or that may affect the significance or accuracy of any such information, which are unknown to Cenovus.
Cenovus Energy Inc.
Cenovus Energy Inc. is an integrated energy company with oil and natural gas production operations in Canada and the Asia Pacific region, and upgrading, refining and marketing operations in Canada and the United States. The company is committed to maximizing value by developing its assets in a safe, responsible and cost-efficient manner, integrating sustainability considerations into its business plans. Cenovus common shares are listed on the Toronto and New York stock exchanges. For more information, visit cenovus.com.
Find Cenovus on Facebook, LinkedIn, YouTube and Instagram.
Cenovus contacts
Investors
Investor Relations general line
403-766-7711
GBP/CAD minulý týden vystoupal na pětitýdenní maximum a byl o více než 0,7 % výše. Podporu mu daly sázky na zvýšení úrokových sazeb BoE a silnější růst britské ekonomiky.
The Pound-Canadian Dollar could stay supported if UK services remain resilient, while weaker Canadian jobs data may weigh on the Loonie. The Pound Canadian Dollar (GBP/CAD) exchange rate saw big swings last week, with Sterling hitting a five-week high against the ‘Loonie’ amid UK interest rate hike bets and stronger GDP growth.
At the time of writing, GBP/CAD was trading at CA$1.8878, up over 0.7% on the week.
Latest — Exchange Rates:
Pound to Canadian Dollar (GBP/CAD): 1.887449 (+0.04%)
Euro to Canadian Dollar (EUR/CAD): 1.605032 (+0.09%)
Dollar to Canadian Dollar (USD/CAD): 1.42531 (+0.02%)
DAILY RECAP:
The Pound (GBP) made a positive start to the week, as remarks from Bank of England (BoE) Deputy Governor Dave Ramsden fuelled expectations that the central bank could raise interest rates in November.
A lack of fresh UK data saw Sterling lose momentum on Tuesday, but the currency regained ground midweek after revised figures revealed stronger-than-expected UK economic growth. GDP expanded by 0.5% in the second quarter, reinforcing market bets on a November rate increase.
However, the Pound’s upward momentum faltered on Thursday after the UK’s final manufacturing PMI was revised slightly lower. Despite the downgrade, the index continued to signal an improvement in manufacturing activity.
Sterling ended the week on a firmer footing, drawing support from Burnham’s remarks on strengthening the UK’s ties with Europe and the possibility of rejoining the EU.
The Canadian Dollar (CAD) edged lower at the start of the week as concerns about the ongoing US-Canada trade war offset support from a surge in global oil prices.
The commodity-linked currency then recovered on Tuesday, shrugging off softer oil prices as a rebound in Canadian GDP in August helped lift sentiment.
However, CAD struggled to build on these gains midweek as oil prices remained below $100 per barrel.
The Canadian Dollar rebounded sharply on Thursday after touching multi-week lows, with a fresh jump in oil prices boosting demand for the crude-linked currency.
Nevertheless, CAD ended the week on the defensive as Brent crude fell back below $100 per barrel.
Near-Term GBP/CAD Forecast: Rising Canadian Unemployment to Dent the ‘Loonie’? Looking ahead, the UK’s final services PMI on Monday is the only British data release on the calendar this week. If the figures confirm a slowdown in the crucial sector, the Pound could come under pressure.
Canada’s services PMI is also out on Monday, although its impact may be limited. Markets expect activity to have improved slightly but remained in contraction territory last month.
Friday’s Canadian jobs data is the key release for the week. A forecast rise in unemployment in September could weigh on CAD.
Meanwhile, oil price dynamics will likely continue to drive the currency. Further turbulence could trigger big swings in the Canadian Dollar.
Exchange Rates UK Research Our currency coverage draws on live market data, official economic releases and published bank research.
CX Institutional ve 3. čtvrtletí otevřela novou pozici v Marvell Technology: 2 370 akcií za zhruba 626 000 USD. Marvell zároveň oznámila čtvrtletní dividendu 0,06 USD na akcii.
CX Institutional bought a new position in shares of Marvell Technology, Inc. (NASDAQ:MRVL – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 2,370 shares of the semiconductor company’s stock, valued at approximately $626,000.
Several other hedge funds have also made changes to their positions in MRVL. Hilton Head Capital Partners LLC raised its stake in shares of Marvell Technology by 978.3% in the first quarter. Hilton Head Capital Partners LLC now owns 248 shares of the semiconductor company’s stock valued at $25,000 after acquiring an additional 225 shares in the last quarter. C M Bidwell & Associates Ltd. acquired a new stake in shares of Marvell Technology in the 2nd quarter valued at $27,000. MidFirst Bank purchased a new stake in shares of Marvell Technology during the 4th quarter worth $28,000. Aberdeen Wealth Management LLC acquired a new stake in Marvell Technology in the second quarter valued at $30,000. Finally, Pittenger & Anderson Inc. lifted its holdings in Marvell Technology by 61.5% during the 1st quarter. Pittenger & Anderson Inc. now owns 315 shares of the semiconductor company’s stock worth $31,000 after buying an additional 120 shares during the last quarter. Institutional investors and hedge funds own 83.51% of the company’s stock.
Key Stories Impacting Marvell Technology Here are the key news stories impacting Marvell Technology this week:
Positive Sentiment: Investors are anticipating another potential guidance increase on October 6. Marvell’s recent record revenue, 37% year-over-year sales growth and raised fiscal 2027 and 2028 outlooks support expectations for continued momentum. Prediction: This Artificial Intelligence AI Chip Stock Will Make a Big Move in October Positive Sentiment: A reported deal with Google highlights Marvell’s custom AI silicon opportunity with hyperscale customers. Management’s projected custom-chip growth through 2028 is reinforcing the view that AI demand could support further revenue expansion. Marvell’s Custom AI Silicon Deals With Hyperscalers Could Redefine Its Growth Story Positive Sentiment: Analysts and financial commentators remain broadly bullish, with Marvell frequently identified as a major beneficiary of AI infrastructure spending. Its data-center business accounted for 79% of fiscal second-quarter 2027 revenue, while several analysts maintain buy or outperform ratings. Broadcom vs. Marvell: One AI Stock Offers More Bang for the Buck Neutral Sentiment: Marvell affirmed its quarterly dividend of $0.06 per share, providing a modest shareholder return but little impact on the investment case because the annualized yield is approximately 0.1%. The Federal Reserve’s upcoming policy decision also remains relevant because interest rates and liquidity can influence high-growth technology valuations. Is Marvell Technology Fully Valued on Its Dividend Affirmation and AI Run? Negative Sentiment: Valuation is the main risk: MRVL trades at roughly 90 times trailing earnings, far above the broader market. Investors are concerned that reliance on a concentrated group of hyperscale customers could leave revenue vulnerable if AI-related capital spending slows. Should You Be Worried About Marvell Stock? Negative Sentiment: COO Chris Koopmans sold 10,000 shares worth approximately $2.6 million under a pre-arranged Rule 10b5-1 plan. The sale is a mild negative signal, though the executive retained more than 207,000 shares, limiting its significance. Insider Selling: Marvell Technology COO Sells 10,000 Shares Insider Buying and Selling at Marvell Technology In other news, COO Chris Koopmans sold 10,000 shares of Marvell Technology stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $262.05, for a total value of $2,620,500.00. Following the sale, the chief operating officer owned 207,941 shares of the company’s stock, valued at $54,490,939.05. The trade was a 4.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Matthew Murphy sold 7,500 shares of the business’s stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $223.39, for a total transaction of $1,675,425.00. Following the transaction, the chief executive officer owned 775,686 shares in the company, valued at approximately $173,280,495.54. This trade represents a 0.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 45,000 shares of company stock valued at $9,904,225 in the last 90 days. Company insiders own 0.12% of the company’s stock. Wall Street Analysts Forecast Growth Several research firms have recently issued reports on MRVL. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $360.00 price objective on shares of Marvell Technology in a research report on Monday, September 28th. Bank of America raised their target price on Marvell Technology from $240.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, June 23rd. The Goldman Sachs Group set a $220.00 target price on Marvell Technology in a research note on Friday, August 28th. Needham & Company LLC upped their price target on Marvell Technology from $270.00 to $300.00 and gave the company a “buy” rating in a report on Friday, August 28th. Finally, Citigroup increased their price target on shares of Marvell Technology from $225.00 to $275.00 and gave the company a “buy” rating in a research note on Friday, August 21st. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-nine have assigned a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $272.00.
Get Our Latest Research Report on Marvell Technology
Marvell Technology Stock Performance Shares of Marvell Technology stock opened at $272.29 on Monday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.62 and a current ratio of 3.17. The company has a market capitalization of $238.77 billion, a P/E ratio of 89.86, a PEG ratio of 2.63 and a beta of 2.26. Marvell Technology, Inc. has a 1 year low of $70.68 and a 1 year high of $329.88. The company’s fifty day moving average is $227.31 and its two-hundred day moving average is $204.87.
Marvell Technology (NASDAQ:MRVL – Get Free Report) last announced its earnings results on Thursday, August 27th. The semiconductor company reported $0.94 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.01. Marvell Technology had a net margin of 27.93% and a return on equity of 13.57%. The business had revenue of $2.74 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same period in the prior year, the company earned $0.67 earnings per share. The business’s revenue was up 36.5% compared to the same quarter last year. Marvell Technology has set its Q3 2027 guidance at 1.050-1.150 EPS. Analysts forecast that Marvell Technology, Inc. will post 3.05 earnings per share for the current year.
Marvell Technology Dividend Announcement The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 29th. Shareholders of record on Friday, October 9th will be given a dividend of $0.06 per share. The ex-dividend date is Friday, October 9th. This represents a $0.24 dividend on an annualized basis and a yield of 0.1%. Marvell Technology’s dividend payout ratio is presently 7.92%.
Marvell Technology Profile (Free Report)
Marvell Technology, Inc (NASDAQ: MRVL) is a fabless semiconductor company that develops technologies for data infrastructure. Its products are used to move, process, store and secure data across cloud data centers, enterprise networks, telecommunications systems, automotive platforms and other communications applications.
The company’s portfolio includes custom application-specific integrated circuits, data processing and networking solutions, Ethernet products, storage controllers, optical and electro-optical components, and connectivity technologies.
Featured Stories Five stocks we like better than Marvell Technology Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for Marvell Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marvell Technology and related companies with MarketBeat.com's FREE daily email newsletter.
Primoco UAV za 9M 2026 zvýšilo tržby na 431 mil. Kč a čistý zisk na 105 mil. Kč. Firma potvrdila celoroční výhled tržeb 900 mil. až 1,0 mld. Kč a EBITDA 225 až 300 mil. Kč.
Český výrobce bezpilotních letounů Primoco UAV zveřejnil na svých stránkách předběžné konsolidované výsledky za první tři čtvrtletí roku 2026.
Předběžné konsolidované výsledky Primoco (BAAPRIUA) za 9M 2026 9M 2026 9M 2025 Tržby (mil. Kč) 431 258 Zisk EBITDA (mil. Kč) 143 75 Čistý zisk (mil. Kč) 105 50 Za první pololetí společnost celkově prodala 2 letouny a 2 letouny dodala, v samostatném druhém kvartálu nedodala ani neprodala jediný letoun. V srpnu společnost dle tiskové zprávy dodala 12 letounů, přičemž v roce 2026 při naplnění smluvního harmonogramu dodá dalších 18 letounů, které představují očekávané tržby přibližně 515 mil. Kč.
Detailní výsledky za třetí čtvrtletí společnost zveřejní 2. listopadu 2026.
Výhled Pro celý rok 2026 společnost očekává konsolidované tržby v rozmezí 900 mil. až 1,0 mld. Kč a zisk EBITDA v rozmezí 225 až 300 mil. Kč.
Akcie Primoco UAV Akcie Primoco UAV (BAAPRIUA) na pražské burze posilují 7,44 % na 664,0 Kč.
Zdroj: Primoco UAV
Jan Prokeš, Fio banka, a.s.
Související odkazy Pražská burza otevírá týden poklesem, Primoco zveřejnilo pololetní výsledky Primoco UAV reportovalo za 1H, dodávky se údajně přesouvají do druhého pololetí Primoco se vyjádřilo ke sporu s akcionářem ohledně změny stanov Primoco UAV posiluje management o dvě nové ředitelky Výrobce bezpilotních letadel Primoco reportoval za 1Q
Redwire získala od Axiom Space zakázku na vývoj a dodávku dvou křídel Roll-Out Solar Array pro druhý modul Axiom Station. Firma už vyrábí ROSA i pro první modul.
Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced it has been awarded a contract by Axiom Space, a leader in next-generation space infrastructure, to develop and deliver two Roll-Out Solar Array (ROSA) wings for Axiom Station’s secondspace station module.
As previously announced, Redwire is also building the ROSA wings for Axiom Space’s first space station module.
“We are excited and grateful for the opportunity to provide Axiom Space with additional ROSAs,” said Mike Gold, President of Redwire Space. “The unparalleled track record of ROSA supporting the International Space Station (ISS) in low-Earth orbit (LEO) makes it the ideal system to provide the robust power needed to support Axiom Space’s global customers and pioneering commercial space station, Axiom Station. At Redwire, we’re committed to leveraging our proven, heritage systems such as ROSA – with its 100-percent success rate in a wide variety of space environments from LEO, to GEO, and beyond – to be a part of Axiom Space’s mission to revolutionize both space and life on Earth via microgravity research, development, and manufacturing.”
Axiom Station will provide a permanent commercial platform in LEO where nations around the world can conduct microgravity research, develop and eventually manufacture commercial products to return to Earth, and access space uninterrupted, through human spaceflight missions.
“Redwire’s Roll-Out Solar Array hardware is a crucial component necessary for Axiom Space to build a sustainable commercial presence in LEO,” said Dr. Jonathan Cirtain, CEO and President of Axiom Space. “The company’s innovative technology will power our space station and its systems, maintaining and expanding access to LEO for more nations and extending the breakthroughs in science and technology-driven solutions that microgravity provides to benefit everyone, everywhere on Earth.”
Axiom Station’s first module is currently undergoing final assembly at Thales Alenia Space, in Turin, Italy, after which the module will be transferred to Houston for integration and testing and ultimately transferred to the Kennedy Space Center in Florida for launch. Axiom Space is planning to launch the first module in 2028. The second module is preparing to undergo final assembly at Thales Alenia Space and is planned to launch less than a year after the first, where it can loiter on orbit until ready to dock with the first module. Together, these two modules will form a four crew-capable, operational free-flying space station.
Redwire’s power systems have supported some of the world’s most high-impact space missions, from sustaining astronauts aboard the ISS to demonstrating planetary defense with NASA’s Double Asteroid Redirection Test. Building on this proven track record of success, the company’s ROSA and ELSA products are powering a new generation of commercial and national security missions, supporting plans for exploration of the Moon and Mars and paving the way for orbital data centers. With more than 65 solar array wings delivered or in development, Redwire is building the power behind humanity’s ambitions in space.
About Redwire
Redwire Corporation (NYSE: RDW) is an integrated space and defense tech company focused on advanced technologies. We are building the future of aerospace infrastructure, autonomous systems, and multi-domain operations leveraging digital engineering and AI automation. Redwire’s approximately 1,400 employees located throughout North America and Europe are committed to delivering innovative space and airborne platforms transforming the future of multi-domain operations. For more information, please visit RDW.com.
About Axiom Space
Axiom Space is a human space exploration company, building era-defining space infrastructure and delivering technology-driven solutions that will empower civilization to transcend Earth. Beginning with Axiom Station, successor to the International Space Station, the company is pioneering a next-generation orbital settlement that will foster groundbreaking innovation and research in microgravity and drive the global space economy of tomorrow. Today, guided by the vision of leading humanity's expansion off planet, Axiom Space is the principal provider of commercial human spaceflight services and developer of advanced spacesuits for the Moon and beyond. For more information about Axiom Space, visit www.axiomspace.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261005570082/en/
TempraMed oznámila, že VIVI Cap Smart nyní podporuje napojení na Apple Health a Google Fit. Cílem je zpřehlednit používání injekčních léků a jejich teplotní data v digitálním zdravotnictví.
Toronto, Ontario--(Newsfile Corp. - October 5, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (OTCQB: TMPTF) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology company transforming the storage, protection and management of temperature-sensitive medications, is pleased to announce that its VIVI Cap Smart™ platform now supports connectivity with Apple Health and Google Fit, advancing the Company's strategy to make injectable medication use visible within leading health and wellness ecosystems.
VIVI Cap Smart™ is TempraMed's connected temperature-protection device for insulin pens, GLP-1 therapies and other injectable medications. The product combines TempraMed's validated passive thermal-shield technology with digital capabilities designed to help patients monitor medication exposure, track injections, receive reminders and share medication-use information with caregivers, healthcare professionals and remote patient management systems.
Management believes this connectivity represents an important strategic milestone for TempraMed as the healthcare market shifts toward home-based care, wearable devices, AI-enabled health platforms and patient-generated health data. While today's wearable and health platforms commonly track activity, heart rate, glucose, sleep, app engagement and health records, injectable medication use remains a major missing signal. VIVI Cap Smart is designed to close this gap by capturing medication-use and temperature-integrity data from the injectable therapies patients use every day.
Highlights
Connects injectable medication use to leading health platforms: VIVI Cap Smart connectivity with Apple Health and Google Fit is designed to allow patients to include injection-related information alongside broader personal health data.
Creates a new data layer for injectables: The platform helps capture injection activity, medication reminders, temperature exposure and adherence-related signals from insulin, GLP-1 and other injectable medication use.
Supports home-care and remote monitoring models: VIVI Cap Smart is designed to enable better visibility for patients, family members, caregivers and healthcare professionals as more chronic therapies move from clinics into the home.
Pen-agnostic and platform-ready: Unlike smart-pen solutions tied to a single drug manufacturer or device format, VIVI Cap Smart is designed to work across multiple pen brands and therapy categories while adding temperature protection.
Positions TempraMed for strategic partnerships: The Company believes injectable medication data is increasingly relevant to wearable, digital-health, AI, pharma, medical-device and payer platforms seeking new clinical signals and better patient engagement.
Supports recurring digital-health revenue: VIVI Cap Smart is built around a connected-device and subscription model, creating the potential for software-enabled revenue in addition to hardware sales.
The Missing Signal in Digital Health: Injectable Medication Use
Hundreds of millions of patients worldwide now use injectable medications for diabetes, weight management, autoimmune conditions, fertility, allergies and other chronic or acute conditions1. At the same time, wearable devices and health platforms are becoming central to how patients and healthcare providers monitor health trends, adherence and outcomes.
Despite this momentum, injectable medication behavior remains largely disconnected from the digital-health ecosystem. Wearables may track vital signs and biosensor data, but they generally do not know whether a patient actually used an injectable medication, when the injection occurred, or whether the medication was exposed to damaging temperatures before use.
VIVI Cap Smart was developed to address that gap. The platform is designed to provide a universal injectable-therapy layer that combines:
Temperature protection for in-use medications;
Automatic injection-event capture;
Medication reminders;
App connectivity;
Voice dose recognition and manual dose entry;
Real-time alerts and data analytics; and
Integration potential for remote patient monitoring and health platforms.
"VIVI Cap Smart is about much more than protecting medication from heat and cold, it turns the injectable medication into a connected data point. For patients, that means better reminders, more confidence and better visibility. For caregivers and clinicians, it means access to information that is usually missing. For digital-health platforms, it adds one of the most important clinical signals they do not currently capture: injectable medication use," said Ron Nagar, Chief Executive Officer of TempraMed. "Apple Health, Google Fit and other health platforms are becoming the operating systems of personal health, Our vision is that every injectable medication—whether insulin, GLP-1 therapy, biologic, epinephrine or other critical medication—should be both temperature protected and digitally visible. VIVI Cap Smart is pen agnostic, and designed to make that possible without requiring drug manufacturers, device makers or platforms to build a new solution for each pen or medication format."
VIVI Cap Smart provides a practical way to connect injectable medication behavior to these ecosystems, while also solving the real-world challenge of medication temperature exposure. VIVI Cap Smart is strategically relevant to the next generation of health platforms because it brings a new layer of patient-generated data into the ecosystem.This creates a differentiated opportunity for TempraMed across several partner categories:
Wearable and health platforms, which can add injectable medication behavior to existing health data streams;
Pharmaceutical companies, which can better support patients using insulin, GLP-1 therapies, biologics and other injectables;
Medical-device companies, which can strengthen connected-care offerings around injection therapy;
Payors and health systems, which can support adherence, reduce waste and improve real-world visibility; and
Remote patient monitoring platforms, which can incorporate medication-use signals into care-management workflows.
Making Every Injection Device Connected and Temperature Protected
TempraMed's long-term strategy is to make every injection device connected and temperature protected. VIVI Cap Smart represents a key step in that strategy by combining the Company's patented thermal-shield platform with smart connectivity and health-data integration.
The Company's broader smart platform roadmap includes connected solutions for insulin pens, GLP-1 therapies, epinephrine auto-injectors, vials, biologics and multi-medication storage formats.
Management believes this approach positions TempraMed as a potential enabling technology layer for the rapidly expanding market of injectable therapies, home care, digital health, wearables and AI-driven health platforms.
About TempraMed Technologies Ltd.
TempraMed Technologies Ltd. is a global medical-device company with a portfolio of innovative, temperature-controlled medication-storage solutions. Founded with the mission to safeguard the effectiveness of life-saving medications, TempraMed develops patented, FDA-registered thermal-insulation devices that operate continuously without batteries or external power. Its commercial product portfolio includes VIVI Cap™, VIVI Cap Smart™, VIVI Epi™, and VIVI Med™. TempraMed enables patients and healthcare providers to confidently manage temperature-sensitive medications anywhere, anytime.
Cautionary Statements
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE'S REGULATION SERVICES PROVIDER.
This press release contains "forward-looking statements" or "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking statements can be identified by words such as "anticipate," "believe," "expect," "intend," "plan," "may," "will," "should," "strategy," "future," "potential," and similar expressions.
Forward-looking statements in this press release include, without limitation, statements regarding the Company's VIVI Cap Smart platform, its connectivity with Apple Health and Google Fit, the expected benefits of such connectivity, the Company's strategy to integrate injectable medication data into digital-health platforms, future partnerships, recurring digital-health revenue, market adoption, patient engagement, remote patient monitoring opportunities, and the Company's broader connected-product roadmap.
Forward-looking statements are based on current expectations, assumptions and estimates of management as of the date of this press release and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied. Such risks include, among others, changes in customer demand, timing of product development and commercialization, technical integration risks, third-party platform requirements, regulatory developments, data-privacy requirements, market acceptance, competitive factors, availability of financing, supply-chain constraints and general economic and business conditions.
Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.
Honda v Indii spojí síly s Tata Technologies a chce snížit náklady až o pětinu a zkrátit vývoj na polovinu. První společný model má být malé SUV s plánovaným uvedením v roce 2028.
Honda Motor (7267.T) aims to cut costs by as much as a fifth and halve development times under its new partnership in India with Tata Technologies (TATE.NS), according to two people familiar with the matter, as pressure from rivals forces the Japanese automaker to rethink its go-it-alone approach.
Reeling from electric vehicle (EV)-related losses that it expects to reach more than $12 billion, Honda is pivoting to gasoline-electric hybrids and slashing expenses. Last month, Reuters reported that it is seeking to cut more than $9 billion in costs over the next four years and has told suppliers to drastically reduce prices.
In May, engineering firm Tata Technologies said it was selected to develop vehicles for a Japanese automaker. It declined to name the partner, but the two people and another person familiar with the matter said it was Honda.
Under the outsourcing agreement, Tata Technologies will develop cars for the Indian market, while Honda expects to see up to 20% in cost reductions and halve its development times from around five years at present, two people said.
Honda decided to bring in Tata Technologies after the automaker's Japanese and Indian managers failed to agree on which suppliers to use for upcoming vehicles in India, two of the people said.
All three sources declined to be identified because the information has not been made public. The cost-cutting and development targets in India, as well as the internal deadlock over supplier strategy, are being reported for the first time.
In a statement, Honda said it has not been able to offer a sufficient product line-up in India that allows customers "value for money." To that end, it was "redefining" its offerings in India and planned to introduce vehicles that strike a balance between quality and price, it said.
It denied there were disagreements between the Japanese and Indian teams over supplier selection.
In a separate statement, Honda India said product development involved close collaboration between different teams, adding that it was inaccurate to characterise collaborative discussions as disagreements.
Tata Technologies did not respond to a request for comment.
STRATEGY DEADLOCK
Japanese managers wanted to retain established suppliers to ensure quality and consistency, while Honda's team in India pushed for greater use of local suppliers to lower costs and speed up development in the world's third-largest car market, two of the people said.
Reuters could not determine how long the deadlock lasted but the disagreement was enough to delay work on some products, the two people said. The partnership had been under discussion for about two years before being finalised, one of them added.
Tata Technologies, which was spun off from Indian automaker Tata Motors (TAMO.NS), was chosen because of its access to a broad network of local suppliers and because Honda managers believed it could design vehicles in line with consumer tastes and spending preferences, the person said.
Honda will oversee the process to ensure quality standards are met and will retain control over areas like technology, connectivity and driver-assistance systems, the person added.
FAMOUS INDEPENDENCE
Honda has long carried the imprint of its famously independent late founder, Soichiro Honda. It developed two of the world's best-selling cars, the Civic and the Accord, along with the most popular motorcycle of all time, the Super Cub.
Like other Japanese automakers, Honda faces the difficult balancing act of defending its legacy business in places like the US while developing new technologies to compete with Chinese firms elsewhere. India, a fast-growing market that remains closed to Chinese EV makers, has become more important.
But Honda's market share there has slumped to 1.3% from a peak of 7.3% more than a decade ago. Its portfolio has shrunk to four models and it is losing to affordable, feature-packed rivals like Tata Motors and Mahindra (MAHM.NS). It also has little to offer in the biggest and fastest-growing SUV segment.
"Honda is already late and behind competitors," one of the people said.
Honda President Toshihiro Mibe is under pressure to turn around the automaker, which recorded its first-ever annual loss in the last financial year.
In May, Mibe said that while India was a "key focus" for Honda, the automaker had not always been successful there.
"We need to rebuild the business on an entirely different footing," he said.
Previously, Honda adapted for India cars that were originally designed for Japan or other global markets. That resulted in it offering vehicles that were seen as over-engineered and pricey.
The first vehicle under development with Tata Technologies is a small SUV that is less than 4 metres (13.1 feet) in length, a segment that accounts for a large portion of India's car market and where Honda has limited presence. It is targeted for launch in 2028, two of the people said.
A second, mid-size SUV is expected to follow, with Honda later trying to revive its strength in sedans, one of them added.
In its statement, Honda said it planned to launch vehicles in India in the sub-4-metre category and the larger midsize category from 2028 onwards.
India is Honda's only major emerging market and it wants to make manufacturing and sourcing there more competitive.
If the first product under the deal is successful in terms of quality, sales and profitability, it will open opportunities for Honda to export from India, one of the people said.
TL;DR: The Nikkei 225 is closing in on a fresh record near 72,831.73, but unlike June’s rally—when USD/JPY ran alongside it to 163.97—a faster BoJ tightening cadence, a more patient Fed, credible intervention risk and the absence of a fresh oil shock mean USD/JPY is unlikely to follow through the 160 zone this time.
Why This Matters Japan’s equity rally is again approaching the point where the Nikkei’s strength and Yen weakness were closely linked earlier this year. But the comparison only goes so far. The equity breakout looks genuine, and the question that matters for traders isn’t whether the Nikkei can retest its record—it’s whether USD/JPY has to follow the same script it did in July. Four specific differences argue it doesn’t, at least not yet, and each one has a clear condition that would reverse it.
The Nikkei 225 surged 2.40% to 69,946.64 today, clearing the 69,608.24 August swing high and moving to within roughly 4% of the 72,831.73 record. When the Nikkei last set a record in June, USD/JPY was already above 161 and subsequently extended its advance to 163.97 in late July. This time, USD/JPY is still around 157.7, almost six yen below that peak.
Nikkei Breakout Has Real Momentum The Nikkei’s break above 69,608.24 strengthens the view that price action from 72,831.73 is merely a correction of the rise from 50,566.99, rather than the start of a larger downtrend.
As long as 68,132.16 support holds, the immediate bias stays higher. The next upside target is 71,885.52, the 100% projection of the 60,448.90–69,608.24 advance from 62,726.18. Above there sits the 72,831.73 record high. The chart therefore gives the Nikkei a credible path back to its record. What is much less clear is whether USD/JPY still needs to accompany it.
July’s Run to 163.97 Needed More Than a Rising Nikkei The last Nikkei record was followed by another leg higher in USD/JPY, but the Yen move was not simply a mechanical consequence of Japanese equity strength. By late July, several forces had aligned in the same direction.
The Fed had turned more hawkish, markets were pricing additional US tightening, Treasury yields were elevated and the Yen had spent enough time above 160 for investors to question where Tokyo’s intervention threshold actually stood.
Then oil supplied another impulse. Brent had been near 70 earlier in the summer before surging above 100 as Middle East risks intensified, following the collapse of the US-Iran ceasefire. That created a fresh inflation shock just as markets were debating how much further the Fed might have to tighten. USD/JPY eventually reached 163.97. That combination is important because the current setup looks different in each of those areas.
1. BoJ Tightening Is Arriving Faster The first difference is the BoJ cadence. The Bank of Japan raised rates in December, again in June and then in September. The interval shortened from roughly six months to around three months.
That does not mean every BoJ hike immediately strengthens the Yen. The June move was followed by USD/JPY rising further toward 164, while the Yen also weakened immediately after September’s increase. But the medium-term significance is different: the market can no longer comfortably assume that the BoJ will wait half a year between every move. A roughly quarterly cadence, if sustained, would allow Japanese rates to rise alongside US rates rather than simply watching the Fed move away. That distinction matters more than the immediate FX reaction to any single meeting.
The BoJ has not explicitly committed to that pace, and expectations for another October hike remain low. December is a more plausible window under the current market view. So the argument should not be that the BoJ is embarking on an aggressive tightening cycle. Rather, the Japan side of the rate differential is now moving faster than it was earlier this year.
2. The Fed Is Still Tightening, But at a More Patient Pace The second difference is the Fed. Markets have not abandoned the tightening cycle. The expected Fed funds midpoint is around 4.12% in December, 4.39% in March and 4.61% in June, before flattening around 4.65–4.70% later in 2027. That is still a hawkish rate path.
But it is a patient tightening path, not an assumption of rapid back-to-back hikes. October hike probability has fallen sharply, while the curve increasingly spreads additional tightening over subsequent meetings. That matters for USD/JPY because the policy gap is not obviously entering another period of rapid expansion.
The most revealing market comparison is elsewhere. US yields have recently traded above the levels seen around July’s USD/JPY peak, yet USD/JPY remains almost six yen beneath 163.97. That suggests the simple mapping between US yields and USD/JPY has weakened. Higher US rates still support Dollar against Yen. But the same yield environment is producing less Yen depreciation than it did in July, indicating that BoJ policy and intervention risk are now carrying greater weight on the Japan side of the equation.
3. Above 160, Intervention Risk Is No Longer Abstract The biggest change since July is not simply that Japan has intervened before. It is that 160 now carries the memory of a joint US-Japan operation, reinforced by persistently tougher official rhetoric since then.
Earlier in the summer, the market had become increasingly comfortable trading above 160. USD/JPY spent weeks above that threshold, and repeated warnings from Tokyo failed to trigger immediate action. That encouraged the view that officials were prepared to tolerate a materially weaker Yen, allowing speculative positioning to build as the pair pushed toward 163.97.
The end-July intervention changed that calculation decisively. The operation was not just another unilateral attempt by Japan to slow Yen weakness; US participation gave the move much greater signalling power. Even though the exchange-rate effect faded relatively quickly, the message was harder to dismiss: both sides were prepared to act when Yen depreciation became disorderly enough.
Since then, Japanese officials have also maintained a consistently tougher rhetorical stance, keeping intervention risk alive rather than allowing the warning to fade with time. That matters because traders are now approaching 160 with a very different risk-reward calculation. The level is no longer merely a psychological threshold or a place where verbal intervention might intensify. It is the zone around which coordinated action has already occurred.
That does not make 160 a hard cap. Intervention cannot permanently overpower monetary-policy fundamentals, and USD/JPY recovered much of its initial decline after the July operation. But it does mean that long positions above 160 now carry a known and credible tail risk that was far less respected during the previous run toward 164.
4. July Had an Oil Shock; Today Has High Oil Oil may be the most important difference. Brent is still expensive above $100, but the dynamic is very different from July. The crucial distinction is: high oil is a condition. Rising oil is a catalyst.
The July USD/JPY rally was reinforced by a rapid oil surge that changed the inflation outlook and encouraged markets to price a more aggressive or extended Fed cycle. Brent near 101 today does not deliver the same incremental shock. Markets already know energy prices are high.
For oil to recreate July’s transmission mechanism, it likely needs to re-accelerate through 109.97 and decisively above the 110 area, rather than simply remain around 100. That would revive the transmission chain: an oil shock would lift inflation expectations, encourage more aggressive Fed pricing and renew pressure on Yen. Until then, energy is providing a high inflation floor without the fresh momentum that helped drive USD/JPY toward 164.
What Could Put 164 Back Into Play? The argument against another immediate move to 164 is conditional, not absolute. The cleanest invalidation would be another oil shock. A decisive Brent break above 109.97–110, particularly if driven by renewed Middle East escalation, could force markets to reconsider the persistence of inflation and push the expected Fed rate plateau higher again.
A second trigger would be a renewed acceleration in Fed tightening expectations. The upcoming FOMC minutes are relevant here: evidence that officials are comfortable with an extended sequence of hikes into 2027 would reinforce the Dollar side of the equation.
The third would simply be price itself. A decisive USD/JPY break through the 159.73–160.38 resistance cluster would indicate that the decline from 163.97 has likely completed. That would put the 162.51 100% projection back into view and dramatically reduce the distance to 163.97. But until those conditions emerge, the July analogy looks incomplete.
ActionForex’s Technical View on the Nikkei 225 Nikkei’s immediate technical structure is bullish while 68,132.16 holds. The break above 69,608.24 resumes the rebound from 60,448.90 and points toward 71,885.52. A break there would put the 72,831.73 record high directly in focus.
The significance of 68,100–68,132 is especially strong because structural support coincides with the 61.8% retracement near 68,101. Holding that zone would keep the latest breakout intact even after a short-term pullback. A close back below 68,100 would weaken the breakout and shift attention toward the 55 D EMA at 65,862.82. For now, however, the chart favors another test of the record.
ActionForex’s Technical View on USD/JPY USD/JPY presents a much less straightforward bullish structure. The rebound from 152.87 stalled at 159.02, and subsequent trading has been consolidative rather than impulsive. Price is currently around 157.7 and pressing the 55 D EMA around 158.09. A fresh rise cannot be ruled out while 156.36 holds, but there is little open space above.
The resistance sequence is:
158.09 — 55 D EMA 159.02 — September swing high 159.73 — 61.8% retracement of 163.97–152.87 160.16 — 61.8% projection of 152.87–159.02 from 156.36 160.38 — structural resistance 160 area — intervention-risk zone
That cluster is the technical expression of the article’s macro thesis. A decisive break through 160.38 would be important: it would suggest the decline from 163.97 has completed and expose 162.51, the 100% projection level, followed by a potential retest of 163.97. But rejection from the zone would leave USD/JPY trapped well below the level reached during the previous Nikkei record run. Below 156.36, attention would return to 155.22, with a deeper break reopening the 152.87 low.
The Nikkei therefore has the clearer bullish chart. Japan’s equity market can retest 72,831 without USD/JPY returning to 164. For the Yen to recreate July, it likely needs more than another equity record—it needs a renewed oil shock, stronger Fed acceleration, or enough momentum to force its way through the intervention-heavy 160 zone.
Key Takeaways The Nikkei 225 surged 2.40% to a fresh high, closing within roughly 4% of its 72,831.73 record—but USD/JPY sits nearly six yen below where it traded during June’s record run. A faster BoJ hiking cadence (roughly quarterly versus the prior six-month gap) means Japan’s side of the rate differential is now moving faster than earlier this year. The Fed’s tightening path remains hawkish but more patient, and US yields above July’s peak are producing less Yen depreciation than before—suggesting BoJ policy and intervention risk now carry more weight. The end-July US-Japan coordinated intervention, plus sustained tougher rhetoric since, has made 160 a zone with known, credible tail risk rather than just a psychological level. Without a fresh oil shock (Brent decisively above 109.97–110) or a hawkish surprise from Fed policy or price action through 160.38, USD/JPY’s path back to 164 looks far less automatic than it did in July.
ActionForex
ActionForex.com was set up back in 2004 with the aim to provide insightful analysis to forex traders, serving the trading community for two decades. We started providing only a daily and a mid-day report, now known as Action Insights. Gradually, we added a lot more in-house contents to the site. Technical Outlook section was expanded to cover more pairs. In addition to that, Top Movers, Heat Map, Pivot Point Charts and Pivot Meters, Action Bias and Volatility Charts, are tools used by traders from all over the world.
Argenx má podporu Wall Street: 10 analytiků čeká během 12 měsíců růst akcie alespoň na 1 200 USD. V posledním čtvrtletí firma vykázala globální čisté tržby z produktů ve výši 1,5 miliardy USD, meziročně o 60 %.
With a market cap hovering near $60 billion, Argenx SE (ARGX -1.79%) is no longer a new kid on the block in the biopharmaceutical world. However, the drugmaker still has a long way to go before becoming one of the largest healthcare companies.
Quite a few people on Wall Street believe that Argenx will make some headway on that goal in the near future, though. While the biotech stock was priced at roughly $919 as of the market close on Friday, Oct. 2, 2026, 10 analysts predict that it's headed to at least $1,200 over the next 12 months.
Image source: Getty Images.
Wall Street's take on Argenx Two analysts are especially bullish about Argenx. Wells Fargo (WFC +0.25%) and UBS (UBS +0.29%) set 12-month price targets of $1,415 and $1,400, respectively, for the stock, reflecting potential gains of more than 50%.
Another two analysts are only slightly less upbeat. TD Cowen (TD +0.23%) thinks Argenx can climb to $1,353, while Citi (C +1.18%) expects the stock to rise to $1,301.
Six others also have price targets of between $1,200 and $1,300: Citizens JMP (CFG +0.99%), H.C. Wainwright, Jefferies (JEF +1.59%), Piper Sandler (PIPR -0.64%), Morgan Stanley (MS +1.22%), and Stifel Nicolaus (SF -0.09%).
Granted, some analysts aren't as enthusiastic about Argenx. Still, the average price target for the stock is around $1,182, which represents potential upside of roughly 29%. Of the 21 analysts who have rated Argenx in the past three months, all but one rated it a "buy." The sole outlier recommending holding the stock.
Premium Feature
Moneyball Superscore
88/100
Today's Change
(
-1.79
%) $
-16.79
Current Price
$
919.21
What's behind the optimism? It shouldn't be surprising that most analysts are optimistic about Argenx. The company delivered $1.5 billion in global product net sales in its latest quarter, up 60% year over year and 17% quarter over quarter.
Vyvgart and Vyvgart Hytrulo are driving Argenx's growth. Both drugs are approved in the U.S. for the treatment of generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), autoimmune diseases that affect different parts of the nervous system. Vyvgart is also approved in Japan for the treatment of primary immune thrombocytopenia (ITP).
More approvals for other autoimmune diseases could be on the way. In August 2026, Argenx announced positive results from a late-stage study evaluating Vyvgart Hytrulo for the treatment of adults with autoimmune myositis. The company expects to report data from two other late-stage studies next year, one targeting primary ITP and another targeting Sjogren's disease.
Argenx isn't a two-trick pony, though. Its pipeline also features empasiprubart, which is being evaluated in registrational clinical trials for the treatment of multifocal motor neuropathy (MMN) and CIDP. The company is testing adimanebart as a treatment for congenital myasthenic syndromes (CMS) and spinal muscular atrophy. Argenx recently completed its acquisition of Forte Biosciences, adding promising experimental autoimmune disease therapy FB102 to its quiver.
Wall Street overwhelmingly views Argenx stock as a great stock to buy right now. But are the majority of analysts right? I think so.
It's important not to ignore the potential challenges for the company, though. Argenx's success hinges on positive results from its multiple ongoing Phase 3 clinical studies. Any disappointments from those trials could cause the stock to decline. More than one clinical setback could send Argenx's shares spiraling downward.
Argenx also faces a headwind in China. Net product sales in the country plunged 62% year over year in the second quarter of 2026. Granted, China accounts for only a small percentage of Argenx's total revenue, but it remains an important long-term opportunity.
Whether or not Argenx's share price can soar 30% or more over the next 12 months, as many Wall Street analysts expect, remains to be seen. However, the risk-reward proposition for this biotech growth stock looks attractive.
On 29 September 2026, the Enterprise Chamber of the Court of Appeal in Amsterdam, the Netherlands (the Enterprise Chamber), rendered its judgment in the statutory squeeze-out proceedings initiated by Kodiak BidCo B.V., an indirectly wholly-owned subsidiary of Keurig Dr Pepper Inc. (KDP), to acquire any and all shares in the capital of JDE Peet’s B.V. (JDE Peet’s) not already held by KDP (the Shares).
The Enterprise Chamber ordered all remaining unknown JDE Peet’s shareholders to transfer the unencumbered right to their Shares to KDP. It determined that the public offer price of EUR 31.85 is the fair price per Share, subject to an increase by statutory interest calculated from 1 April 2026 until the date of transfer or consignment of the Shares pursuant to article 2:201a of the Dutch Civil Code. KDP was ordered to pay this fair price plus statutory interest in exchange for the transfer of the unencumbered right to the Shares.
Voluntary transfer
KDP calls upon all JDE Peet’s shareholders to effect the voluntary transfer to KDP of the unencumbered right to the Shares between now and 16 October 2026 at 15:00 CET, by instructing their bank, broker or other financial intermediary, to transfer their Shares electronically through the systems of Euroclear Nederland via MT 565 SWIFT or Easyway to KDP’s securities account. On 19 October 2026, KDP will pay the price of EUR 31.85 per Share, plus statutory interest from 1 April 2026 up to the date of transfer, to those JDE Peet’s shareholders that have voluntarily transferred their Shares before 16 October 2026, 15:00 CET. No brokerage or bank fees or other costs incurred by such JDE Peet’s shareholders will be reimbursed by KDP.
Transfer by operation of law
For all Shares not offered within the aforementioned voluntary transfer period, an amount per Share equal to EUR 31.85, plus statutory interest accrued from 1 April 2026 up to the date of consignment, will be paid by KDP into consignment with the Dutch consignment office (a body of the Dutch Ministry of Finance). Following the consignment, the unencumbered title to such Shares will transfer to KDP by operation of law, pursuant to article 2:201a paragraph 8 of the Dutch Civil Code. Any attachments (beslagen) or limited rights (beperkte rechten) resting on such Shares will, from that moment, rest on the consigned amount instead. KDP shall request Euroclear Nederland to apply the Euroclear Nederland consignment procedure. Pursuant to this procedure, Euroclear Nederland shall ensure the payment of the squeeze-out price plus interest to the remaining JDE Peet's shareholders.
Keurig Dr Pepper (Nasdaq: KDP) is a leading beverage company with more than 150 owned, licensed and partner brands that meet a wide range of needs and occasions. Our North American refreshment beverage business holds leadership positions across carbonated soft drinks, water, juice and mixers with a portfolio of iconic brands such as Dr Pepper®, Canada Dry®, Mott’s®, A&W®, Peñafiel®, GHOST®, 7UP®, Snapple®, Clamato® and Core Hydration®. Our global coffee business spans more than 100 markets and includes the leading Keurig® single-serve brewing system in the U.S. and Canada, along with powerhouse brands such as Peet’s, L’OR and Jacobs, and other regional coffee leaders. Our more than 50,000 employees aim to enhance the experience of every beverage and coffee occasion while making a positive impact for people, communities and the planet. Learn more at www.keurigdrpepper.com and follow us @KeurigDrPepper on LinkedIn and Instagram.
About JDE Peet’s
JDE Peet’s – now part of the KDP Group – is the world’s leading pure-play coffee company, with a presence in more than 100 markets. Guided by our ‘Reignite the Amazing’ strategy, we are focused on brand-led growth across three big bets: Peet’s, L’OR, and our 10 strategically selected local icons led by Jacobs. In 2025, JDE Peet’s generated total sales of EUR 9.9 billion and employed a global workforce of more than 21,000 employees. Discover more about our journey to deliver a coffee for every cup and a brand for every heart at www.jdepeets.com.
General restrictions
The distribution of this press release may, in some countries, be restricted by law or regulation. Accordingly, persons who come into possession of this document should inform themselves of and observe these restrictions. To the fullest extent permitted by applicable law, JDE Peet’s and KDP disclaim any responsibility or liability for the violation of any such restrictions by any person. Any failure to comply with these restrictions may constitute a violation of the securities laws of that jurisdiction. Neither KDP nor JDE Peet’s, nor any of their advisors, assumes any responsibility for any violation by any of these restrictions. Any JDE Peet’s shareholder who is in any doubt as to his or her position should consult an appropriate professional advisor without delay.
Hyperliquid, a decentralized perpetual futures exchange, has made its perpetual contracts available on the Bloomberg Terminal, according to a report from @coinbureau. This marks a significant step for Hyperliquid, integrating its market data into a major professional workstation. The exchange, built on its own layer-1 blockchain, supports over 100 assets and handles its operations via HyperCore. The inclusion on Bloomberg Terminal suggests increasing institutional interest and represents a potential shift in how traditional finance engages with decentralized platforms.
Advertisement
Market participants appear to view this development as supportive of scenarios where Hyperliquid’s market reach broadens, potentially influencing price predictions for the asset. Current market pricing on platforms like Polymarket suggests increased optimism about Hyperliquid’s ability to reach its price targets by the end of 2026. This optimism is reflected in the December 31 sub-market, which shows a 71.5% likelihood of Hyperliquid reaching $100, up from 68% just 24 hours ago.
Key Takeaways Hyperliquid’s integration with Bloomberg Terminal appears to enhance its visibility and accessibility to institutional investors. Market pricing suggests increased confidence in Hyperliquid meeting the $100 price target by the end of 2026, with current odds at 71.5% YES. The development may indicate a growing acceptance of decentralized platforms by traditional financial institutions. What to Watch The response from institutional investors and other exchanges could provide further indicators of Hyperliquid’s impact on the broader market. Monitoring Bloomberg’s future coverage and any potential strategic partnerships will be crucial. Additionally, any regulatory developments or changes in market sentiment could affect the outlook for Hyperliquid’s price trajectory as the year-end approaches.
Get live prediction-market analysis, powered by Vera. Sign up for Vera.
Term Structure
Contract Odds Δ since publish Volume 24h December 31 71.5% — — View market → January 1 2027 2.4% — — View market → January 1 2027 1.4% — — View market → January 1 2027 2.8% — — View market → January 1 2027 2.2% — — View market → January 1 2027 3.9% — — View market → January 1 2027 3.3% — — View market → January 1 2027 4.5% — — View market → January 1 2027 7% — — View market → January 1 2027 10.5% — — View market →
Pump.fun za 30 dní dosáhl výnosů 55,5 milionu USD a překonal Hyperliquid s 54,34 milionu USD. Objem obchodů PUMP vzrostl z asi 5 milionů USD denně v červenci na více než 40 milionů USD v říjnu.
Pump.fun’s revenue surge is reshaping the competition for protocol earnings, driven by renewed trading activity across its Solana launchpad. Over a 30-day time frame, Pump.fun earned $55.5 million, exceeding Hyperliquid’s $54.34 million, earning it third place in total earnings.
The large increase in revenue for Pump.fun will alter the competitive landscape of who receives earnings from protocols due to renewed levels of trading on all launchpads offered by Pump.fun on Solana.
This is important because Pump.fun [PUMP] earns money through rapid launching of tokens and their subsequent trading. On the other hand, Hyperliquid [HYPE] generates revenue through perpetual activity.
In addition, Pump.fun has shown upward momentum, generating $17.54 million over seven days. Therefore, this recent upward trend continues to be active.
Source: DeFiLlama Hyperliquid’s $11.19 million weekly revenue trails that pace, widening the short-term gap. As such, sustained memecoin trading may reinforce Pump.fun’s position relative to Hyperliquid and significantly increase PUMP’s economic relevance.
However, if the demand for trading declines rapidly, the order of the rankings will likely shift, and Hyperliquid would reclaim its spot.
Pump.fun’s trading volume surges Pump.fun’s trading volume went from approximately $5 million per day in July to over $40 million in October. Thus, it appears that demand is no longer limited to short-term or occasional spikes.
PUMP’s daily turnover was clearly rising in mid-August and accelerated into early September. This was as turnover frequently reached $30-$45 million per day and occasionally exceeded $60 million.
Why does this matter? Pump.fun generates revenue based on user activity such as launching, trading, and rotating through tokens. Thus, an increase in trading volume will expand pump.fun’s base of revenue-generating activities.
Source: X This trend also supports PUMP’s economic narrative. Sustained volume provides an additional foundation for continued revenue growth. However, a decline in volume would quickly reduce that support.
Whale accumulation strengthens PUMP Meanwhile, after an entire year with little to no movement, Netherlol made its comeback, purchasing 383.34 million PUMP valued at $2.4 million. Following this transaction, another wallet withdrew 189.22 million PUMP, valued at $1.18 million, from MEXC.
Together, these withdrawals remove a portion of the available tokens to be traded during periods when there has already been an increase in trading volume.
As long as these two whales hold onto the coins they have purchased or withdrawn, fewer tokens will be available to trade on exchanges. This can lead to tighter supplies of tokens, which will also allow buyers to have a greater impact on price movement.
Source: Arkham This will provide more substantial support to Pump.fun’s revenue, thus allowing for a stronger form of growth that is no longer solely dependent upon platform activity.
However, renewed deposits could reverse this effect, making whale movements important for confirming whether accumulation becomes a durable trend.
Final Summary Pump.fun leads Hyperliquid in 30-day revenue as volume and whale demand rise. PUMP could extend its lead if trading activity and whale accumulation persist.